Tun yaushe waɗannan alamun suke faruwa?
Wannan shine yadda za a bi da duk ciwon kirji, musamman a shekarunku.
Kuma, tare da zazzabi
Idan kana da jini mai kyau, za ka iya yin gwajin jini.
Kuma, shin kuna da zazzabi a yanzu?
Kuma, shin kuna da ciwon kirji a yanzu?
Kuma bãbu kõme a cikinku fãce wannan, wanda yake bã ku da wata wahala a cikin numfashi?
Kuma za ku iya gaya mini wasu alamun da kuke gani?
Kuma, yaya zafin zafinku ya kasance?
Kuma ina da ciwon ciki.
Ina da sanyi da kuma tari mai tsanani.
Kuma, ina da ciwon kirji a yau.
Shin wannan lokaci ne da za ku iya samun mura mai saurin ƙura?
Kuma, ciwon kirji yana zuwa
Kuma ina ganin ina da zazzabi mai tsanani.
Kuma, kuna buƙatar ku bayyana mini inda ciwon kirji yake faruwa.
Kuma suna da ɗan zazzabi.
Kuma, idan kana da tarihin ciwon sukari,
Kuma, kun san cewa zan ji kamar na yi rauni a ƙirjina.
Kuma, kamar yadda kuka sani, mutane suna tare da ni a kowane lokaci.
Kuma, kuna da ciwon kirji
Kuma, ka ce yana da matsa lamba a kirjinka
Ko akwai wani a cikin iyalin da ke da matsalar zuciya, cututtukan zuciya, bugun jini, yawan jini, da kuma hawan jini?
Shin kun lura cewa akwai wasu alamomi ko kuma matsaloli da ke tattare da ciwon tsoka?
Shin akwai wani a cikin iyalin da ke da cututtuka kamar naka?
Shin kana da wasu alamun cutar?
Shin kana jin kunyar numfashi?
Kana da ciwon kirji a yanzu?
Domin wannan lokacin ne na cutar sanyi.
Ba za a iya ajiye shi ba domin ciwon kirji na iya zama alamar ciwon zuciya
Amma yanzu akwai matsala mafi muhimmanci, wannan ciwon kirji ne.
Amma ina da wahalar numfashi fiye da numfashi.
Amma na san cewa mutane da yawa suna kusa da ni.
Amma duk wani ciwon kirji dole ne a kula da shi sosai.
Amma yanzu kuna numfashi sosai, dama?
Na manta da shi duka saboda wannan ciwon kirji.
Kana jin kamar wani yana matsa maka kirji?
Shin har yanzu kana jin cewa ba za ka iya numfashi ba?
Shin suna da alamun rashin lafiya iri ɗaya?
Shin kana fama da wata cuta mai tsanani kamar hawan jini ko kuma wani abu makamancin haka?
Shin kana da wasu cututtuka masu tsanani kamar ciwon sukari?
Shin kana fama da matsalar numfashi ko da yana ciwo a kirji?
Kana da hawan jini?
Shin hakan yana sa ka yi sanyin gwiwa?
Ka san alamun cutar da ta kamu da ita?
Shin kun ga wannan hoton?
Ka sha ruwa mai yawa a yau
Amma na yi gwajin ciwon sukari.
Amma, ta na da irin alamun da na samu.
Yaya za ka ji da zazzabi?
Yaya za ka ji game da hawan jini?
Idan ka ci gaba da samun zazzabi mai tsanani
Idan kana da zazzabi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi mai zafi.
Idan kana son ka lura da alamun ka ko kuma matsalolin ka,
Na yi rashin lafiya sosai.
Ina da zazzabi mai tsanani.
Na yi zazzabi a jiya.
A zuciyata akwai wani abu mai zafi a nan.
Ina da wahalar numfashi.
Zan aika muku da hoto.
Ina da ciwon kirji mai tsanani a yau.
Ina da ciwon kai da zazzabi a yau.
A ganina, wannan sanyi ne.
A ganina, wannan sanyi ne mai matsakaici.
Kana jin kamar wani yana zaune a kan kirji?
Dukkanin sun fara ne da ciwon kai da zazzabi a lokaci guda.
Na ji zafi sosai a tsakiyar ƙirjina
Yana da matsa lamba kamar ciwon kirji
Yana a cikin ƙirjina
Yana tsakiyar ƙirjina
Yana tsakiyar ƙirjina
Na ji zafi a ƙirjina
Ina matukar damuwa game da wannan ciwon kirji.
Ka gaya mini game da wannan ciwon kirji.
Idan ka yi tunani game da irin wannan yanayin, ka yi tunani game da yanayin da kake ciki.
daidai a tsakiyar ƙirjin
Yanzu zaka iya shan tachypyrina don zazzabi
Mary, tsawon lokacin da kake da waɗannan alamun?
Yanzu kun ce kuna da ciwon kirji
A wasu lokatai, ina samun ciwon kirji.
To, shin kuna da wasu alamun bayyanar cututtuka banda ciwo?
Ko kuma kamar wani yana zaune a kirjinka?
Haka yake da zazzabi da tari da ciwon kai da kuma ciwon tsoka.
daidai a tsakiyar ƙirjina
Ka nuna mini a wannan hoton inda kake jin zafi.
Idan kana da zazzabi,
Shin kuna ganin wadannan alamun suna da alaƙa da daukar ciki?
Shin yaranku suna da irin wannan cuta?
Ka gaya mini game da ciwon kirjinka.
A cikin dare, zazzabin zai iya ƙara yawan zazzabi
Na yi fama da zazzabi na kwanaki biyu da suka shige.
A daren jiya, zazzabin ya soma ƙaruwa.
Wannan shi ne Dr. Porter daga gaggawa dakin
Za ka iya gaya mini ƙarin bayani game da ciwon kirjinka?
A gaban jikina, a nan a kirji na na ji zafi.
Na ji zafi sosai a ƙirjina.
Lokacin da na ji zafi a kirji
Wane irin ciwo ne kake ji a kirji?
A wane lokaci ne wannan ciwon ya soma?
A ina kake jin zafi a kirji?
A wace sassa na ƙirjinki kuke jin wannan ciwon?
Kana jin cewa ka yi taurin kai a kirjinka
Kuma kun san cewa ina da ciwon sukari.
Ka ce kana da wannan ciwon kirji.
Daga 1 ga Janairu zuwa 15 ga Maris, 2020, an yi nazarin abubuwan da suka biyo bayan karuwar cutar coronavirus (COVID-19) a cikin EU/Yankin Tattalin Arziki na Turai da kuma a cikin United Kingdom.
Ta hanyar nuna irin wannan yanayin a cikin EU/Yarjejeniyar Tattalin Arziki ta Turai da kuma a cikin United Kingdom, ciwon COVID-19 wanda ke da nau'i daban-daban na yaduwar cutar (COVID-19) ya tabbatar da cewa cutar ta COVID-19 tana ci gaba da sauri a duk ƙasashe.
Bisa ga gogewar da aka samu daga Italiya, dole ne kasashe, asibitoci da cibiyoyin gaggawa su kara shirye-shirye don karuwar adadin marasa lafiya da suka kamu da COVID-19 da ke bukatar kulawa ta musamman.
A ranar 31 ga watan Disamba na shekarar 2019, an samu rahoton mutane da dama da suka kamu da cutar pneumonia wadda ba a san dalilin da ya sa ta faru ba a Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta bayyana cewa, a halin yanzu, sabon nau'in cutar coronavirus da ake kira SARS-CoV-2 shine alamar rashin lafiyar numfashi mai tsanani.
Saboda haka, an sanya sunan SARS-CoV-2 (COVID-19) don rashin lafiyar da ke haifar da kamuwa da cutar.
A cewar shaidun da aka samu zuwa yau, kusan kashi 80 cikin dari na mutanen da suka kamu da COVID-19 sun kamu da cututtuka masu matsakaici, wato, cututtukan numfashi masu dauke da cutar pneumonia ko babu su, kuma mafi yawansu sun warke.
A cikin kusan kashi 14 cikin 100 na mutanen da suka kamu da cutar, COVID-19 ya zama wani mummunan cuta wanda dole ne a yi musu asibiti, yayin da sauran kashi 6 cikin 100 ke fuskantar mummunan rashin lafiya wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke asibiti da COVID-19 kusan kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin COVID-19 a cikin kowace ƙasa ta EU/Yankin Tattalin Arziki na Turai da kuma a cikin United Kingdom, kuma mun kwatanta su da lardin Hubei na China.
Muna kwatanta yawan mutanen da suka kamu da COVID-19 a cikin EU/Yankin Tattalin Arzikin Turai da kuma a cikin United Kingdom da na yanzu a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
An samu kamuwa da COVID-19 a cikin EU/Yankin Tattalin Arzikin Turai da kuma a cikin United Kingdom.
Bayan China, COVID-19 ya ci gaba da yaduwa a wurare daban-daban, kuma yanayin annobar COVID-19 a sauran sassan duniya ya kasance a baya da na yanzu.
A ranar 11 ga watan Maris na shekarar 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 a matsayin annoba.
A cikin mujallar EuroServance na 5 ga Maris, 2020, Spiteri da sauransu sun ba da rahoton farkon tabbatar da COVID-19 a Turai bisa ga ma'anar Hukumar Lafiya ta Duniya (WHO).
A cikin EU/Yankin Tattalin Arziki na Turai, manyan mutane uku da suka kamu da cutar sun dawo Faransa daga Wuhan, lardin Hubei, China, a ranar 24 ga Janairu, 2020.
A ranar 15 ga Maris, 2020, an gano kamuwa da COVID-19 a cikin ƙasashe 30 na EU/Yankin Tattalin Arzikin Turai da kuma a cikin United Kingdom. Saboda haka, a tsakanin 31 ga Disamba, 2019, an samu kamuwa da cutar 39,768 da mutuwar 1,727 a cikin wannan kwanan wata, daga cikinsu, a Italiya kadai, adadin kamuwa da cutar ya kai 17,750 da mutuwar 1,441.
Ana samun bayanan bayanan bayanan da suka biyo baya game da cutar COVID-19.
A Cibiyar Tarayya ta Turai don Rigakafin Cututtuka da Kula da Cututtuka (ECTC), a duk duniya, ana sabunta bayanan da aka samu game da lambobin da aka sanar game da COVID-19 daga ma'aikatar lafiya ta kowace ƙasa, daga hukumomin lafiya na ƙasa da ƙasa da na yanki da kuma Hukumar Lafiya ta Duniya a kowace rana a karfe 8 na safe.
An yi amfani da wannan bayanan ne don tantance yanayin COVID-19 a cikin EU/Economics da United Kingdom da kuma kwatanta su da yanayin da ke faruwa a Italiya.
A cikin martani ga yankin da ke da cutar COVID-19 a halin yanzu, mun lissafa jimlar lokutan 14 na mutane da suka kamu da COVID-19 cikin sauri, don haka a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020, mun yi la'akari da yanayin COVID-19 a cikin kowace EU/Yankin Tattalin Arzikin Turai da kuma a cikin United Kingdom.
Mun kuma samar da adadin wadanda suka kamu da cutar a kowace kasa, a lokacin da aka kwatanta da Italiya, a lokacin da aka samu a lokacin da aka samu a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a lokacin da aka yi amfani da shi a cikin kasar.
Yanayin COVID-19 a cikin EU/Yankin Tattalin Arziki na Turai da kuma United Kingdom.
A cikin EU/Yankin Tattalin Arziki na Turai da kuma a cikin United Kingdom, yanayin yanayin yanayin COVID-19 na kwanaki 14 na sauri ya bi yanayin lardin Hubei (China) (Figure 1).
A ranar 21 ga Fabrairu ne aka fara samun karuwar COVID-19 a fadin EU/Yankin Tattalin Arzikin Turai da kuma Burtaniya, kuma an kara samun karuwar ta a ranar 28 ga Fabrairu, 2020 (subject).
Wannan ya samo asali ne daga saurin karuwar yawan wadanda suka kamu da cutar a Italiya, amma duk sauran kasashen EU/Yankin Tattalin Arzikin Turai da kuma United Kingdom sun nuna irin wannan karuwar yanayin a cikin abubuwan da suka biyo bayan COVID-19 (subject).
Hoton 2 ya nuna jimlar adadin mutanen da suka kamu da COVID-19 a lokacin da aka kwatanta da kasashen EU/Yankin Tattalin Arzikin Turai da Italiya a lokacin 31 ga Janairu - 15 ga Maris, 2020.
A ranar 15 ga Maris, da misalin karfe 8 na safe, sauran kasashe 15 na EU/EEA da kuma United Kingdom sun riga sun yi rajistar adadin wadanda suka kamu da cutar a Italiya, makonni 3 a gaba ko kuma kafin hakan.
Sakamakonmu ya nuna cewa adadin mutanen da suka kamu da COVID-19 da aka sanar suna ƙaruwa cikin sauri a cikin EU/Yankin Tattalin Arziki na Turai da kuma a cikin United Kingdom.
Idan aka duba yanayin yanayin COVID-19 gaba ɗaya, cutar ta bayyana cewa cutar ta ci gaba da sauri a duk ƙasashe.
Wannan ya faru ne duk da cewa, a cikin ƙasashe daban-daban, ana amfani da ma'auni daban-daban na kamuwa da cutar, da kuma hanzari don zaɓar marasa lafiya don gudanar da gwajin tabbatar da COVID-19, duk da cewa akwai bambancin tsarin kula da lafiyar jama'a a cikin ƙasa.
A farkon watan Maris na shekarar 2020, likitoci daga yankunan da ke fama da cutar a Italiya sun ce kusan kashi 10 cikin 100 na marasa lafiya da ke fama da cutar COVID-19 suna bukatar gaggawa.
Bayanai game da COVID-19 da aka kwantar a asibiti da/ko a cikin dakin gaggawa a halin yanzu suna samuwa a matsayin kashi 6% da 1% a matakin EU/Yankin Tattalin Arziki na Turai (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su cikin tsari don tallafawa bayanan sa ido na yanzu wanda ke mai da hankali kan yawan kamuwa da cutar da mutuwar da aka yi rikodin.
Wani bincike da aka gudanar a shekara ta 2010-11 ya nuna cewa akwai bambanci sosai tsakanin wuraren da ake yin jinya a Turai, wato, a Jamus, yawansa 29.2 ne ga mutane 100,000, a kuma a Portugal, yawanci 4.2 ne.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu fiye da Italiya (da 12.5 ICU da matsakaiciyar kulawa a kowace 100,000 a 2010-2011).
A cikin yanayin samfurori masu alaƙa da yanayin ƙwaƙwalwar kulawa, an ba da sabuntawa na shida game da saurin COVID-19 na ECTC ga kowane EU/Yankin Tattalin Arzikin Turai da United Kingdom, inda aka kiyasta cewa yawan marasa lafiya yana da haɗari sama da 90% na ƙaruwa fiye da yawan gado a cikin wuraren kulawa masu tsanani.
A yanzu haka, an kafa kungiyoyin kamuwa da cuta a cikin ƙasashen EU/Yankin Tattalin Arziki na Turai da kuma wasu yankunan United Kingdom. Kuma kamar yadda asibitoci da wuraren kulawa da gaggawa suka saba yi wa yawan jama'ar yankin, dole ne a samar da bayanai game da kamuwa da cuta da kuma wuraren kula da gaggawa a cikin tsarin tsarin 2 (Nuts-2) don samun bayanai game da iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar iyakar
Kwarewar Italiya da kuma abubuwan da ke faruwa a sauran ƙasashe sun nuna cewa cutar COVID-19 tana ci gaba da sauri a cikin EU/Yankin Tattalin Arziki na Turai da kuma United Kingdom.
Kasashe, asibitoci da cibiyoyin gaggawa, suna bukatar su shirya kansu don yanayin da ake fama da cutar SARS-CoV-2 da kuma yawan mutanen da suka kamu da cutar COVID-19, da kuma yanayin da ake buƙatar kulawa da lafiya, musamman ma a cikin gaggawa.
Kamar yadda ECTC ta bayyana a cikin sabon kimantawar hadarin gaggawa, sauya tsarin kulawa daga na hanawa, da kuma daukar mataki mai karfi da dukkan matakan da za su iya kawo karshen yaduwar SARS-CoV-2 yana da mahimmanci, idan ba a aiwatar da shi a farkon lokaci ba, saurin karuwa da ake tsammani a cikin adadin masu kamuwa da cutar zai ba masu yanke shawara da asibitoci lokaci don fahimtar halin da ake ciki, karɓa, daidaitawa da kuma daukar matakan da suka dace don amsawa.
Saurin kimanta haɗari yana lissafin matakan kiwon lafiya na jama'a da kuma rage tasirin cutar.
Akwai karamin taga na dama, wanda zai iya amfani da shi don ƙasashe su rage yaduwar SARS-CoV-2, rage rikicin da ke tattare da masana'antar kiwon lafiya, da kuma kara kokarin hana cutar.
Idan ba a yi haka ba, a cikin kwanaki ko makonni masu zuwa, za a iya fuskantar ci gaban da ke tattare da yawan marasa lafiya da ke bukatar kulawa mai tsanani a cikin ƙasashen da suka gaji da EU/Yankin Tattalin Arzikin Turai.
2019 Cutar coronavirus (COVID-19), cuta mai tsanani ta rashin numfashi (SARS) cuta mai tsanani ta coronavirus 2 (SARS-CoV-2) - ta kashe mutane 3,000 a China da sauran sassan duniya, ta shafi mutane 80,000, kuma ta haifar da bala'i ga mutane.
Kamar SARS-CoV, wanda ya haifar da SARS-CoV-2 a shekara ta 2003, wanda yake da tsarin tsarin iri ɗaya, SARS-CoV-2 na iya yadawa daga kwayar cutar, kuma yana iya haifar da alamun cutar iri ɗaya a cikin irin wannan aikin.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwar fiye da SARS, amma yana da ƙarancin yaduwa kuma yana shafar maza fiye da matasa da tsofaffi da mata fiye da matasa.
Don amsa yawan wallafe-wallafen da ke faruwa game da cutar, wannan labarin yana ƙoƙarin samar da cikakken lokaci da cikakkiyar fahimta game da batun binciken da ke faruwa cikin sauri.
Za mu bincika abubuwan da suka shafi cututtukan cututtuka, yadda cututtuka suka samo asali, ilimin halittu, ganewa, magani, warkarwa, da kuma hana cutar.
Ko da yake akwai tambayoyi da yawa da ake bukatar amsawa a yanzu, muna fatan wannan bincike zai taimaka mana mu fahimci cutar da ke barazana kuma mu kawar da ita.
Bikin bazara na 25 ga Janairu, 2020, wanda aka tilasta wa duk Sinawa su kasance a gida har tsawon makonni na hutu saboda yaduwar sabon cutar, ya zama abin tunawa da ba a taɓa mantawa da shi ba.
Wannan kwayar cutar tana da halaye iri ɗaya da cutar coronavirus (CoV) wanda ya haifar da yaduwar cutar ta SARS a shekara ta 2003, don haka, an sake masa suna SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020.
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma da sauri ta bazu zuwa kusan kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, adadin mutanen da suka kamu da cutar COVID-19 ya kai 80,000, wanda ya hada da mutane 40,000 da aka kwantar da daga asibiti kuma sama da mutane 3,000 sun mutu.
"Kungiyar lafiya ta duniya (WHO) ta ce COVID-19 ita ce "abokin gaba na farko", kuma ta ce ta fi ta'addanci ƙarfi".
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu bayan fitowar rahoton farko na gano kwayoyin halitta daga marasa lafiya daban-daban a ranar 7 ga Janairu, 2020, an buga fiye da 200 takardun bincike game da ilimin kwayoyin halitta, cututtukan cututtuka, asalin cututtuka, ganewar asali da magani game da COVID-19.
Wannan bincike na iya taƙaita ci gaban bincike game da sabon abu da ke ci gaba da sauri.
A duk lokacin da zai yiwu, muna gwada COVID-19 da SARS da sauran cututtukan da ke haifar da cutar coronavirus, da kuma cututtukan da ke haifar da cutar ta Middle East (wanda ya barke a shekara ta 2012).
Za mu tattauna abin da muka koya game da rigakafin cutar da kuma tasirin cutar, da kuma sauran tambayoyi masu gaggawa.
Tun da kusan kashi 15 cikin 100 na kowa suna haifar da sanyi, an yi imani da cewa kwayar cutar ta zama cutar da ba ta haifar da mutuwa ga mutane.
Duk da haka, a wannan karni, mun fuskanci cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Saboda haka, COVID-19 na yanzu shine yaduwar cutar ta uku a tarihin ɗan adam.
A ranar 31 ga watan Disamba na shekarar 2019, an sanar da Hukumar Lafiya ta Kasa ta kasar Sin daga Wuhan cewa cutar ta shafi wasu kungiyoyin mutane da ba a san asalin cutar ba, kamar yadda aka nuna a hoto na 1.1.
Bayan kwana bakwai, an bayyana jerin sunayen COVID-19.
A ranar 15 ga Janairu, 2020, an yi rahoton mutuwar farko a Wuhan.
A halin yanzu, cutar ta bazu cikin sauri zuwa sauran birane da larduna da ke kusa da ita.
A ranar 20 ga watan Janairu, an samu rahoto game da kamuwa da cutar a tsakanin masu ba da kula da lafiya, wanda ya nuna yiwuwar kamuwa da cutar daga mutane zuwa mutane.
A ranar 23 ga Janairu, birnin Wuhan ya rufe gaba daya, kuma duk hanyoyin sufuri na jama'a sun tsaya.
A ranar 24 ga watan Janairu, binciken farko na asibiti ya nuna cewa daga cikin marasa lafiya 41 da suka kamu da cutar, 21 ne kawai suka yi hulɗa da kasuwar abincin teku ta Wuhan, wanda ake ganin ita ce tushen da cutar ta fara yaduwa daga dabbobi da ba a tabbatar da su ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya (WHO) ta ayyana dokar ta baci ta duniya.
A lokacin da aka wallafa wannan rahoton, cutar ta riga ta bazu zuwa kusan ƙasashe 50 a China da kuma duniya (Figure 2) 2.
Yayin da yanayin ya canza, har yanzu ba a tabbatar da matakin da kuma tsanani na yaduwar ba.
A cikin binciken da aka gudanar a kan mutane 8,866 da suka kamu da cutar COVID-19 a cikin wani babban bincike, wanda ya hada da mutane 4,021 da suka kamu da cutar COVID-19 a ranar 11 ga Fabrairu, 2020, an gano karin misalan da ke dauke da sabon bayani game da cutar ta COVID-19 kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na iya kamuwa da mutane na kowane zamani, amma mafi yawan wadanda suka kamu da cutar suna tsakanin shekaru 30 zuwa 65.
Kusan rabin masu kamuwa da cutar (47.7%) sun fi shekaru 50, kuma kaɗan ne kawai ke ƙasa da shekaru 20, kuma kawai 14 daga cikin waɗanda suka kamu da cutar sun fi shekaru 10 shekaru.
SARS-CoV-2 ya fi kamuwa da maza (0.27/100,000) fiye da mata (0.31/100,000).
COVID-19 ya bazu ne a cikin jama'a a Hubei da kewaye da shi.
A matsakaita, ya ɗauki kwanaki 5 (2-9) kafin a gano cutar tun lokacin da COVID-19 ya fara.
Matsakaicin lokacin da ake nuna alamun cutar shi ne kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga kamuwa da cutar zuwa mutuwa shine kwanaki 9.5 (4.8 - 13).
Ƙididdigar asali (R.0) ta kasance 3.77 (95% CI: 3.51-4.05) kuma an sake tsara R.0, 2.23-4.82.
A cikin kasar Sin, yawan mutanen da suka kamu da cutar ya karu da sauri kafin 23 ga Janairu, 2020, daidai da yawan zirga-zirgar da ta gabata kafin bikin bazara.
Yawan mutuwar da aka samu tsakanin marasa lafiya da aka tabbatar da shi ya kasance 1.44% (95% CI: 1.10-1.86%) kuma an samu allurar rigakafin da aka yi wa dukkan marasa lafiya a 3.06% (95% CI: 2.02-4.59%).
Gender (maza), shekaru (60 da sama da haka) da kuma matsanancin cutar huhu sune manyan abubuwan haɗari guda uku na COVID-19.
Kwayar cutar Corona tana cikin manyan kwayoyin cuta masu ƙonewa, waɗanda ke cikin ƙananan dangin kwayoyin cuta na RNA (RNA).
Ana iya rarraba su zuwa nau'i hudu, wato alpha, beta, gamma, da delta. An gano cewa alpha- (alpha-) da beta-CoV (beta-CoV) suna iya kamuwa da mutane.
A cikin yanayin yanayi, spike (S) glyco protein yana ɗaure da ƙwayoyinsa masu karɓar ƙwayoyin cuta, antiadenin-transforming enzyme 2 (ACE2) da tipeptide peptide 4 (TPB4) don SARS-CoV da MERS-CoV, bi da bi, wanda ke haifar da haɗin membrane.
A cikin kwayoyin cutar, an saki RNA (RNA) a cikin ƙwayar cuta; bayan an kwafe kwayoyin cutar, an samar da kwayar halitta mai girma da ke dauke da kwayoyin halitta (RNA) wanda ke dauke da glycoprotein da kuma kwayar halitta mai gina jiki, wanda zai iya haɗuwa da sinadarin kuma ya bayyana cutar.
An yi rikodin farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 (SARS-CoV-2) an gano shi ne sabon nau'in beta-CoV (beta-CoV) wanda ke da fiye da kashi 99.98% na kwayoyin halitta tsakanin samfurin 10 da aka tattara a kasuwar abincin teku ta Huanan a Wuhan, inda cutar ta fara.
SARS-CoV-2 ya bambanta da SARS-CoV-2 a cikin kwayoyin halitta fiye da MERS-CoV.
Ta hanyar microscope mai watsawa, an gano kwayoyin SARS-CoV-2 a cikin m membrane na iska mai iska na mutum.
An gano cewa mutum yana da amfani da ACE2, SARS-CoV-2 da SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 yana da rauni sosai wajen ɗaurewa da ACE2 na mutane fiye da SARS-CoV-2 wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da rashin lafiya mai tsanani a cikin marasa lafiya fiye da SARS-CoV-2.
SARS-CoV-2 zai iya samar da wani karamin furotin da aka yi wa ORPH3B ko kuma wani furotin mai karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin karamin
SARS-CoV-2 na iya yin tasiri a cikin cutarwa na ORF.3.B na SARS-CoV-2 wanda zai iya hana bayyanar IFNbeta; duk da haka, ORF8 ba shi da sanannen aiki ko ma'auni.
A ranar 18 ga Fabrairu, 2020, Jow da sauransu, tare da amino acid Nampa B.0.AT.1. sun yi rikodin tsarin microwave na cikakken tsawon mutum ACE2 a cikin 2.9 Å fission.
An haɗa haɗin haɗin buɗewa da rufewa a cikin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin
Za a iya amfani da maganin B0.AT1 (B0AT1) don lura da cutar SARS-CoV-2 don kashe cutar.
Farawa da kuma tsakiyar span bearings
An san cewa SARS-CoV da MERS-CoV sun fito ne daga kwayar cutar kuma an watsa su zuwa mutane ta hanyar cats da raƙuma masu haihuwa, bi da bi.
Ta hanyar kwatanta wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
Amma, har yanzu ba a san abin da ya hana cutar ta yaduwa cikin mutane ba, kuma ba a san yadda za ta yadu ba.
Ji da wasu sun yi hasashen cewa wannan cuta ta iya yaduwa daga wando zuwa mutum ta hanyar maciji ta hanyar daidaitaccen tsarin S na su.
A cewar wani bincike, masu bincike a Guangzhou, China, sun nuna cewa karfe masu cin naman kaza da kuma tsalle-tsalle masu cin naman kaza da aka fi amfani da su a cikin maganin gargajiya na kasar Sin, karfe masu cin naman kaza ne suka iya kamuwa da SARS-CoV-2 saboda cutar coronavirus da aka gano a cikin karfe da kuma SARS-CoV-2 sun yi kama da juna a kashi 99 cikin dari.
Amma, bambancin kashi 1 cikin 100 da ke tsakanin kwayoyin halitta biyu ya kasance bambanci mai girma, kuma muna jiran tabbataccen sakamako don tabbataccen tushe (Fig. 33).
Har yanzu ba a san abubuwa da yawa game da sunadarai na jiki na SARS-CoV-2 ba.
SARS-CoV) da MERS-CoV suna iya kai hari a cikin yanayin bushewa na waje har tsawon awanni 48 da kwanaki 5 a yanayin 20 °C da 40%-50% zafi.
SARS-CoV-2 na iya samun irin wannan hali.
An bayar da rahoton cewa SARS-CoV-2 (SARS-CoV-2) yana da tasiri ga UV da kuma kasancewa a 56 °C a kowane minti 30; 75% ethanol, chlorine-containing disinfectants, paracidic acid, chloropharm, da sauran fatty solvents na iya kashe cutar ta hanyar ƙuƙwalwa, amma chlorhexidine ba ya aiki haka.
Dukan 'yan Adam ba su da kariya ga SARS-CoV-2 kuma suna da saukin kamuwa da cutar.
A halin yanzu, babu wani cikakken bincike game da tasirin rigakafi game da SARS-CoV-2.
Saboda haka, za mu iya yin la'akari da binciken da aka yi a baya game da sauran cututtukan corona, musamman SARS-CoV da MERS-CoV (Fig. 4).
A yadda aka saba, idan mutum ya kamu da cutar, tsarin garkuwar mutum zai fara gano shi ta hanyar masu karɓar bayyanar cututtuka (PRRs), ciki har da masu karɓar C-type lectin, masu karɓar kamar DOL (DLR), masu karɓar NOL (NOLR), da masu karɓar RIG (RLR).
Kwayar cutar tana haifar da bayyanar cututtuka, tsufa na ƙwayoyin cuta, da kuma samar da kwayar cutar ta hanyar samar da furotin mai hana rigakafi na farko (IFNs), wanda ke iyakance yaduwar kwayar cutar da kuma kara yadda kwayar cutar ke cinyewa ta hanyar hallaka kwayoyin cutar a cikin jini.
Duk da haka, furotin na SARS-CoV na iya taimaka wa kwayar cutar ta tsere daga amsawar rigakafi.
Nan gaba, rigakafin da ke canzawa zai shiga cikin yaki da cutar.
D-hydrocarbons, ciki har da CD4+ da CD8+ suna taka muhimmiyar rawa wajen kare kai.
Ct.4+ T ƙwayoyin cuta suna motsa B ƙwayoyin cuta kuma suna samar da wasu ƙwayoyin cuta da ke hana cutar.
Don taimaka wa ƙwayoyin da ke kare kansa, ƙwayoyin T-helper suna samar da cytoskeleton mai kyau don ciwon daji.
Koyaya, cutar ta iya haifar da mutuwar kansa ta hanyar hana aikin kwayoyin cuta.
Don magance cutar, ana buƙatar rigakafi da sauran magungunan rigakafi, gami da kayan aiki kamar C.3.A da C5.A.
Alal misali, wasu kwayoyin cutar da aka samu daga marasa lafiya da suka warke sun hana su amfani da MERS-KV.
A gefe guda, tsarin rigakafi zai iya fitar da ƙwayoyin cuta masu yawa a yankin saboda yawan aiki, wanda zai haifar da mummunan lalacewa ga huhu da sauran ƙwayoyin cuta, kuma zai iya haifar da aiki da mutuwa ga wasu gabobin jiki a cikin mummunan yanayi.
SARS-CoV-2 (SARS-CoV-2) cutar ta iya shafar tsofaffi da mata masu juna biyu da ke da cututtuka biyu, saboda abubuwan da ke cikin rukunin farko.
Mutane da ke da ƙwayoyin cuta da yawa ko kuma waɗanda ke da ƙwayoyin rigakafi masu daidaitawa suna da mafi yawan haɗarin kamuwa da cutar fiye da sauran mutane.
SARS-CoV-2 (SARS-CoV-2) a cikin wani bincike da aka gudanar a Wuhan, an kiyasta cewa mafi karancin lokaci na bayyanar cututtuka shine kwanaki 1-14 kuma mafi yawan kwanaki 3-7.
Duk da haka, a cikin binciken da aka gudanar a kan mutane 1,099 da suka kamu da cutar, an nuna cewa a matsakaita, tsawon lokacin bayyanar cututtuka ya kai kwanaki 3 kuma zai iya kasancewa daga kwana 0 zuwa 24.
A cikin wani binciken da aka yi kwanan nan, an tabbatar da cewa a cikin yawan mutane 8,866 da aka bayyana a sama, lokacin bayyanar cututtuka ya kasance kwanaki 4.8 (3.0-7.2).
Abu mafi mahimmanci da jami'an lafiya zasu yi shi ne daidaita lokacin keɓewa mai amfani dangane da lokacin bayyanar cututtuka, don haka mutane da suka kamu da cutar amma ba su da alamun cutar za su iya guje wa yada cutar ga wasu.
A cikin al'ada, ana buƙatar keɓewa na kwanaki 14 ga waɗanda suka kamu da cutar ko kuma waɗanda suka kamu da cutar.
Shin za a kara tsawon kwanaki 24 a cikin zaman killace?
Babban alamar COVID-19 ita ce zazzabi, wanda zai iya kasancewa ba tare da alamun bayyanar cututtuka ba ko kuma yana iya kasancewa tare da bayyanar cututtuka kamar tari, numfashi, ciwon jiki, rashin hankali, ciwon kai, ƙonawa a wuyan, hanci, ciwon kirji, ciwon ciki, kumburi da kuma kumburi.
Wasu marasa lafiya sun sami numfashi da/ko jini a cikin mako guda bayan kamuwa da cutar.
A cikin matsanancin yanayi, marasa lafiya sun sami bayyanar cututtuka na rashin jin daɗi, tashin hankali, acidity na jiki da kuma karuwar jini.
Dole ne a gwada marasa lafiya da ke da zazzabi da/ko rashin lafiyar numfashi da kuma matsanancin zazzabi a lokacin gwajin farko na ganewar asali, koda kuwa ba su da cututtukan huhu.
Wani binciken da aka gudanar a ƙarshen Disamba na 2019 ya nuna cewa yawan cututtukan sun kasance 98% na zazzabi, 76% na tari, 55% na numfashi, 3% na ciki; 8% na marasa lafiya suna buƙatar goyon bayan iska.
Akwai binciken da aka yi a cikin wasu bincike guda biyu da suka yi da suka nuna cewa an kamu da cutar daga wani rukuni na iyali da kuma wani rukuni na mutum wanda ba shi da alamun cutar.
A wani bincike na 2012 da aka gudanar, an gano cewa masu dauke da cutar MERS-CoV sun kamu da cutar da zazzabi (98%), tari (47%) da kuma numfashi (55%).
Amma, kamar yadda cutar ta cutar ta cutar ta COVID-19 ta fi mutuwar mutane, kashi 80 cikin dari na marasa lafiya na cutar na COVID-19 na bukatar samun iska fiye da marasa lafiya.
An kuma gano ciwon ciki (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, cututtuka masu mahimmanci sune tari (99-100), tari (29%-75%), numfashi (40%-42%), ciwon ciki (20-25%), da kuma ƙonawa (13-25%).
A ranar 14 ga Fabrairu, adadin masu kamuwa da cutar a duniya ya kai 66,576, yayin da adadin mutuwar COVID-19 ya kai kashi 2%.
A cikin kwatancen, mutuwar SARS ta kasance 10% na 8,096 da aka kamu da ita a watan Nuwamba 2002.
A cikin binciken da aka gudanar a watan Yuni na shekarar 2012, an samu kashi 37 cikin dari na mutane 2,494 da suka kamu da cutar.
A cikin binciken da aka yi a baya, an gano cewa SARS-CoV-2 yana da R.0, 6.47 a sama da 5.71-7.23 tare da 95% amintaccen matsakaici (CI), kuma SARS-CoV-2 yana da R.0, 2 zuwa 4.
Ana nuna kwatancen a cikin Table 1.1 game da alamun cutar SARS-CoV-2 da MERS-CoV da kuma SARS-CoV, da yawan mutuwa da kuma R.0.
Ƙididdigar da aka nuna a sama ta nuna cewa akwai karin yaduwar cutar SARS-CoV-2 fiye da cutar MERS-CoV da SARS-CoV, amma na baya zai haifar da ƙananan mutuwar fiye da sauran biyu.
Saboda haka, yana da matukar wuya a sarrafa cutar SARS-CoV-2 fiye da cutar MERS-CoV da SARS-CoV.
A wasu lokatai, ana iya samun kamuwa da cutar a cikin iyali ɗaya ko kuma a cikin taro ɗaya ko a cikin motoci kamar jiragen ruwa masu daraja.
Yawancin lokaci, marasa lafiya suna da bayanan cutar kamar tafiya zuwa Wuhan ko wasu yankunan da suka kamu ko kuma zama a can, ko kuma saduwa da mutane ko marasa lafiya da suka kamu da cutar makonni biyu kafin yaduwar cutar.
Duk da haka, an bayar da rahoton cewa mutane na iya ɗaukar cutar ba tare da alamun bayyanar cututtuka ba har tsawon makonni biyu, kuma waɗanda aka sake dawowa daga asibiti suna iya sake ɗaukar cutar, wanda ke aika da gargadi game da ƙara lokacin keɓewa.
A farkon lokaci, marasa lafiya za su sami ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Alal misali, a cikin marasa lafiya 1,099 da suka kamu da COVID-19, an gano ƙwayoyin cuta masu ƙarancin jini na jini da ƙarancin jini na jini na jini da ƙarancin jini na jini da ƙarancin asphate amino transmutant da ƙarancin kwayoyin halitta a cikin jini.
Wasu marasa lafiya sun sami karuwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
A cikin marasa lafiya masu fama da cutar, akwai ƙarancin adadin D-ray, wanda ke rage yawan jini.
A cikin yawancin masu cutar COVID-19, an gano wani abu mai ban mamaki a cikin radiology na ƙirjin, kuma akwai yanayin haske kamar inuwa mai launin fata ko tabarau mai launin toka a cikin huhu.
A wasu lokatai, marasa lafiya suna fama da cutar pneumonia, ciwon huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
Lokacin da ARDS ya faru, rashin ƙonewa, ƙara ruwa, da haɓakar fiber mai ci gaba suna yin tasiri sosai ga canja wurin gas.
Ayyukan jini na jini na farko da na jini na biyu na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini na jini
Saboda haka, binciken da aka yi na radiation na nono na yau da kullum ya nuna cewa cutar tana da tsanani sosai.
A ranar 18 ga Fabrairu, 2020, an gano cewa a cikin binciken farko na COVID-19, an gano cewa an gano ƙwayar cuta, samar da ƙwayar cuta, da kuma shigar da jini a cikin huhu na mai haƙuri da ya mutu.
Ana amfani da gano SARS-CoV-2 (RNA) ta hanyar kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwafin kwa
Duk da haka, saboda ƙimar ƙin yarda da karya, wanda zai iya ƙara cutar kwayar cutar, a China, a ranar 13 ga Fabrairu, 2020, asibitoci sun yi amfani da hanyoyin gano cutar (ba tare da dogaro da RT-PCR kawai ba).
Haka kuma yanayin da aka samu na binciken SARS.
Duk da haka, bayanai game da cututtuka da suka wanzu, bayyanar cututtuka, gwaje -gwaje da kuma binciken radiology suna da muhimmanci kuma wajibi ne don gano cutar daidai.
A ranar 14 ga Fabrairu, 2020, kungiyar Feng Shang ta bayyana aikin gano SARS-CoV-2 ta amfani da fasahar CRISPR, inda ta yi amfani da kwayoyin RNA na artificial SARS-CoV-2 a cikin minti daya, ba tare da buƙatar kayan aiki mai zurfi ba, ta hanyar yin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zurfin zur
Idan aka tabbatar da shi a cikin samfurin likita, ana tsammanin cewa sabuwar fasaha za ta iya haɓaka haɓaka da haɓaka hankali.
Saboda rashin isasshen gogewa game da cutar COVID-19 ta cutar, likitoci suna ba da kulawa ta taimako ga marasa lafiya na COVID-19 yayin da suke gwada nau'ikan magunguna daban-daban da aka yi amfani da su ko kuma aka gabatar da su a matsayin hanyar magani ga sauran cututtukan cutar kamar SARS-CoV) da MERS-CoV). (Table (Table 2) 2.)
Magungunan rigakafi, rigakafi, steroids, plasma daga marasa lafiya da suka warke, magungunan kasar Sin da kuma goyon bayan tunani sune hanyoyin da suke gudana a halin yanzu kuma suna da amfani.
An yi amfani da ƙwayar jini na marasa lafiya da suka warke kafin a yi amfani da ita don magani.
Kamfanonin samar da magunguna suna gaggauta yin gasa don samar da wasu magungunan rigakafi da rigakafi.
SARS-CoV-2 (SARS-CoV-2) yana fara kai hari ga huhu, kuma yana iya kai hari ga sauran kwayoyin halitta kamar su tsarin hanji da koda da ke samar da ACE2 (ACE2).
Amma, rashin numfashi ko kuma rashin numfashi yana da babbar barazana ga marasa lafiya kuma babban dalilin mutuwa.
Saboda haka, taimako na numfashi yana da mahimmanci don kawar da alamun cutar da kuma kare rayuka, wanda zai ba da maganin oxygen na yau da kullun, high oxygen flow, iska mai iska da kuma iska mai iska mai iska, dangane da yanayin cutar.
Ana buƙatar tallafawa marasa lafiya da ke da alamun rashin lafiyar zuciya ta hanyar ingantaccen fasahar jujjuyawar zuciya (EQM), wanda za a yi amfani da shi don magance lokacin da zuciya ta kasance cikin haɗari ko kuma mutuwa ta hanyar dakatar da numfashi.
Bugu da kari, kula da daidaiton sashi na lantarki, hanawa da kuma magance kamuwa da cuta ta biyu da kuma shan wahala na nutrition, da kuma kare aikin manyan kwayoyin halitta (SARS-CoV-2) na da mahimmanci ga marasa lafiya.
A cikin SARS da MS, an gano cewa yawan aikin garkuwar jiki na haifar da sake zagayowar cytokine.
Cytokine Storm wani nau'i ne na ƙwayar cuta mai ƙonewa wanda zai iya fitar da jerin cytokines, ciki har da DNA-alpha, IL-1beta, IL-2, IL-6, IFN-alpha, IFN-beta, IFN-gamma, da MCP-1.
Waɗannan masu sarrafawa suna sa kwayoyin rigakafi su saki ƙwayoyin cuta da yawa, wanda ke haifar da rashin ƙarfi na ARDS da sauran kwayoyin halitta.
Domin magance cutar cytokine, musamman ga marasa lafiya masu tsanani, hana rigakafi ya zama dole.
Ana amfani da tasilzumab don magance cutar cytokine, wanda yake da ƙwayar cuta da kuma maganin IL-6.
Sauran hanyoyin maganin rigakafi don maganin rigakafi na cytokine sigina 4; da suka hada da gyaran rigakafin rigakafin da DNA ke motsawa; hanawa da kuma hanawa da kuma hanawa da kuma hanawa da kuma hanawa da maganin rigakafi na cytokine.
Ana amfani da steroids a matsayin masu hana rigakafi a cikin maganin SARS don rage girman lalacewar kumburi.
Duk da haka, ba a samu sakamako mai kyau ba a cikin masu cutar SARS da COVID-19 saboda mummunan rauni na huhu.
A maimakon haka, suna da mummunan sakamako masu illa, musamman lalata ƙwayoyin ƙashi ba tare da samun jini ba, kuma suna da tasiri sosai a kan kimantawa.
Duk da haka, ana ba da shawarar cewa a ba da ƙwayar cuta ga marasa lafiya na COVID-19 na rayuwa, aƙalla a cikin gajeren lokaci, tare da fasaha mai matsakaici.
A lokacin rubuce-rubuce, babu wani maganin rigakafi da aka tabbatar da cewa yana da amfani.
Duk da haka, an gano cewa yin amfani da jini na REMDESI, wanda shine jerin kwayoyin acid na Uttara, ya ba da sakamakon da ake so ga wani mai cutar COVID-19 a Amurka.
Remdesvir ne sabon nau'in maganin kashe kwayoyin cutar da aka fara samarwa da Gilad don magance cututtukan da ke haifar da cutar Ebola da Marlburg.
Daga baya, har ma da Remdeswire, wasu kwayoyin cuta masu dauke da fiber guda daya (RNA) sun nuna ikon hana kwayoyin cuta.
A cewarsa, Kalit ta ba kasar Sin kayan aiki don gudanar da gwaje-gwaje a kan mutane da suka kamu da cutar SARS-CoV-2 da ake sa ran sakamakon.
Bugu da ƙari, ana ba da shawarar paracetamol, interveron-alpha, lobinavir/redonavir, da ribavirin a matsayin magani mai inganci ga marasa lafiya da ke da alamun rashin lafiyar numfashi mai tsanani.
Bayan an bi da maganin da aka haɗa da lobinavir/ridonavir, za a iya samun ciwon ciki, kumburi, vomiting, ciwon hanta, da sauran sakamako masu illa.
Dole ne a lura da yadda wadannan magunguna suke hulɗa da sauran magunguna da ake ba marasa lafiya.
Ana samar da jini da kuma sauran abubuwa daga marasa lafiya da suka warke.
Akwai dogon tarihi na tattara jinin marasa lafiya da suka warke daga cutar da ta kamu da cutar, da kuma kula da sauran marasa lafiya da ke fama da cutar ko kuma kare lafiyar mutane daga cutar.
A wasu kalmomi, marasa lafiya da suka warke suna da ƙarin ƙwayoyin cuta a cikin jinin su idan aka kwatanta da su.
Abubuwan da ke hana cutar su ne ƙwayoyin rigakafi (IG) da ke samar da ƙwayoyin B-Highway don yaƙi da ƙwayoyin cuta da sauran ƙwayoyin cuta, kuma suna gano kwayoyin da ke cikin ƙwayoyin cuta kuma suna kashe su kai tsaye.
A cewar wannan binciken, an karɓi plasma daga cikin marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke cikin yanayin mafi hatsari.
A cikin sa'o'i 24, alamun sun inganta, kuma an rage yawan kumburi da kuma cutar, kuma an samu ci gaba a cikin jini.
Amma, da yake ba a riga an samar da takamaiman hanyoyin magance cutar ba, ana bukatar a tabbatar da kuma bayyana su kafin a gabatar da su a wani babban taro.
Bugu da ƙari, ko da yake akwai sakamako mai kyau, dole ne a yi la'akari da wasu rashin amfani da ke tattare da jini.
Alal misali, wasu kwayoyin za su iya sa mutum ya yi amfani da maganin rigakafi sosai don ya nuna alamun da ke nuna cewa yana da sinadarin da zai iya sa mutum ya zama mai guba.
A cikin jini, yawan kwayoyin halitta da ke ƙunshe da su a cikin jini yana da ƙasa, kuma ana bukatar ƙarin jini don kula da marasa lafiya masu haɗari.
Yana da wuya a samar da wasu takamaiman makamai masu amfani da za su iya magance cutar ta duniya da sauri.
Saboda haka, cire kwayoyin B daga marasa lafiya da suka warke, gano alamun kwayoyin halitta na wasu kwayoyin cutar masu amfani, ko gano wasu kwayoyin cutar masu amfani da su don magance ƙwayoyin cutar masu mahimmanci, ya zama mafi mahimmanci kuma ya zama dole a aikace.
Ta wannan hanyar, za mu iya ƙara yawan kwayoyin halitta nan take.
An yi amfani da TCM a kasar Sin don magance cututtuka na shekaru dubbai.
Duk da haka, sakamakon zai dogara ne akan haɗuwa da abubuwa daban-daban na tsarin, wanda zai bambanta dangane da gano cutar bisa ga ka'idodin TCM.
Yawancin abubuwa masu amfani ba a sani ba ko kuma ba a bayyana su ba saboda yana da wuya a cire su kuma a tabbatar da irin waɗannan abubuwa ko kuma abubuwan da suka dace da su.
A halin yanzu, saboda COVID-19 ba shi da magani na musamman da zai iya taimakawa, DCM shine babban maganin maye gurbin da ake ba da marasa lafiya tare da alamun cututtuka na matsakaici zuwa matsakaici ko waɗanda suka warke daga matsanancin yanayi.
Alal misali, an gano cewa Shu Feng Ji Duu capsules da Lian Hua Shing Wen capsules suna da tasiri wajen magance COVID-19.
A kasar Sin, an samu karin murmurewa a larduna da dama, ciki har da Kansu (63.7%), Ningxia (50%) da Hanan (50%) inda aka yi amfani da TCM a kan kashi 87 cikin dari na masu dauke da COVID-19 yayin da aka samu karamin murmurewa a lardin Hubei (13%) inda aka yi amfani da TCM a kan kusan kashi 30 cikin dari na masu dauke da COVID-19
Duk da haka, wannan kwatancen yana da matukar dacewa, saboda akwai wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma tsanani da za a yi la'akari da su.
A ranar 18 ga Fabrairu, 2020, Fake Zhang da abokan aikinsa sun buga wani binciken da suka yi na kwatanta maganin maganin maganin maganin maganin maganin yamma (WTM) da kuma maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar (TCM) da kuma maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar cutar cutar cutar.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, ɓoye bayyanar cututtuka, da kuma lokacin da ake buƙatar shiga asibiti sun fi na rukunin da ke shan magani na gargajiya na kasar Sin da ke shan magani na yammacin Turai fiye da na rukunin da ke shan magani na yammacin duniya.
Abin lura, yawan rashin bayyanar cututtuka (karfi daga cikin cutar) ya kasance ƙasa da yawa a cikin WM + DCM (7.4% vs. 46.2%) fiye da na WM + DCM kawai.
Duk da haka, don sanin yadda za a iya yin amfani da TCM da kuma yadda za a iya yin amfani da shi, dole ne mu jira don gudanar da bincike a cikin manyan cibiyoyi da yawa a cikin yanayin da aka tsara sosai.
Bayyana tsarin aiki da kuma bayanin abubuwan da ke cikin maganin DCM ko kuma abubuwan da ke cikin haɗuwa da su idan ya yiwu suna da ban sha'awa.
Masu kamuwa da cutar da aka tabbatar da ko kuma ake zargin suna fuskantar tsoro mai yawa game da cututtukan da ke da cutar ko kuma waɗanda ke haifar da mutuwa.
Hakanan, rashin jin daɗi da baƙin ciki na iya haifar da mummunan sakamako kamar rashin jin daɗi da ke tattare da cututtukan cututtuka kamar zazzabi, rashin iska, tari, da rashin barci da ake samu daga maganin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin karantin
A farkon barkewar cutar, an samu rahotanni game da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Wani ɓangare na ayyukan kiwon lafiya na jama'a da aka yi a cikin amsa ga yaduwar COVID-19, wanda ke iya sa mutane su ƙara damuwa da jin laifi game da sakamakon kamuwa da cuta, keɓewa da kuma rashin kula da danginsu da abokansu.
Don haka, dole ne a samar da kulawar kiwon lafiya ta tunani ga masu cutar COVID-19, waɗanda ake zargi da cutar da waɗanda ke da alaƙa da su, da kuma jama'a masu buƙata.
Dole ne a sami tallafin ilimin halayyar mutum wanda ya ƙunshi ƙungiyoyin kiwon lafiya na daban, tare da sadarwa mai kyau da shirye-shiryen magani tare da ci gaba da sabuntawa game da yaduwar SARS-CoV-2 da kuma amfani da na'urorin lantarki da na'urori masu sarrafawa don guje wa kusanci da juna.
Ana buƙatar allurar rigakafi don hana hanyar watsawa daga mutum zuwa mutum daga wanda ya kamu da cutar da dabba, kuma ana buƙatar maganin rigakafi don sarrafa cutar da ke faruwa ta hanyar kwayoyin cuta.
Ana kokarin samar da alluran rigakafi na S-protein wanda zai haifar da rigakafin antibacterial da/ko kariya mai tsawo da kuma rashin ƙarfi akan SARS-CoV-2.
An kimanta samfurin da aka yi wa SARS a kan samfurin dabba wanda ya cire allurar rigakafi kai tsaye.
Amma, har yanzu ana bukatar a tantance yadda rigakafin zai yi tasiri a kan tsofaffi da kuma wadanda ke mutuwa kafin a fara nazarin asibiti game da lafiyarsu ga cututtukan dabba.
Wannan shi ne dalilin da ya sa SARS ta mutu shekaru 17 da suka gabata, kuma ba a sake samun cutar ba.
A akasin haka, cutar ta ci gaba da faruwa a cikin yankunan Gabas ta Tsakiya a cikin ƙungiyoyi da kuma ƙungiyoyi, kuma tana yaduwa zuwa wasu yankuna saboda akwai dabbobi a cikin yankunan da ke fama da cutar.
An kirkiro dabarun rigakafin cutar ta MERS ta amfani da ƙwayoyin cuta da aka kashe, plasmids na DNA, microorganisms, nanoparticles, pathogenic particles, da kuma na'urorin haɗin gwiwar sunadarai, wasu daga cikinsu an kimanta su a cikin samfurin dabba.
Samar da alluran rigakafi masu aminci da tasiri ga mutanen da ba su da rigakafi ga SARS-CoV-2 (SARS-CoV-2) aiki ne na gaggawa da kuma gagarumin aiki wajen sarrafa cutar ta yau da kullun.
Duk da haka, saboda tsawon lokaci (ma'ana watanni 18) da kuma bambancin yanayin cutar, cin nasara a kan matsalar yana da ƙalubale.
A matsayin sabon cuta, COVID-19 ya riga ya fara aikinsa na likita tare da dubban marasa lafiya.
A yawancin mutane, marasa lafiya suna iya warkewa a hankali ba tare da sakamakon binciken ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da ƙarin kamuwa da cuta da yawan mutuwa a cikin marasa lafiya masu rauni.
Saboda haka, samar da samfurin tsinkaye na cutar yana da mahimmanci ga hukumomin kiwon lafiya, musamman a yankunan da ke da karancin albarkatu, su ƙayyade fifiko ga ayyukan su.
Bisa ga binciken asibiti da aka yi a yanzu, waɗannan dalilai na iya shafar ko kuma suna da alaƙa da ƙididdigar cutar COVID-19 (Table (Table 33):
Shekara: Shekara ita ce muhimmiyar mahimmanci wajen hango yadda SARS zai warke, kuma haka yake a cikin COVID-19.
A cikin binciken da aka gudanar a kan mutane 8,866 da suka kamu da cutar, an gano cewa COVID-19 ya shafi 47.7% na mutanen da suka wuce shekaru 50 a tsakanin shekaru 30 zuwa 65.
Marasa lafiya da ke bukatar kulawa mai tsanani sun riga sun sami cututtuka biyu da matsaloli, kuma sun kasance manya sosai fiye da waɗanda ba su buƙatar irin wannan kulawar (tsayin tsufa 66 vs. 51), wanda ke ba da shawarar cewa shekaru wani abu ne don yin kimantawar cutar ga marasa lafiya na COVID-19.
Jima'i: Kamar yadda aka bayyana a sama, SARS-CoV-2 ya fi kamuwa da maza (0.31/100,000 vs. 0.27/100,000) fiye da mata.
Rashin lafiya da kuma matsaloli: Masu fama da COVID-19 da ke bukatar kulawa mai tsanani, na iya samun rashin lafiya daga cututtukan zuciya da kuma rashin abinci mai gina jiki.
Sauran cututtukan zuciya sun kasance sanadiyyar mutuwar marasa lafiya na SARS.
An ce SARS-CoV-2 (SARS-CoV-2) zai iya kamuwa da kwayoyin cuta masu cutar collagen-positive (ACE2-) wanda zai iya haifar da cututtukan hanta a cikin masu cutar COVID-19.
Yana da kyau a lura cewa akwai dangantaka mai ƙarfi tsakanin tsufa da cututtuka masu tsawo kuma suna iya haɗuwa.
Abubuwan da ba a saba gani ba na dakin gwaje-gwaje: Yawan c-reactive protein (CRP) a cikin jini yana nuna cewa ƙwayar ƙwayar cuta ko ƙwayar cuta tana da tsanani. An kuma ba da shawarar maganin cutar don cutar, amsa ga magani, da kuma warkarwa ta ƙarshe a matsayin abubuwan da suka dace.
An gabatar da wani dangantaka tsakanin matakin CRP da kuma yadda COVID-19 ke da tsanani da kuma yadda za a warke.
Bugu da kari, kara lactate dehydrogenase (LHT), asphate amino substituent (ASD), alanine amino substituent (ALD) da creatinine kinase (CK) zasu taimaka wajen hango sakamakon.
Wadannan enzymes suna bayyana sosai a cikin kwayoyin halitta daban-daban, musamman a zuciya da hanta, kuma ana fitar da su lokacin da aka lalata nama.
Saboda haka, suna da alamun alamun cututtukan zuciya ko hanta.
Muhimman alamun asibiti: Za a yi la'akari da ci gaban wucin gadi na radiology na kirji da kuma alamun asibiti, da tasirin COVID-19 da kuma matsalolin da za a yi tare da sauran matsalolin hasashen.
Amfani da Steroids: Kamar yadda aka bayyana a sama, steroids suna da anti-disease a matsayin maganin anti-disease wanda aka fi amfani dashi azaman ƙarin magani don rage girman lalacewar da za a iya haifar da kumburi yayin cututtukan cututtuka.
Tun da aka yi amfani da maganin ƙwayoyin cuta mai yawa a kan marasa lafiya masu tsanani na SARS, mutane da yawa da suka warke daga cutar sun sha wahala daga rashin iya rayuwa da rashin ingancin rayuwa tare da lalata ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta.
Saboda haka, idan ya cancanta, a yi amfani da ƙananan adadin steroids ga marasa lafiya na COVID-19 na ɗan gajeren lokaci.
Rashin damuwa: Kamar yadda aka bayyana a sama, mutane da yawa suna fuskantar matsanancin damuwa a lokacin yaduwar COVID-19 saboda dalilai kamar warewar lokaci mai tsawo da rashin tabbas mai tsanani da kuma ganin mutuwar dangi da abokan aiki.
Ana iya ba da shawara ta tunani da kuma goyon baya na dogon lokaci ga waɗannan marasa lafiya don dawowa daga yanayin da suka ji rauni.
A cewar binciken da aka gudanar a yanzu, yanayin da COVID-19 ya samo asali ya bambanta da na SARS.
A cikin numfashi, ana samun karuwar yawan mutane a cikin numfashi, kuma SARS-CoV-2 (SARS-CoV-2) yana karuwa cikin numfashi, kuma yana karuwa cikin jiki, ba tare da wata alama ba, kamar sauran cututtukan corona da ke haifar da sanyi a farkon lokacin kamuwa da cutar.
Saboda haka, marasa lafiya masu cutar za su iya samar da ƙwayoyin cuta masu yawa a farkon lokaci ko kuma a lokacin bayyanar cututtuka, a yayin ayyukan yau da kullum, kuma hakan zai sa ya yi wuya a hana yaduwar cutar.
Koyaya, yawancin yaduwar ba su faru a farkon lokaci ba, ana tsammanin yaduwar SARS-CoV ta faru ne lokacin da marasa lafiya suka sami mummunan rauni.
Saboda haka, halin da ake ciki na COVID-19 yana da matukar tsanani kuma yana da wuyar sarrafawa fiye da yadda SARS ke yaduwa.
Da fatan hana yaduwar SARS-CoV-2, an yi wasu manyan ayyuka, ciki har da kulle-kulle a Wuhan da garuruwan da ke kewaye da shi da kuma keɓe kusan dukkanin jama'a.
Duk da cewa wadannan ayyukan na da matukar illa ga tattalin arzikin kasar da sauran bangarorin, adadin sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa cutar ta kasance mai iyakancewa.
Mafi kyawun kimantawa shine cewa cutar za ta ƙare a cikin Maris kuma lokacin raguwa zai kasance watanni 3-4 na ƙarshe.
Amma, wasu masana ba su da tabbaci sosai.
Paul Hunter da sauransu sun kiyasta cewa COVID-19, wanda ya fi sars yawa, ba zai ƙare a shekarar 2020 ba.
Ira Lankini da wasu sun kafa samfurin don hango ko hasashen sakamakon cutar kwayar cutar, kuma sun ba da shawarar cewa kashi biyu bisa uku na yawan mutanen duniya za su kamu da cutar SARS-CoV-2.
Wani rukuni na Kanada ya ce an gano SARS-CoV-2 a cikin ƙashin ƙugu da ƙashin wuyan marasa lafiya da suka dawo daga asibiti makonni biyu da suka gabata, wanda ya nuna cewa sabon cutar tana iya faruwa a cikin jujjuyawar jiki kamar mura.
Duk da haka, a cikin ƙarancin adadin sababbin cututtuka, akwai alamun da za su iya tabbatar da cewa a kasar Sin, dabarun da ake amfani da su a yanzu suna da tasiri.
An yi hasashen cewa mutane miliyan ɗaya za su kamu da cutar Ebola kuma mutane miliyan biyar za su mutu.
Amma, ta hanyar yin zaman kadaici da keɓewa, cutar ta samu ci gaba.
Kamar SARS-CoV, akwai yiwuwar cutar SARS-CoV-2 ta raguwa da kuma raguwa a hankali, ko kuma ta zama mai ƙarancin cutar da ke faruwa a cikin mutane.
Ga kwatancin SARS da MERS da COVID-19 (Fig. 55).
SARS-CoV-2 (SARS-CoV-2) zai iya yadawa ta hanyar tari da kumburi, kuma akwai yiwuwar yadawa ta hanyar taɓa abubuwa da ke da cutar kai tsaye.
An gano cutar a cikin maniyyi kuma hakan ya haifar da sabon yiwuwar yaduwar cutar daga maniyyi zuwa baki.
Wani binciken da aka yi kwanan nan da mutane 138 da suka kamu da cutar ya nuna cewa kashi 41 cikin 100 na waɗanda suka kamu da cutar sun iya kamuwa da cutar ta hanyar kamuwa da cutar ta asibiti, ciki har da marasa lafiya 17 da ke da wasu cututtuka da kuma masu ba da kula da lafiya 40.
Don haka, dole ne a dauki matakan da suka dace don kare mutane, musamman ma masu ba da kulawa ta kiwon lafiya, ma'aikatan zamantakewa, 'yan uwa, abokan aiki da marasa lafiya da kuma wadanda ke tare da mutanen da suka kamu da cutar.
Ana iya amfani da rigakafin fuska, wanda shine hanyar farko na rage haɗarin kamuwa da cuta, da kuma amfani da masks na tiyata da N.95 respiratory masks (sashi # 1860S) don taimakawa wajen hana yaduwar cutar.
A cikin yanayin da kwayoyin cutar za su iya tafiya ta iska daga mutumin da ke da cutar ko kuma su manne a saman kayan, ana iya ɗaukar su daga wurin zuwa wani, masks na tiyata suna guje wa saukad da ruwa.
Duk da haka, N.95 (sarai # 1860S) kawai ke ba da kariya daga numfashi daga ƙananan ƙwayoyin cuta masu girma daga 10 zuwa 80 mm, kuma kashi 5% na ƙwayoyin cuta masu girma ne kawai ke iya shiga cikin su; SARS-CoV-2 (SARS-CoV-2) matakin yayi kama da SARS-CoV, dukansu suna da kusan 85 nm.
Tun da kwayoyin suna tafiya tare da rufe fuska guda biyar na tiyata, masu ba da kula da lafiya da ke hulɗa kai tsaye da marasa lafiya suna buƙatar sanya N-95 (serial line # 1860S) maimakon rufe fuska na tiyata.
Koda a cikin abin rufe fuska, dole ne masu ba da kulawar lafiya su sa rigakafin da ya dace don rage haɗuwa da cutar
Ana iya samun cututtukan ta hanyar idanun mutane.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 ko da yake yana da abin rufe fuska na N.95, wanda zai iya shiga jikinsa ta hanyar idanun da suka kamu da cutar.
Saboda haka, masu ba da kulawa ta kiwon lafiya suna buƙatar sanya abin rufe fuska ko tabarau masu tsaro yayin aiki tare da marasa lafiya.
Ana ba da shawarar sosai ga dukan jama'a a yankunan da ke da cutar ko kuma waɗanda za su iya kamuwa da cutar su yi amfani da sabulu mai guba don wanke hannayensu fiye da yadda suka saba, su yi ƙoƙari su kasance cikin gida don su kasance cikin keɓewa da kuma rage yawan hulɗa da mutanen da ke da yiwuwar kamuwa da cutar.
Ana ganin cewa mutum yana da nisan ƙafa uku daga mai haƙuri don ya kasance a cikin aminci.
Waɗannan ayyukan suna da tasiri wajen rage haɗarin kamuwa da cutar yayin da suke hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo duniya a matsayin sabon cutar, an gano cewa haɗuwa da SARS-CoV-2 da tsarinsa na musamman ya haifar da yanayin rashin ƙarfi a China, bisa ga bayanan da aka bayar a ranar 7 ga Janairu, 2020, bisa ga zurfin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwal a cikin ƙasar.
Amma har zuwa 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya yi ta'aziyya ga jama'a cewa sabon cutar ba za ta iya kamuwa da cutar ba, kuma za ta iya yaduwa daga mutum zuwa mutum, kuma hanawa da kuma sarrafa cutar ba matsala ba ce.
Wannan bayanin ya sa jama'a suka yi fargaba, musamman ma a lokacin da kasar ta shirya don bikin bazara, lokacin da ake bukatar a rage yawan cutar a Wuhan.
Hukumar kula da cututtuka a kasar Sin za ta iya daukar wadannan darussa masu wuya kuma ta samu ci gaba mai muhimmanci a nan gaba.
Alal misali, waɗannan hukumomi (1) suna bukatar su yi hankali sosai wajen yin sanarwarsu, domin kowane kalma za ta iya shafan ra'ayin da kuma yanke shawara na 'yan ƙasa; (2) su yi aiki da ƙarin hankali da kuma motsawa ga rashin daidaito daga asibito ba tare da jira don samun takamaiman rahotanni daga likitoci ko jami'ai ba; (3) su yi ƙoƙari su hana cutar ta saurin kaiwa a hankali ba, ba tare da ƙoƙarin ta'azantar da jama'a ba; da kuma, (4) su ba da horo na musamman da kuma amfani don ƙara wayar da kan jama'a game da cutar saurin kai, da kuma inganta tsarin saurin kai na al'umma.
An fara yaduwar COVID-19 a karshen watan Disamba na 2019 sakamakon cutar SARS-CoV-2.
A lokacin da na rubuta wannan, a cikin kasa da watanni biyu, ya riga ya bazu zuwa kusan kasashe 50 a duk faɗin duniya, ko da yake a China.
Wannan cutar tana kama da SARS-CoV, kuma bayyanar cututtuka tsakanin SARS-CoV-19 da COVID-19 sun kasance iri ɗaya, saboda haka, COVID-19 ya haifar da wani motsin rai na SARS.
Duk da haka, akwai bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, wanda ke sa ya zama dole don hana yaduwar cutar ta kwayar cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa, kuma ya fi rinjayar maza fiye da mata, kuma yana da tsanani da kuma yawan mutuwa a tsakanin matasa fiye da tsofaffi.
Yawan mutuwar SARS ya fi na COVID-19 girma (10.91% zuwa 1.44%).
Masu dauke da COVID-19 suna yada cutar ne kawai idan ba su da wata alama, yayin da masu dauke da SARS ke yada cutar ne kawai idan suna da rashin lafiya sosai, wanda ya sa ya zama da wuya a hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ya yi sauri da kuma yaduwa fiye da SARS-CoV.
Wasu masu cutar COVID-19 sun samu sakamako mara kyau daga gwajin RNA (Rabibo-carboxylate) na yau da kullum don gano ko akwai SARS-CoV-2 (SARS-CoV-2).
A wani bangare kuma, idan aka gwada marasa lafiya da suka warke, za a iya gano cewa suna da cutar.
Waɗannan binciken na iya ƙara haɗarin yaduwar cutar.
Duk da irin wannan ci gaba mai sauri a cikin bincike game da COVID-19, akwai wasu manyan batutuwa da ba a warware su ba:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano cewa akwai daidaituwa tsakanin kwayoyin halitta na SARS-CoV-2 da SARS-like, amma har yanzu ba mu iya tabbatar da cewa SARS-CoV-2 ya fito ne daga kwayar cutar ba.
Wane irin dabba ne ya sa an yi amfani da ƙwayoyin cuta don ya yadu daga ƙwayoyin cuta zuwa mutane?
Idan ba mu san amsoshin # 1 da # 2 ba, ba za mu iya hana yaduwar cutar yadda ya kamata ba, kuma za ta sake yaduwa a kowane lokaci.
A cikin binciken kwayoyin halitta da kuma nazarin kwayoyin halitta, an gano cewa cutar ta shiga cikin kwayoyin halitta na iska kuma ta haifar da canje-canje masu zuwa.
Shin ƙwayoyin cuta suna ɗaure da ƙwayoyin da ke fitar da ACE2 a wasu gabobin jiki?
Idan ba mu da amsoshin waɗannan tambayoyin, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Har yaushe za a iya samun cutar?
Ta yaya za a iya canja halittar kwayoyin halitta da ke sa mutum ya kamu da cutar?
Shin annoba ce ta duniya ko kuma za ta ɓace kamar SARS ko kuma za ta kasance a wani lokaci kamar mura?
Wannan yana da muhimmanci, amma yana bukatar ƙarin lokaci don neman amsoshin waɗannan tambayoyin da yawa.
Duk da haka, duk abin da zai iya faruwa, ba mu da wani zaɓi sai dai mu hana cutar ta yaduwa da wuri-wuri kuma mu dawo da rayuwarmu ta yau da kullun.
Hanyar da ake samu daga dabbobi ta hanyar kamuwa da cutar korona ta mutum (HCoV)
Tun shekaru dubbai, an yi amfani da coevolution, mutation, da kuma daidaitawa na coronavirus (CoVs - coronavirus) da kuma na kwayoyin halitta, ciki har da mutane.
Kafin 2003, an san cewa kwayoyin cuta guda biyu na mutum (HCoVs - Human Coronavirus) suna da ikon haifar da cututtuka masu matsakaici kamar mura.
Cutar ta mummunar cutar ta matsananciyar cutar ta numfashi (SARS-SARS), da kuma ta ta tsakiyar gabashin numfashi (MERS-MERS) sun nuna yadda cutar ta mutum ta coronavirus take da lahani da kuma barazana ga rayuwa.
An yi mamakin cewa a karshen shekarar 2019 ne SARS-CoV-2 ya sake jan hankalin mutane kan cutar coronavirus a tsakiyar kasar Sin, inda ya yi mamakin yadda ta ke yaduwa amma kuma ta kasance da kasa kamuwa da cutar idan aka kwatanta da 'yar'uwarta SARS-CoV.
Kwayar cutar ta mutum ta fito ne daga dabbobi kuma fahimtar asalin dabbobi na kwayar cutar ta mutum (HCoV) zai iya taimaka mana sosai.
Yawancin cututtukan cutar korona na mutum sun fito ne daga kwayar cutar, kuma ba su haifar da cutar ba.
An kuma san dabbobi masu ragowa a matsayin masu tsayar da wasu cututtukan cutar korona a cikin mutane.
Gano dabba mai gida yana da tasiri kai tsaye a rigakafin cututtuka a cikin mutane.
Binciken hulɗar kwayar cutar korona-tsokoki a cikin dabbobi na iya ba da mahimman bayanai game da kamuwa da kwayar cutar korona a cikin mutane.
A cikin wannan bita, muna ba da hangen nesa game da ilimin da ake samu game da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Ainihin, muna kwatanta HCoVs daban-daban daga ra'ayi na juyin halitta da kuma sake tsara kwayoyin halitta.
A cikin wannan labarin, an tattauna halin yanzu na cutar COVID-19 a cikin wannan labarin.
Bugu da kari, an nuna bukatun don nasarar maye gurbin kwayar cutar da kuma tasirin juyin halitta na kwayar cutar a cikin rashin lafiyar.
Kwayar cutar Corona (Coronavirus) ta kasance daga cikin 'Coronaviridae' iyali, wanda ya ƙunshi rukuni na kwayoyin cuta masu ƙarfi, masu ƙarfi, masu ƙarfi, masu ƙarancin ƙwayar cuta (RNA).
Wadannan kwayoyin da ke da babbar adadin kwayoyin halitta na 26 zuwa 32 kilobes na RNAs, an kira su Coronaviruses saboda tsarin da suke gani a cikin microscope na lantarki.
A tsarin, kwayoyin corona suna da layin halittar da ba a rarraba su ba, kuma suna da tsari iri ɗaya.
A cikin kwayoyin halitta, kusan kashi biyu bisa uku na kwayoyin halitta suna da manyan kwayoyin biyu (Overlaping Open Reading Frames (ORF1A, da ORF1B)) waɗanda aka canza zuwa 'repex' iri-iri, PP1A da PP1AB.
Wadannan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'
Sauran kwayoyin halitta suna da ORFs don furotin na tsarin, ciki har da furotin (S), membrane (E), membrane (M), da nucleoprotein (N).
Ana ba da takamaiman ƙwayoyin cuta na kowace jini ta hanyar kwayar cutar coronavirus da suka samo asali ta hanyar daban.
Dangane da bambancin jerin sunadarai, ana rarraba coronavirus zuwa huɗu (alpha-coronavirus, beta-coronavirus, gamma-coronavirus, da Delta-coronavirus), waɗanda suka ƙunshi mafi yawan nau'ikan beta-coronavirus na ɗan adam, kuma an rarraba su zuwa hanyoyi huɗu na asali (A, B, C, da D).
Shaidar ilimin halittu ta nuna cewa fararen fata da kuma fungi suna aiki a matsayin tushen kwayoyin halitta na yawancin alpha-coronavirus da beta-coronavirus, yayin da tsuntsaye sune tushen tushen tushen gamma-coronavirus da Delta-coronavirus.
A cikin dubban shekaru, ƙwayoyin cuta na coronavirus sun ci gaba da wucewa ta hanyar rarrabuwa, kuma wasu daga cikinsu sun samo asali ne daga manyan ƙwayoyin cuta na mutum.
A yau, an gano nau'ikan cutar coronavirus guda bakwai.
Daga cikin su, kwayar cutar korona ta mutum -229E (HCoV-229E) da kwayar cutar korona ta mutum -NL63 (HCoV-NL63) sune kwayar cutar alpha-corona.
Sauran kwayoyin beta-corona sun hada da human coronary virus-OC43 (HCoV-OC43), human coronary virus-HKU1 ((HCoV-HKU1), matsanancin cututtukan numfashi (SARS-CoV), cutar ta numfashi ta tsakiyar gabashin (MERS-CoV) da SARS-CoV-2 .
Kwayar cutar korona ta mutum-229E (HCoV-229E), kwayar cutar korona ta mutum-OC43 (HCoV-OC43), kwayar cutar korona ta mutum-HKU1 (HCoV-HKU1) da kwayar cutar korona ta mutum-NL63 (HCoV-NL63) suna haifar da alamun cututtuka masu matsakaici kamar sanyi da / ko kumburi.
A akasin haka, SARS-CoV, MERS-CoV, da kuma sabon gano SARS-CoV-2 sun fi kamuwa da cutar, wanda ke haifar da kamuwa da cutar huhu mai tsanani, wanda ya fi shafar marasa lafiya da ke da cutar huhu mai tsanani (ARDS) da marasa lafiya da ke da alamun rashin huhu.
An cire nau'in mutum na farko na coronavirus-229E (HCoV-229E), B814, daga nasal discharge na masu cutar sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an tattara ƙarin bayanai game da kwayar cutar mutum -229E (HCoV-229E) da kwayar cutar mutum -OC43 (HCoV-OC43), dukansu suna haifar da alamun sarrafa kai.
A gaskiya ma, har zuwa lokacin da SARS ya fara, an yarda da cewa cutar ta mutum ta coronavirus ba ta da lahani.
Cutar SARS da ta faru a shekara ta 2003 ta kasance daya daga cikin cututtukan da suka fi muni a tarihin zamani, inda ta shafi fiye da mutane 8,000 kuma ta kashe kusan 10% na mutane.
Shekaru goma bayan haka, cutar ta barke a yankin Larabawa sakamakon barkewar cutar ta cutar ta MERS, wadda ta bazu zuwa sauran sassan duniya.
An sake masa suna SARS-CoV-2 (2019-nCoV), wanda shine wakilin cutar sankarar corona ta 2019 (COVID-19), wanda a halin yanzu yake gudana, ya kashe rayuka sama da 3,120 kuma mutane 91,000 sun kamu da cutar a ranar 3 ga Maris, 2020.
Ana sautin ƙararrawa, kuma dole ne duniya ta shirya don kamuwa da cutar SARS-CoV-2.
Kungiyoyi bakwai na cutar sankara ta mutum (HCoV) sun samo asali ne daga dabbobi, ko dai daga dabbobi ko kuma daga dabbobi.
Akwai shaidu da dama da suka goyi bayan cewa dukkanin kwayoyin cuta na mutum (HCoV) sun samo asali ne daga kwayoyin halitta, wanda kwayoyin su ne masu daidaitawa da rashin kamuwa da cutar amma suna nuna bambancin kwayoyin halitta mai yawa.
Cutar COVID-19 ta kawo babbar kalubale na kiwon lafiya, kimiyya, zamantakewa da kuma ɗabi'a ga kasar Sin da kuma duniya.
Gano asalin dabbobi na kwayar cutar corona (HCoV) na mutum yana ba da tsarin fahimtar abubuwan da suka shafi tarihin halitta, motsi da kuma abubuwan da ke hana yaduwar tsakanin jinsuna.
Wannan na iya jagorantar ko kuma taimakawa wajen gano dabba mai hana, matsakaici, da kuma karuwa na SARS-CoV-2, tare da tasiri mai mahimmanci wajen hana yaduwar cutar a nan gaba.
A cikin wannan bita, mun gabatar da wani ra'ayi game da asalin dabbobi na kwayar cutar ta mutum, yaduwar tsakanin jinsuna, da kuma tsarin kamuwa da cutar.
Musamman, muna jaddada kuma muna tattauna batun gama gari cewa kwayoyin halittar cutar sankarar ɗan adam (HCoV) ba su da cutar a cikin rundunansu na halitta, amma suna kamuwa da cutar a cikin sabbin rundunansu bayan yaduwar tsakanin jinsuna.
Muna kuma nazarin yanayin juyin halitta na cutar sankarar cuta ta mutum (HCoV), wanda ke nuna cewa yawan kamuwa da cutar ya ragu idan ya karu.
A cikin wannan mahallin, ana tattauna tasirin yaduwar SARS-CoV-2 a halin yanzu.
An gano cewa akwai kwayar cutar ta dabba tun daga ƙarshen shekarun 1930.
An cire kwayar cutar daga cikin hanci na marasa lafiya da ke fama da cutar ta yau da kullun, kafin a cire kwayar cutar B814 na cutar ta mutum - 229E (HCoV-229E), daga wasu dabbobi masu cutar, ciki har da kaza, beraye, shanu, alade, cats da karnuka.
A cikin shekarun da suka gabata, an gano nau'ikan cutar coronavirus (HCoV) guda bakwai a cikin mutane.
A takaice, a cikin jerin abubuwan da suka faru na gano cutar ta mutum (Table 1) a cikin lokaci, zai zama mai bayani da kuma bayani.
An cire kwayar cutar ta farko ta mutum -229E (HCoV-229E) daga huhu na marasa lafiya da ke da cutar huhu ta sama a shekara ta 1966 kuma an daidaita ta don girma a cikin layukan ƙwayoyin huhu na WI-38.
Alamu na yau da kullum na rashin lafiya na marasa lafiya da ke fama da cutar ta mutum ta coronavirus -229E (HCoV-229E) sune ciwon kai, kumburi, rashin lafiya da ciwon wuya, tare da zazzabi da tari a cikin 10 ~ 20% na kamuwa da cutar.
Daga baya a 1967, an cire kwayar cutar mutum-OC43 (HCoV-OC43), daga cikin kwayoyin halitta da kuma hanyoyin da ke cikin kwakwalwar beraye.
HCoV-OC43 yana da halayen cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na cutuka na
Kwayar cutar korona ta mutum-229E (HCoV-229E) da kuma kwayar cutar korona ta mutum-OC43 (HCoV-OC43) sun bazu a duniya, kuma suna yaduwa a lokacin hunturu a yanayin yanayi mai matsakaici.
A cikin waɗannan nau'ikan, a cikin nau'ikan biyu, lokaci na bayyanar cututtuka ya wuce, ƙasa da mako guda, kuma yana da tsawon mako biyu.
Wani bincike da aka gudanar tare da masu aikin sa kai na nuna cewa, mutane masu lafiya da suka kamu da cutar korona ta mutum -229E (HCoV-229E) sun samu karamin adadin al'ada.
Wasu marasa lafiya da ke da rashin ƙarfi ne kawai suka sami mummunan cutar ta hanyar huhu.
SARS, wanda kuma ake kira "Rashin cutar huhu", shine farkon cutar HCoV-inflammatory da aka rubuta sosai a tarihin ɗan adam da kuma wakili mai cutar SARS-CoV, wanda shine gano HCoV na uku
A ƙarshen shekara ta 2002, an gano cewa an fara samun SARS a lardin Guangdong, China.
An samu kamuwa da cutar SARS da yawa, wanda ya kai mutum 8,096 da kuma mutum 774 da suka mutu.
Baya ga manyan cututtuka, an kiyasta cewa kowane kamuwa da cuta zai haifar da kusan kamuwa da cuta biyu na biyu, wanda lokacin bayyanar cututtuka ya kasance daga kwanaki 4 zuwa 7 kuma cutar ta fara a rana ta 10 na kamuwa da cuta.
Masu kamuwa da cutar SARS-CoV suna da ciwon tsoka, ciwon kai, zazzabi, rashin lafiya da sanyi, sannan kuma suna da rashin numfashi, tari da rashin numfashi.
Lymphonia, gwajin aikin hanta da kuma yawan adadin cretin kinase sune yanayin rashin lafiyar Lab na Sarcasin.
A cikin marasa lafiya na SARS, ana ganin lalacewar ƙwayar huhu, karuwar ƙwayoyin epithelial, da karuwar macrophages.
Kimanin kashi 20-30 na marasa lafiya suna bukatar kulawa mai tsanani da kuma numfashi.
Baya ga ƙananan huhu, wasu gabobin ciki har da hanji, hanta, da koda na iya kamuwa da waɗannan cututtukan masu tsanani, wanda yawanci yana haɗuwa da tsarin cytokine, wanda zai iya zama haɗari ga marasa lafiya masu rashin lafiya.
An fara ware cutar ne daga kwayar cutar ta bude huhu ta dangin wani mai asibitin Indus da ya tashi daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an ba da babbar ƙoƙari ga binciken kwayar cutar ta mutum.
A cikin marigayi 2004 an cire kwayar cutar corona-NL63 (HCoV-NL63) daga jariri mai watanni 7 a Netherlands.
An gano cewa yana da yawa a cikin yara, tsofaffi, da marasa lafiya masu rashin ƙarfi waɗanda ke fama da cututtukan numfashi.
HCoV-NL63 na mutum yana haifar da cututtuka na kowa kamar cutar coronary artery, mura, zazzabi, da kumburi.
Wani bincike na daban da aka yi a Netherlands ya bayyana cewa an cire wannan cutar daga kwayar hanci na wani yaro mai shekara 8 da haihuwa da ke fama da cutar pneumonia.
Ko da yake an gano shi a Netherlands, amma a gaskiya ya bazu ko'ina cikin duniya.
An kiyasta cewa kusan kashi 4.7% na cututtukan numfashi na yau da kullun ana haifar da cutar corona ta mutum -NL63 (HCoV-NL63), kuma ana samun mafi yawan lokuta a lokacin bazara, bazara da hunturu.
HCoV-NL63 (HCoV-NL63) wanda ake kira ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
A wannan shekarar, an cire kwayar cutar HCoV-1 (HCoV-HKU1) daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti a Hong Kong da ke fama da cutar pneumonia da kumburi.
Baya ga cutar pneumonia da ake samu a cikin al'umma da kuma kumburi na huhu, ana ganin cewa cutar sankarar mutum -HCoV-HKU1 tana da alaƙa da karuwar cutar asma.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, HCoV-HKU1 an gano shi a duk duniya, wanda ke haifar da cututtukan numfashi masu laushi.
Wadannan kwayoyin cuta guda hudu na mutum (HCoV) da aka karɓa daga al'umma suna da kyau tare da mutane, kuma suna da ƙananan damar haifar da cututtukan cututtuka masu cutar, duk da haka, haɗari suna faruwa don dalilai da ba a sani ba. Kamar yadda yake da wuya a cikin mafi munin subtype na mutum-CoV-63 (HCoV-NL63), an sanar da su kwanan nan a China don haifar da mummunan kamuwa da cutar ta hanyar ƙananan ƙwayar cuta.
A yadda aka saba, yayin da wadannan kwayoyin cutar korona (HCoV) suka sami damar yadawa da kuma ci gaba da kasancewa cikin mutane, suna zama marasa tsanani ko masu kamuwa da cutar.
An fara cire cutar MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da ke fama da mummunan cutar huhu da kuma rashin aikin koda a Saudiyya.
Ko da yake yawancin cututtukan da aka tabbatar da su ta hanyar dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an samu rahoton cututtukan da suka shafi yaduwar cutar ta biyu a cikin kasashen Turai da Tunisia, wanda ya haifar da kusanci daga waje.
A shekarar 2015 an samu karin kamuwa da cutar a Koriya ta Kudu, inda aka samu kamuwa da cutar 186 a shekarar.
Maganin likita na Mers ya yi kama da SARS, wanda ake kira progressive acute pneumonia.
Ba kamar SARS ba, yawancin marasa lafiya da MERS ta shafa sun sami mummunan rashin aikin koda, wanda ya zama na MERS kaɗai a cikin cututtukan da ke haifar da kwayar cutar ta mutum.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun hanji kamar su kumburi da kumburi.
A ranar 14 ga Fabrairu, 2020, an samu kamuwa da cuta a cikin fiye da 2,500 dakunan gwaje-gwaje, inda aka samu karuwar mutuwar da suka kai kashi 34.4%, wanda ya sa cutar ta MERS-CoV ta zama daya daga cikin cututtukan da suka fi lalacewa da mutane suka sani.
Daga tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin mutane da ke fama da cutar huhu da aka sani da ke da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar lafiya ta duniya (WHO) ta ayyana cutar ta hanyar huhu ta SARS-CoV-2 a matsayin dokar ta baci ta duniya da ke da alaƙa da lafiyar jama'a, kuma ta sanya sunan COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar 90,053 a duniya, tare da mutuwar kamuwa da cutar mai tsanani da kashi 3.4 cikin ɗari.
A cewar wani rahoto, an samu kashi 4.2 cikin dari na mutuwar a birnin Hubei na kasar Sin, yayin da a wajen kasar akwai kashi 1.2 cikin dari.
Kamar yadda SARS-CoV da MERS-CoV ke haifar da cutar, SARS-CoV-2 na haifar da kamuwa da cuta mai tsanani ta hanyar numfashi tare da zazzabi, tari da kuma rashin numfashi.
Wasu marasa lafiya suna fama da ciwon ciki.
Rashin numfashi yana daya daga cikin alamun bayyanar cututtuka mafi tsanani, kuma yana iya kaiwa ga cututtukan huhu masu tsanani.
Kodayake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda homology na 82% high nucleotide, suna zama ƙungiyoyi daban-daban a cikin itacen halitta.
SARS-CoV-2 yana da ƙananan kamuwa da cutar amma yana da iyakantaccen yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
Rahotanni sun nuna cewa marasa lafiya sun kamu da cutar SARS-CoV-2 ba tare da alamun bayyanar cututtuka ba, wanda zai iya haifar da yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Na farko, lokaci na bayyanar cututtuka da kuma lokacin kamuwa da cutar ta mutum suna kama da juna.
A wannan yanayin, SARS-CoV-2 yana bin tsarin sauran cututtukan cututtukan mutum guda shida.
Na biyu, tsananin bayyanar cututtukan COVID-19 yana tsakanin SARS-CoV da HCoVs huɗu da aka samu a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, cutar SARS-CoV-2 ta bayyana halaye da aka saba gani a lokacin annobar cutar ta mutum mai dauke da cutar coronavirus (HCoV) da ta yadu a cikin al'umma, wanda ya ƙunshi rashin ƙarfi, matsakaici ko babu alamun bayyanar cututtuka.
A gefe guda kuma, an gano karamin adadin mutanen da COVID-19 ya yi wa mummunan rauni kamar cutar SARS-CoV, duk da cewa yawanta ya ɗan ragu.
Na uku, yaduwar SARS-CoV-2 na nuna halaye masu ban sha'awa na biyu, HCoV da SARS-CoV, wanda ke karɓar al'umma.
A gefe guda, watsa SARS-CoV-2 ya kasance ƙasa da HCoVs da aka samu a cikin al'umma.
A gefe guda kuma, ana buƙatar bincika ko yaduwar SARS-CoV-2 daga mutane yana raguwa a hankali kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cut
Za a bayyana a nan gaba da nazarin ko ma'amala ta baka ta SARS-CoV-2 tana taka rawa a akalla wasu yanayi, kamar SARS-CoV.
Ana matukar sha'awar ganin ko SARS-CoV-2 zai bayyana kansa kamar yadda yake a cikin yanayin cutar ta mutum (HCoV) da ke yaduwa a cikin al'umma.
Duk da haka, siffofin SARS-CoV-2, ciki har da yaduwar sa, kamuwa da cutar, da kuma ci gaba da yaduwa bayan shiga jikin mutum, zasu iya tasiri kan hukuncin cutar COVID-19 da ke gudana yanzu.
HCoVs guda hudu da al'umma ta saya waɗanda ke haifar da bayyanar cututtuka masu sauƙi sun dace da mutane.
A wani bangare kuma, zai iya zama gaskiya cewa mutane sun yi rayuwa mai kyau da wadannan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
A wasu kalmomi, za su iya tsira daga cutar ta coronavirus ta zamanin dā.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma waɗanda suka haifar da cututtukan HCoV masu tsanani.
Don yin haka, dole ne a yi kwafin kwayar cutar HCoV a cikin mutane don ba da damar maye gurbin kwayoyin halitta masu daidaitawa waɗanda ke hana masu sarrafawa.
A wannan yanayin, yayin da SARS-CoV-2 ke yadawa na dogon lokaci kuma yana rinjayar mutane da yawa, yana da mafi kyawun damar zama cikakkiyar jituwa tare da mutane.
Idan ya daidaita kansa da yanayin, zai yi wuya a hana yaduwar cutar zuwa mutane ta hanyar warewa ko wasu matakan hana kamuwa da cutar.
A cikin shekaru da yawa, kwayoyin cutar ta hudu da al'umma ta samu sun bazu cikin yawan mutane, wanda ke haifar da rashin lafiyar al'ada a cikin mutane marasa lafiya.
Waɗannan ƙwayoyin ba sa bukatar dabbobi masu kula da dabbobi.
A akasin haka, masu cutar da suka fi ƙarfin hali, irin su SARS-CoV da MERS-CoV, ba su dace da mutane ba kuma ba za su iya faɗaɗa yaduwarsu cikin mutane ba.
Dole ne su rayu kuma su haihu a cikin hanyoyin dabbobi da kuma samun damar zuwa ga burin ɗan adam mai sauƙi, watakila ta hanyar ɗaya ko fiye na masu matsakaici da masu haɓaka.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV/MERS-CoV da kuma HCoV guda hudu na mutum.
A halin yanzu, aƙalla yana da yawa kamar yadda yake da cutar HCoV mai alaƙa da zamantakewar al'umma.
Koyaya, yana da ƙarancin kamuwa da cutar fiye da kwayar cutar ta ɗan adam da aka karɓa ta hanyar al'umma kuma yana da ƙarancin kamuwa da cutar fiye da SARS-CoV ko MERS-CoV.
Dole ne a duba ko za a iya daidaita shi da mutane sosai kuma ya yi yaduwa cikin mutane ba tare da wani dabba mai tsakiya ko dabba mai tsakiya ba.
Kafin mu tattauna asalin kwayar cutar ta mutum a cikin dabbobi, zai yi kyau mu tattauna ma'anar da halayyar kwayar cutar ta mutum game da juyin halitta, yanayi, matsakaici da kuma karuwar gidaje.
Idan dabba tana da kakannin da suka yi kama da juna sosai a matakin tsarin nucleotide, dabba tana aiki a matsayin mai karɓar HCoV
Wannan kwayar cutar ta asali tana sauya kanta ta hanyar dacewa da wannan mai karɓar baƙi kuma ba ta da cutar a cikin baƙon.
Hakazalika, masu karɓar bakuncin bakuna suna riƙe da kwayar cutar ta mutum na dogon lokaci.
A lokuta biyu, dabbobi masu cutarwa sun kamu da cutar ta halitta kuma sun kasance dabbobi masu cutarwa na mutum ko kuma na iyayensu.
Akasin haka, idan an gabatar da cutar HCV a cikin mutane kafin ko a kusa da sabon gidan, ba zai dace da sabon gidan ba kuma zai iya haifar da cutar.
Wannan matsakaiciyar makami na iya zama tushen zoonotic na kamuwa da mutum kuma yana iya yin aikin mai karɓa na karɓa ta hanyar ba da damar cutar ta sake dawowa ba tare da bata lokaci ba, sannan kuma ya tura shi ga mutane don karɓar cutar.
Idan HCoV ba zai iya ci gaba da yaduwarsa a cikin wani gidan matsakaici ba, zai iya ɗaukar kansa zuwa ga kamuwa da cutar ta ƙarshe.
A akasin haka, HCoVs na iya maye gurbin su tare da mai masaukin baki kuma su haifar da kamuwa da cutar ta dogon lokaci.
A cikin wannan, an yi amfani da matsakaiciyar dabba don zama dabba mai nutsuwa.
Bayanin binciken da aka yi ya nuna cewa cutar ta farko da aka sani ta SARS tana da tarihin hulɗa da dabbobi masu wasa.
A binciken da aka gudanar a baya, an gano cewa masu sayar da dabbobi suna da karin maganin rigakafin SARS-CoV fiye da talakawa.
A cikin kasuwannin dabbobi masu rai, Mascud Palm Plum Cats (Baguama Larvata) da Racoon Dogs ne suka fara zama masu ɗaukar kwayoyin cuta kamar SARS-CoV, wanda yayi kama da SARS-CoV.
Wannan ya nuna cewa babu wani karin SARS da aka samu bayan an kashe duk masu amfani da kwayoyin a cikin kasuwanni.
Koyaya, an ruwaito cewa masks na masks daga gandun daji ko gonaki ba tare da haɗuwa da kasuwanni na kai tsaye ba sun kasance masu cutar SARS-CoV. Waɗannan masks na masks na iya zama masu karɓar bakuncin kawai, amma ba a matsayin mai adanawa na SARS ba.
A cikin wani labari na musamman, da yake dabbobi daban-daban a cikin kasuwannin Guangzhou suna da kashi 80% na antibodies na SARS-CoV-2 ba za a iya musun cewa wasu ƙananan dabbobi masu shayarwa na iya zama masu karɓar SARS-CoV-2 a matsayin matsakaici ba.
Dukkanin wadannan sun zama masu karbar bakuncin cutar SARS-CoV-2
Binciken kwayoyin halitta na SARS-CoV-2 ya gano wani nau'in cutar korona mai suna SARS-related rhinoplastus wavelength HKU3 (SARS RRH-WAV) wanda ke cikin kudancin da ke cikin kudancin kasar Sin.
Wadannan kwayoyin sun dace da tsarin kwayoyin SARS-CoV da SARSr-Rh-BatCoV HKU3.
Wannan da sauran ƙwayoyin cuta na Wuhan suna da kama da su na nucleotide na 88-92% tare da SARS-CoV.
Waɗannan binciken sun kafa wani sabon ra'ayi game da ƙwayoyin cuta na mutum da ke tasowa.
An gano wasu kwayoyin cutar corona (SL-CoV) kamar SARS daga kwayar cutar, amma ba za a iya gano wani abu ba sai dai WIV1 na musamman.
An san enzyme 2 (ACE2) mai canza cutar ta mutum (ACE2) a matsayin mai karɓar cutar SARS-CoV.
An tabbatar da cewa WIV1, wanda aka samo daga samfurin kwayar halitta na kwayar halitta, zai iya amfani da kwayar halitta, CIVET (mai ƙwayoyin cuta) da kuma ACE2 a matsayin mai karɓar shiga cikin sel.
Abin sha'awa, maganin hana cutar SARS na da ikon hana rigakafin WIV1.
Ya zuwa yanzu, WIV1 na nufin mafi kusa da kakan SARS-CoV a cikin kwayoyin halitta, wanda ke da kashi 95% na kama da acidic acid.
Duk da irin kamanceceniya da ke tsakanin wadannan kwayoyin, ana ganin cewa WIV1 ba shine mai haifan SARS-CoV ba, kuma ƙwayoyin cuta ba su da ƙwayoyin cuta na SARS-CoV.
Ƙungiyoyin nazarin halittu sun nuna cewa cutar MERS-CoV tana da alaƙa da ƙungiya ɗaya kamar CoV-HKU4 da CoV-HKU5 na WAL.
Kwayar cutar korona ta Wauwall -HQ4 da kuma cutar MERS-CoV suna amfani da digestive receptors guda ɗaya, dipeptide peptidase 4 (DPP4) don shigar da cutar.
Wadanda ke cikin nau'ikan kwayar cutar beta-corona da aka gano daga Turai da Afirka suna da alaƙa da tsarin DNA na MERS-CoV (RNA) da kuma RNA-based RNA polymerase sequences.
Har zuwa yanzu, babu wani nau'in cutar MERS-CoV da ke rayuwa a cikin daji.
MERS-CoV da kuma nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Saboda haka, ƙwayoyin cuta ba za su iya zama ainihin abin da ke hana cutar ta MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa kamar yadda yake a kan raƙuman da ke fitowa daga Gabas ta Tsakiya a ƙasashen Afirka da yawa, raƙuman sun kasance masu ƙwarewa ga maganin rigakafi na musamman na cutar MERS-CoV.
An cire kwayar cutar MERS-CoV mai rai daga cikin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, wanda yake kama da wanda aka samo a cikin mutane, wanda ke nuna cewa raƙuma suna aiki a matsayin ainihin mai riƙewa na cutar MERS-CoV.
A lokacin da aka yi gwaji da kwayoyin cutar MERS-CoV, an lura da ƙananan alamomi amma an sami ƙarancin cutar a cikin raƙuma.
Ruwa da aka yi wa kamuwa da cutar ba ta hanyar numfashi kawai ba, amma ta hanyar magungunan da ke cikin jiki, kuma wannan shi ne babban hanyar da ake samun cutar a cikin farji.
Koyaya, saboda yawancin tasirin cutar da aka tabbatar da MERS ba su da tarihin hulɗa da raƙuma kafin bayyanar bayyanar cututtuka, ana iya cewa akwai hanyar watsawa daga mutane zuwa mutum ko kuma hanyoyin watsawa da ba a san su ba waɗanda ke da nau'ikan dabbobi da ke dauke da MERS-CoV.
Wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Kamar SARS-CoV da MERS-CoV, bambancin da ke tsakanin SARS-CoV-2 da RADG13 ya fi dacewa da iyayen iyaye.
Wannan yana nufin cewa idan ba a samu nau'ikan kwayoyin cutar korona ba a nan gaba, ba za a iya samun kwayoyin cutar SARS-CoV-2 ba.
Ba da gangan ba, nau'ikan da aka sayar da su a cikin abincin teku na Huan da aka kashe a cikin babban kasuwar, dole ne su kasance masu watsa shiri na SARS-CoV-2 na dabbobi, tare da su akwai wasu farkon abubuwan da suka shafi COVID-19, wanda shine yanayin watsawar dabba - mutum.
Yawancin binciken da aka yi kwanan nan dangane da lissafin kwayoyin halitta na al'ada sun nuna cewa wata ƙungiya ta ƙananan dabbobi masu haɗari da ake kira Manis Giovannica, suna iya samun beta-corona viruses, wanda ya danganci SARS-CoV-2.
Wannan labari ya nuna cewa kwayoyin cutar coronavirus na ant din suna da kashi 85-92% na tsarin acidic acid da ke cikin sars-coronavirus-2 (SARS-CoV-2).
Duk da haka, suna da alaƙa da RADG13 tare da kusan 90% na alamar a cikin tsarin acidic acid.
Suna cikin wasu nau'ikan halittu biyu na halittu masu cutarwa kamar SARS-CoV-2 a cikin itacen halittar, ɗayan yana da yankin ɗaurewa mai kama da 97.4% amino acid tare da SARS-CoV-2 (RBD).
A akasin haka, RBDs na SARS-CoV-2 da RADG13 (RaTG13) sun bambanta sosai, duk da cewa suna da yawa a cikin kwayoyin halitta.
Wani binciken da aka yi a kan karamin karamin karamin ne ya nuna cewa an gano karamin cutar daga samfurori na huhu, wanda ke da alaƙa da SARS-CoV-2.
Wannan binciken ya dauki hanyoyi daban-daban na hadawa da kuma tsarawa don samar da wani yanki na kwayoyin halitta wanda ya ƙunshi kusan 86.3% na dukan tsawon kwayoyin cutar.
Ba za mu iya ƙaryata cewa bangolin yana cikin nau'in dabba na SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da za ta goyi bayan bayyanar SARS-CoV-2 kai tsaye a cikin tsutsa saboda bambancin jerin tsakanin beta-CoVs da suka shafi SARS-CoV-2 da kuma tsutsa SARS-CoV-2.
Bugu da kari, nisan da ke tsakanin SARS-CoV-2 da RADG13 ya fi nisan da ke tsakanin SARS-CoV-2 da kuma beta-CoVs da ke da alaƙa da SARS-CoV-2 na tururuwa.
Za a kafa hanyar juyin halitta na SARS-CoV-2 a cikin lobsters, tururuwa da sauran dabbobi masu shayarwa.
An gano mafi girman kamanceceniya tsakanin SARS-CoV-2 da kuma ant-RBTs, kuma beta-corona viruses masu alaƙa da SARS-CoV-2 da SARS-CoV-2 da RADG13 suna da mafi girman daidaituwa ta hanyar kwayoyin halitta.
Wani kyakkyawan zato shine cewa babban daidaituwa tsakanin RBDs na SARS-CoV-2 da SARS-CoV-2 na tsutsa tsutsa yana motsawa ta hanyar juyin halitta na zaɓi na matsakaici.
Akwai wani anti-scheme na sake haɗuwa tsakanin beta-CoV-CoV-2 da RaTG13, wanda ke da alaƙa da SARS-CoV-2 a cikin nau'in dabba na uku na daji.
A matsayin mai motsawa a cikin juyin halitta, ana samun karuwar sake yin jima'i tsakanin beta-corona.
Har yanzu ba a haɗa mai tsakiya a cikin asalin cutar ta hanyar dabbobi ta SARS-CoV-2 ba.
Baya ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cututtukan cututtuk
Shaidar ilimin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar hali
An ruwaito cewa kwayar cutar corona ta kwayar cutar Appalachian Ridge, wadda aka gano a cikin kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta.
A gefe guda kuma, kwayar cutar korona ta mutum -229E (HCoV-229E) tana da alaƙa ta hanyar kwayoyin halitta da wani kwayar cutar korona ta Wuwaval, mai suna hypocytosis / kanagwam / 19/2008, wanda aka gano a Ghana, yayin da ake zargin raƙuma na iya zama tsakiya.
Don bayyanawa, an taƙaita bayanan yanzu game da asalin dabbobi na sanannun cututtukan cututtukan mutum (HCoV) a cikin hoto na 1 da kuma Table 2.
Nazarin kabilanci ya samar da bayanan da suka nuna yadda cutar ta mutum ta kamu da cutar ta coronavirus a tsakanin kabilun mutane.
An yi rikodin cutar ta hanyar numfashi a 1890 lokacin da kwayoyin cuta na mutum -OC43 (HCoV-OC43) suka wuce daga dabbobi na gida don cutar da mutane.
Tarihin watsawa tsakanin jinsunan cutar ta mutum -229E (HCoV-229E) bai bayyana ba.
An gano kwayoyin cutar Alpha-Corona ta hanyar cutar ta Wuhan, wanda ke da alaƙa da cutar ta mutum HCoV-229E.
Daga cikin su akwai cutar Alpha-Corona.
Akwai wasu bayanai da suka nuna cewa cutar tana yaduwa daga ƙwayoyin cuta zuwa mutane kai tsaye.
Na farko, mutane ne ba al'umma ba, amma suna iya yin hulɗa da 'yan Wuli a cikin yanayin da aka raba.
A maimakon haka, mutane suna da dangantaka ta kusa da alfukat.
Na biyu, cutar ta Alpha-Corona ta mutum mai suna HCoV-229E tana da bambanci da rashin kamuwa da cutar a cikin kwayoyin halitta, yayin da Albacca-Alpha-Corona ta haifar da rashin lafiya na numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a sami cutar Alpha-Corona a cikin namun daji ba.
Saboda haka, ba za a iya hana alfalanci samun kwayar cutar Alpha-Corona ta mutum ba, wanda ke da alaƙa da cutar HCoV-229E.
A gaskiya, ƙwayoyin cuta sun kasance tushen kai tsaye na cututtukan da ke kamuwa da mutum, ciki har da cutar Rabies, Ebola, Nifa, da cutar Hendra.
Saboda haka, ba abin mamaki ba ne cewa ƙuƙwalwa na iya watsa cutar coronavirus ta mutum -229E (HCoV-229E) kai tsaye zuwa mutane.
A madadin haka, bat alpha-CoVs suna aiki a matsayin bankin kwayoyin HCoV-229E, alfabbots da raƙuman trophy na iya aiki a matsayin masu watsa shirye-shiryen watsa shirye-shiryen cutar zuwa mutane, kamar yadda MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar kwayoyin halitta daga raƙuma zuwa raƙuma guda ɗaya da kuma raƙuma zuwa mutane.
An san asalin cutar MERS-CoV daga kwayar cutar daga lokacin da aka fara gano ta, kuma an ƙarfafa ta ta hanyar binciken da aka samu.
A bayyane yake cewa kwayar cutar tana aiki a matsayin banki mai kyau don rarraba kwayoyin halitta da kuma watsawa na dabbobi.
Tsawon rayuwa, ƙungiyoyi masu yawa, kusanci da haɗin kai da kuma ƙarfin tashi suna da kyakkyawan yanayi don yin 'tabbataccen' yaduwar cutar.
A gefe guda kuma, an gabatar da cutar MERS-CoV ga raƙuma a cikin gida ɗaya na shekaru da yawa.
Wannan kwayar cutar ta dace da raƙuma sosai, ta sauya raƙuma daga mai karɓar bakuncin mai karɓar bakuncin zuwa mai karɓar bakuncin na ɗorewa da na halitta.
MERS-CoV yana haifar da rashin lafiya mai matsakaici kuma yana riƙe da ƙarancin canjin yanayi a cikin waɗannan dabbobi.
Yaduwar cutar a cikin mutane ta faru ne ta hanyar hatsari. Mutane ne suka zama makomar ƙarshe na cutar ta MERS-CoV saboda ba za su iya jurewa ba.
Idan akwai wani abu da ya shafi tsutsa a cikin yaduwar SARS-CoV-2 sabanin yadda raƙuma ke da shi wajen yaduwar cutar MERS-CoV, to, zai zama daban.
Musamman, cutar beta-corona ta zama mafi ƙarancin kamuwa da cutar a cikin tsutsa.
Kamar yadda yake a SARS-CoV, kwayoyin cutar za su iya zama makoma na ƙarshe don beta-corona viruses masu alaƙa da SARS-CoV-2.
Akwai yiwuwar da yawa na watsa SARS-CoV-2 daga dabbobi zuwa mutane, wanda za a tabbatar ko a ƙi a cikin nazarin nan gaba.
Na farko, ƙwayoyin cuta na iya zama ƙwayar cuta ta SARS-CoV-2, wanda zai zama kama da SARS-CoV-2.
Ta hanyar hayaki ko kuma ta wurin hakowa, mutane za su iya raba wuraren da ke cikin yanayi da kuma wuraren da suke cikin yanayi.
Na biyu, tsutsa za su iya zama ɗaya daga cikin sababbin masu karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar
Mutane suna samun kwayar cutar ta hanyar cin naman dabbobi masu cin nama da kuma farauta.
Akwai yiwuwar cewa dabbobi masu shayarwa da dama, ciki har da dabbobi masu gida, za su iya kamuwa da cutar SARS-CoV-2.
Ana buƙatar nazarin dabbobi na gida da na daji don wasu abubuwa.
Na uku, kamar yadda aka ambata a sama, ana iya gano cewa SARS-CoV-2 yana da sassauci da kuma dacewa da jinsin na uku wanda ya danganta da tsutsotsi da tururuwa.
Ana ci gaba da bincike kan asalin dabba na SARS-CoV-2.
Baya ga nau'ikan dabbobi masu yawa, akwai manyan abubuwa uku da ke taimakawa kwayar cutar ta wuce hana haihuwa.
Na farko, suna da yawan mutuntaka a cikin kwayoyin halitta da suke da yawa a cikin RNA.
Idan aka kwatanta da sauran ƙwayoyin RNA guda ɗaya, ana iya ɗaukar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙ.
Kwayar cutar ta Korona tana da kuskuren exoribonucleic alphagalysis, kuma kawar da su na haifar da babban canjin kwayoyin halitta da kuma sanyin gwiwa ko rashin aiki.
Abin sha'awa, an san Reductivir mai suna Uttara acid analogue don hana cutar ta coronavirus ta hanyar hana polymerization na wannan exoribonucleic acid da RNA-based RNA-based RNA.
Remdesvir yana daya daga cikin magungunan anti-SARS-CoV-2 da ake bukata don gwaji a cikin gwaji.
Duk da haka, yawan kwayoyin cutar korona ya ninka na kwayoyinta sau miliyan daya fiye da na kwayoyinta.
Bugu da kari, yawanci ana samun karuwar kwayoyin halitta idan mutum bai dace da cutar coronavirus (HCoV) ba tare da cutar omeira ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canjin kwayoyin halitta, SARS-CoV-2 yana da ƙananan canjin kwayoyin halitta, wanda ke nuna cewa mutane suna da yawa.
Ba a sani ba, an riga an maye gurbin shi da wani rundunar da ke kusa da mutane.
Bugu da kari, ba wai kawai SARS-CoV-2 ba, amma kuma cutar MERS-CoV, wadda ta dace da raƙuma a cikin guda ɗaya.
A ka'idar, kwayoyin halitta, allurar rigakafi da rigakafin cutar za su iya zama marasa amfani ga SARS-CoV-2.
Na biyu, manyan kwayoyin RNA a cikin CoVs suna ba da ƙarin filastik ga canjin kwayoyin halitta don maye gurbin da sake tsarawa, wanda ke ƙara yiwuwar haɓaka haɓaka na ɓoye, wanda ke ba da damar bayyanar da CoVs na labari lokacin da yanayi ya dace.
Wannan yana tallafawa ta hanyar ƙididdigar ƙididdigar buɗewa da ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ.
Na uku, kwayoyin corona suna canza abubuwa a bazuwar kuma sau da yawa yayin amsawa ga RNA ta hanyar fasaha ta musamman ta kwafin kwafin kwafin.
A cikin rundunar da ke taka rawa, sauyin igiya yana faruwa sau da yawa yayin da ake yin kwafin COVID RNA.
Abubuwan da ke cikin kwayoyin halitta masu yawa da ke da cikakken tsawon lokaci da kuma RNA na iya haifar da sabon kwayar cutar.
Ana samun shaidar ilimin halittar halittar halitta a cikin kwayoyin halittar dabba kamar HCoV-HKU1 (HCoV-HKU1) da HCoV-OC43 (HCoV-OC43), da kuma SARS-like-coronavirus-HKU9 (batCoV-HKU9) a cikin kwayoyin halittar dabba.
A cikin wannan labarin, an rubuta cewa: "A cikin Littafi Mai Tsarki, an rubuta cewa: 'Daga cikin ruhu mai tsarki, akwai wani abu da za a iya yi da za a iya yi da shi.
Baya ga abubuwan da aka ambata a sama, haɗuwa da kwayoyin cuta tare da mai karɓar kwayoyin cuta na Umpire yana da wani muhimmin tasiri a cikin yaduwar tsakanin jinsuna.
A nan, an dauki sake fasalin SARS-CoV a matsayin misali mai mahimmanci, wanda ke nuna shaidar gwaji mai kyau a yayin abubuwan da suka faru na watsawa tsakanin jinsuna.
Dangane da kwatancen bincike tsakanin SARS-CoVs na mutum da na kwayar cat, an yi tunanin cewa SARS-CoV na iya fuskantar saurin karbuwa a cikin gidaje daban-daban, musamman tare da canji a cikin RBD na furotin S.
A cikin al'ada, RBD a cikin S Protein na coronavirus yana hulɗa da mai karɓa na kwayoyin halitta kuma ana zaɓar shi sosai ta hanyar maganin rigakafi na host.
A cikin SARS-CoV, RPD yana cikin amino acid 318 zuwa 510 a cikin sashin S1, wanda ke ɗaure da mutum ACE2 (ACE2) da kuma manyan masu karɓar sa don shigar da cutar.
RBD na SARS-CoV yana da ikon gane masu karɓar ACE2 (ACE2) na dabbobi daban-daban, gami da wauwall, fox, rat, da kuma raccoon kare, don haka yana ba da damar watsa cutar tsakanin jinsunan.
A gaskiya ma, an gano cewa amino acid guda shida ne kawai suka bambanta da na mutum da na ciwon daji a cikin RPD, 4 daga cikinsu suna da halayen haɗuwa da mai karɓa don hulɗa da mai karɓa na ACE2.
Civeed SARS-CoV yana da bambance-bambancen K479N da S487T a cikin RBD, wanda zai iya haɓaka haɗin hulɗar furotin na spike tare da mai karɓar ACE2 na mutum.
A wasu kalmomi, waɗannan amino acid iri biyu suna iya zama masu mahimmanci wajen daidaita kwayoyin cutar zuwa mutane.
Ana kuma lura cewa SARS-CoV-2 yana da karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV na nuna cewa an canza haɗin S na S tare da mutum ACE2 a cikin S-protein S1 na S.
A gaskiya ma, wani binciken da aka yi na CREO-EM ya nuna cewa akwai dangantaka tsakanin wannan haɗin kai sau 10 zuwa 20 fiye da tsakanin kwayoyin halitta na mutum ACE2 (ACE2) da SARS-CoV S.
Za a kuma so a tantance ko akwai wasu abubuwan da za su iya haifar da yaduwar SARS-CoV-2.
Abin ban mamaki, kwayar cutar ta mutum -NL63 (HCoV-NL63) tana ɗaure da ACE2 (ACE2), amma tare da bambancin S.
Akwai masu karɓar kwayar cutar ta mutum da yawa, kamar aminopeptidase N don kwayar cutar mutum-229E (HCoV-229E) da 9-o-acetyllated ciatic acid don kwayar cutar ta mutum-OC43 (HCoV-OC43).
Wannan na iya zama dalilin nasarar da aka samu na CoVs a cikin mutane bayan an samu karuwar dabbobi a cikin gidajensu.
Ana sarrafa tasirin cutar ta mutum (HCoV) ta hanyar tafiyar da masu karɓar kwayoyin halitta, da kuma sauran abubuwan da ke tattare da kwayoyin halitta da kuma sarrafawa.
Bambancin waɗannan furotin na furotin tsakanin mutane da kuma nau'ikan kwayoyin halitta na cutar sankarar cuta ta mutum (HCoV), kamar su wolves, guda-daya-daya-daya da kuma dabbobi masu rarrafe, na iya zama cikas ga yaduwar tsakanin jinsuna.
Dole ne cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cutting.
A wannan yanayin, za a gano kuma a rarraba ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta a wannan muhimmin ɓangaren hulɗar ƙwayoyin cuta.
CRISPR zai yi amfani da fasaha ta zamani don yin gwaji na gaba-gaba na kwayoyin halitta game da abubuwan da ke da alaka da kuma sarrafa SARS-CoV-2 ta hanyar amfani da kwayoyin halitta.
Bayyana cutar korona ta mutum (HCoV): An sake fara
Wannan labari na Kwayar cutar korona ta Wawal yana ba da dama ga samar da kwayar cutar korona ta mutum (HCoV).
A wannan yanayin, CoVs na Wal-Wal suna aiki a matsayin bankin kwayoyin HCoVs.
Bugu da kari, saurin maye gurbin kwayoyin halitta da kuma maye gurbin kwayoyin halitta suna haifar da juyin halittar kwayar cutar sankara ta mutum (HCoV), kuma wannan aikin yana aiki a matsayin matakai biyu masu mahimmanci.
Alal misali, samun ko rasa kwayar cutar ta ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta suna da ikon canza yanayin kwayoyin cuta.
A cikin SARS-CoV subprotein, ana ganin cewa canzawa na ORF8 zuwa mutum ne mai mahimmanci, saboda an cire ƙwayoyin cuta na SARS-CoV wanda ke da alaƙa da ƙwayoyin cuta na yau da kullun waɗanda ke encoding daban-daban ORF8 proteins.
An gano wani nau'in kwayar cutar da aka killace a farkon annobar mutum, wanda ke dauke da cutar ta 29 nucleotide-removal of SARS-CoVs.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8B kuma an yi tunanin shi ne gyare-gyare na kwayoyin halitta wanda ke haifar da canjin da ke haifar da maye gurbin da ke cikin urine (host).
Bugu da kari, SARS-CoV yana da tarihin sake haɗuwa da kwayoyin halitta na alpha da gamma coronavirus, inda aka gano ƙananan ƙananan sassan sake haɗuwa a cikin RNA-based RNA polymerase.
An gano wuraren sake fasalin a cikin nsp9, mafi yawan nsp10 da kuma yankunan nsp14.
Hakazalika, an gano cewa cutar ta MERS-CoV tana cikin juyin halitta tsakanin kwayoyin halitta daban-daban, wanda ya faru a cikin kyamarori guda ɗaya a Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an sami halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen ha
Dole ne a yi hankali da cewa zabin na iya ba da gudummawa ga canje-canje na ba zato ba tsammani a cikin kwayoyin cutar, kuma yana iya zama cewa yana kawar da kwayoyin cutar daga matsin lamba kamar tsarin rigakafi na masu masaukin baki.
Misali na irin wannan sakamako shine asarar ORF4 na tsawon lokaci a cikin kwayoyin halitta na mutum na HCoV-229E, saboda kawar da acidic acid.
Tunda ana samun ORF4 wanda ba shi da cutar ta cutarwa da ƙwayar cuta ta mutum da ke da alaƙa da cutar coronavirus-229E (HCoV-229E), alpha-corona alpha-corona yana nuna shigar da acid mai zama ɗaya, wanda ke haifar da canji.
A karshe, juyin halittar kwayar cutar korona ta mutum (HCoV) na faruwa ne sakamakon matsin lamba a cikin masu karbar bakuncin su.
An gano rashin bayyanar cututtuka ko kuma alamun rashin bayyanar cututtuka lokacin da cutar ta kamu da cutar coronavirus, wanda ke nuna daidaituwa tsakanin cutar coronavirus da cutar.
A cewar wasu, 'yan sanda sun yi matukar dacewa da cutar ta Corona a fannin jiki da na jiki.
Alal misali, rashin inganci a cikin maganin rigakafi na kumfa yana rage tasirin maganin rigakafi na masu cutar ta coronavirus.
Bugu da ƙari, aikin kwayoyin halitta masu kisa a cikin ƙwayar cuta yana da damuwa ta hanyar sake fasalin kwayoyin halitta masu kisa na NKG2/CD94, kuma yana faruwa ne saboda ƙananan matakan fallasa kwayoyin aji na I waɗanda ke da manyan kwayoyin cuta.
Bugu da ƙari, ƙwayoyin oxygen masu ƙaruwa (ROS) da aka samar daga aikin haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓ
Ana iya haifar da kwayar cutar ta coronavirus mai cutarwa ta hanyar sake fasalin, wanda ke haifar da samun sabon furotin ko fasalin furotin don daidaitaccen ƙwayar cuta.
Saboda haka, ba zato ba tsammani bane cewa an samu sabon kwayar cutar mutum guda uku (HCoV) a cikin shekaru biyu da suka gabata.
Kwayar cutar ta haifar da alamun rashin lafiya a cikin kwayoyin halitta masu cutarwa ko kuma a cikin masu karɓar bakuncin su kamar su raƙuma da raƙuma.
Suna kwafin kwafin da ba su da ƙarfin hali ba, ba tare da haifar da maganin rigakafi ba.
Ga asirin dalilin da ya sa ake samun rigakafin da ba shi da wata alama da kuma abin da ke haifar da kamuwa da cuta mai tsanani a cikin mutum.
Alamun cututtuka masu tsanani suna haifar da motsa jiki na maganin rigakafi da kuma sake zagayowar cytokine, wanda idan maganin rigakafi ya kasance mai karfi, cutar huhu za ta kasance mafi tsanani.
A akasin haka, a cikin masu hana cutar cutar, an cire maganin rigakafi daga amsawar cutar.
Wannan dabarar ta kawar da rigakafin mutum na iya zama da amfani wajen magance cutar SARS-CoV-2.
Maganin rigakafin kwayoyin cuta yana da ƙarfi musamman a cikin ƙwayoyin cuta.
Saboda haka, ana iya amfani da maganin saurin jini na Interferon na nau'in I a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin mutane.
Bugu da ƙari, an samu rashin ƙoshin lafiya a cikin ƙwayar cuta na NLRP3.
Ta hanyar wannan tunani, an gano cewa hana NLP3 (NLRP3) inflorescome tare da MCC950 zai iya zama tasiri a cikin maganin COVID-19.
An samo asali ne daga SARS-CoV-2 wanda ya biyo bayan wani babban jigon da ya samo asali daga SARS-CoV da MERS-CoV.
Ko da yake an gano cewa beta-cov yana da kashi 95% na nucleotide analogy da SARS-CoV, akwai kuma coronavirus wanda ke da kashi 96% na nucleotide analogy da SARS-CoV-2
An gano cats da sauran dabbobi a cikin kasuwa suna da kwayoyin cutar da suka yi kama da SARS-CoV, duk da haka ba a gano masu karɓar bakuncin SARS-CoV-2 ba.
An gano wasu kwayoyin cutar cutar SARS-CoV-2 na cutar, wanda ke nuna cewa ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
Duk da cewa akwai tambayoyi, babu wata hujja da ta nuna cewa SARS-CoV-2 ta kasance na mutum ko da gangan ko kuma ta hanyar kuskure.
A kwanan nan, an sake gano cutar coronavirus saboda sabon kamuwa da cutar SARS-CoV-2.
Binciken kwayar cutar korona a cikin albasa da sauran dabbobi, da asalin dabbobi a cikin yaduwar mutum da kuma muhimmancin kwayar cutar ta mutum (HCoV) a cikin dabbobi sun canza ra'ayinmu sosai.
Akwai wadataccen hujja cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun samo asali ne daga kwayar cutar Vavaulin kuma suna watsawa zuwa mutane ta hanyar masu karɓar bakuncin.
Idan cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da kwayoyin cuta a kasuwa, ana iya kawo karshen cutar ta SARS ta hanyar rufe kasuwannin nama da kashe kwayoyin cuta.
A cikin wannan dalili, ya kamata a cire tururuwa daga kasuwannin nama don hana yaduwar dabbobi, saboda gano wasu nau'ikan kwayoyin halitta na tururuwa beta-corona, wanda ke da alaƙa da SARS-CoV-2.
Koyaya, ana son bayyana yadda SARS-CoV-2 ke yaduwa zuwa mutane ta hanyar tururuwa da sauran dabbobi masu shayarwa a cikin binciken da za a yi a nan gaba.
A gefe guda kuma, cutar MERS-CoV ta kasance a cikin raƙuma a cikin shekaru da yawa.
Wadannan raƙuman suna da mahimmanci a cikin sufuri kuma suna da mahimmanci ga tushen nama, madara, fata da kayan auduga ga mazauna yankin.
Ana samun su a dukan Gabas ta Tsakiya da Afirka.
Don haka, ba zai yiwu a yi hadaya da dukkan raƙuman don sarrafa cutar ba, kamar yadda aka yi a kasuwannin dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana ci gaba da yaduwar cutar MERS, tare da sauran matakan hana kamuwa da cuta, ya kamata a samar da cikakkiyar hanyar samar da alluran rigakafi masu tasiri ga kyamarori akan cutar MERS-CoV.
Ba za mu iya kawar da waɗannan ƙwayoyin ba, kuma hakan zai iya haifar da sabon nau'in kwayoyin halitta da za su iya haifar da cututtuka masu tsanani.
Akwai nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'
Musamman, ana samun bambancin da ke tsakanin kwayoyin cutar ta hanyar cutar dabba da cutar ta hanyar cutar ta hanyar dabba.
Akwai wadataccen dama ga waɗannan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
Don rage hulda da dabbobi tsakanin mutane, dole ne a kawar da al'adun cin dabbobi a wasu yankunan kasar Sin.
Tare da gwajin SARS, MERS da COVID-19, dole ne a sami kyakkyawan shiri na amsawa.
A gaskiya, akwai wasu ƙwayoyin cuta da suka daɗe a cikin wannan duniyar.
Za su zauna a cikin gidajensu har sai sun sami damar yin yaduwa.
Ko da yake ƙuƙwalwar tana da halaye masu yawa da ke taimakawa wajen yaduwar ƙwayoyin cuta, sanin mutane game da wannan zai iya rage haɗarin da suke da shi na yin hulɗa da ƙuƙwalwar da sauran jinsunan dabbobin daji.
Ana buƙatar ci gaba da lura a cikin dabbobi masu shayarwa don fahimtar yanayin yanayin coronavirus da kuma masu masaukin su na halitta, wanda zai zama da amfani wajen hana yaduwar daga dabbobi zuwa mutum da kuma yiwuwar kamuwa da cutar a nan gaba.
A ƙarshe, hanya mafi kyau ta hana yaduwar cutar ta hanyar dabbobi ita ce ta nisantar mutane daga wuraren da ke cikin yanayin dabbobin dabbobi ke rayuwa.
Har yanzu ba a gano wasu abubuwa da yawa game da asalin cutar ta hanyar dabbobi ta SARS-CoV-2 ba.
Na farko, idan tsutsa suka yada cutar SARS-CoV-2 zuwa tsutsa, za su yi sha'awar ganin a wane yanayi tsutsa da tsutsa suna da muhimmancin muhalli iri ɗaya.
Na biyu, idan akwai wani abu da ke da muhimmanci a wajen yada kwayoyin halitta, dole ne a gano yadda mutane ke hulɗa da kwayoyin halitta.
Na uku, idan dabba ta uku ta zama ainihin dabba mai matsakaici, dole ne a bayyana yadda take hulɗa da halittu daban-daban, ciki har da mutane, da kuma tururuwa da kuma tururuwa.
A ƙarshe, ana buƙatar gudanar da bincike da gwaji na kamuwa da cutar saboda yawancin dabbobi masu shayarwa, gami da dabbobi na gida, na iya kamuwa da cutar SARS-CoV-2.
Idan ya kasance wata dabba ce, ko kuma wata dabba ce, ana sa ran za a iya gano SARS-CoV-2 ko kuma kusan irin wannan mai karɓar bakuncin a cikin gidajensa na halitta a nan gaba.
Ci gaba da sake dubawa a wannan yanki yana bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman tasirin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana bukatar sabunta ka'idojin gano COVID-19 Hukuncin da ake zargi Hukuncin da aka tabbatar 
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganowa da magance kamuwa da cutar Coronavirus (2019-nCoV) ta 2019 kuma jagorar ta ba da kwarewarmu kuma ta samar da kyakkyawan tsari don yaƙar cutar a duniya.
(COVID-19) 2019 sabuwar cuta ce, kuma a lura cewa, ta hanyar binciken da ake yi a yanzu da kuma kwarewar asibiti, hankali da ilimi na ci gaba da karuwa, saboda haka, ana ci gaba da sabunta dabarun gano ko akwai cutar.
A cikin wannan wasikar, mun amsa wani bayani daga cikin jagororinmu, da kuma samar da sabon tsarin ganewar asali na National Health Commission of the People's Republic of China don tabbatar da kamuwa da cutar COVID-19 (suna bakwai) da kuma tabbatar da kamuwa da cutar, bisa ga sabuwar hanyar ganewar asali da kuma jagororin kula da cutar COVID-19.
A watan Disambar 2019, an fara yaduwar cutar coronavirus ta 2019 (2019-nCoV), wanda yanzu ana kiran shi COVID-19 (Coronavirus Disease 2019), wanda kuma ake kira SARS-CoV-2 (Covid-2).
A ranar 11 ga watan Maris na shekarar 2020, Hukumar Lafiya ta Duniya (WHO) ta bayyana COVID-19 a matsayin annobar annoba.
A cikin binciken da aka yi a kan SARS-CoV-2, ƙungiyarmu ta samar da jagorar jagora don magance cutar ta SARS-CoV-2 da aka buga a cikin binciken asibiti na soja a kan shafin yanar gizonmu a ranar 06 ga Fabrairu 2020.
Tun lokacin da aka buga shi, ya sami babban kulawa.
Ka lura cewa COVID-19 sabon cuta ne, kuma ta hanyar binciken da ake yi a yanzu da kuma kwarewar asibiti, hankali da ilimi na mu suna karuwa, saboda haka, ana ci gaba da sabunta dabarun gano ko akwai cutar.
Alal misali, a cikin tsarin ibada don ganowa da kuma magance cutar COVID-19 da Kwamitin Lafiya na kasar Sin ya fitar daga 16 ga Janairu zuwa 3 ga Maris, 2020, (http://www.nhc.gov.cn/), an gabatar da nau'ikan bakwai, wasu daga cikinsu sun canza sosai.
Yanzu haka, akwai ra'ayoyi daga Shu da wasu game da jagorarmu, kuma sun gabatar da tsarin kimantawa mai sauki bisa ga kwarewarsu ta likita.
Ayyukan su sun kara sabon tushe ga jagorarmu kuma sun samar da ingantaccen bayani game da cutar a duniya.
Muna godiya da kuma amincewa da aikin da suka yi.
Duk da haka, dole ne a sabunta ayyukansu don dacewa da sababbin hanyoyin ganewa da magani na COVID-19 (suratar bakwai) da kuma nazarin da aka yi kwanan nan.
A cewar bugu na bakwai (3 ga Maris, 2020), don tabbatar da cewa akwai kamuwa da cutar, dole ne a haɗa abubuwan kamuwa da cutar tare da abubuwa biyu na bayyanar cututtuka don gudanar da nazarin da ya cinye su duka, ko kuma idan babu tarihin bayyanar cututtuka, dole ne ya gamsar da abubuwa uku na bayyanar cututtuka.
Tarihin kamuwa da cutar: (1) tafiya ko zama a birnin Wuhan da kewaye da shi, ko kuma wasu yankunan al'umma da aka samu rahoton COVID-19 a cikin kwanaki 14 na ƙarshe kafin bayyanar bayyanar cututtuka; (2) tuntuɓar marasa lafiya da ke da cutar mura da kuma rashin numfashi daga wasu yankunan al'umma a cikin kwanaki 14 na ƙarshe kafin bayyanar cututtuka; (2) tuntuɓar marasa lafiya da ke da cutar mura da kuma rashin numfashi daga wasu yankunan al'umma a cikin makonni 2 na ƙarshe kafin bayyanar cututtuka; (4) tuntuɓar marasa lafiya daga wasu yankunan al'umma da ke da cutar mura da kuma rashin numfashi daga cikin 'yan ofis da ke da cututtuka masu yawa da suka kamu da cutar, kamar su ofis, makaranta da kuma taro na 2 da suka kamu da cutar da cutar da kuma 2 da suka kamu da cutar a cikin makonni 2 na ƙarshe kafin bayyanar cututtuka.
Bayyanawar asibiti: (1) bayyanar cututtuka na zazzabi da/ko rashin numfashi; (2) bayyanar cututtuka na COVID-19; (3) yawan adadin farar jini a lokacin fara yaduwar jini ya kasance na yau da kullum, ko kuma ya ragu, ko kuma ya ragu.
Gano wani tabbataccen hali ya kamata ya dogara da abin da ake zargi da cutar ko kuma shaidar serological da ke cewa: (1) gwajin PCR na ainihi na SARS-CoV-2 ya kasance mai kyau; (2) cikakken tsarin kwayoyin cutar da ke nuna babban daidaituwa ga sanannun ƙirar coronavirus; (3) IgM antibody da IgG antibody ga SARS-CoV-2 a cikin gwajin magani; ko kuma sauyawa zuwa tabbatacce daga mummunan IgG antibody ga SARS-CoV-2 ko kuma sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa zuwa sauyawa.
Za mu iya ganin cewa an haɗa da gwajin PCR na ainihi don gano ko akwai acid a cikin bututun numfashi ko kuma a cikin samfurin jini a cikin na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara da cewa, a cikin na hudu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020) an kara da cewa, a cikin na bakwai, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, an kara da cewa, a wannan.
Waɗannan canje-canjen da aka yi wa masu bincike sun ci gaba da aiki don nemo ingantaccen kayan aikin gano nucleic acid don saurin ganewa, da kuma samfurori daga cikin bututun numfashi, gami da samfurin jini, wanda ya kara samun samfurori daban-daban, kuma ya goyi bayan kawo tabbataccen sakamako na tabbataccen maganin rigakafi a cikin ka'idodin da aka tabbatar.
Bugu da ƙari, muna da ƙarin hujja don yin hankali da marasa lafiya masu bayyanar cututtuka da marasa bayyanar cututtuka.
"Saboda haka, dole ne a sabunta tsarin aiki na Shu da wasu da ke nuna cewa mutanen da ba su da alamun cutar suna da "ƙarancin haɗari".
Dole ne a sake duba tsarin a cikin asibiti da kuma nazarin.
A ƙarshe, muna fatan samun ƙarin shaidu kai tsaye kuma muna gayyatar masu karatu su ba da ra'ayinsu.
Muna ba da shawarar cewa a gudanar da bincike tsakanin mutanen da ake zaton suna da cutar da kuma mutanen da aka tabbatar da cutar, a gano da kuma bi sababbin ka'idojin da aka kafa a ƙasashensu.
Ƙungiyarmu za ta sabunta ka'idodinmu na ba da taimako daga lokaci zuwa lokaci.
Bangladesh ta samu sabbin mutane biyar da suka mutu a rana daya sakamakon COVID-19, wanda ya kai matsakaicin adadin mutuwar yau da kullum.
Jiya, Bangladesh ta tabbatar da wasu sabbin mutuwar biyar sakamakon COVID-19.
Wannan shi ne adadin mutuwar da aka yi a rana daya da cutar ta yi.
A yau, a cikin adadin cututtukan da aka yi rajista da Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IETCR) ya kai mutane 114 da suka warke daga cutar.
An samu mutuwar mutane 17 a total.
A wani taron manema labarai na yanar gizo, Darakta Mirzadi Sabrina Flora, darektan IETCR, ya ce maza hudu da mace daya sun mutu a hatsarin.
A cewar Dr Mirzadi, mutane biyu sun wuce shekaru 60, mutane biyu sun kai shekaru 51 zuwa 60, kuma mutane 41 zuwa 50.
Ya ce, biyu daga cikin wadanda suka mutu mazauna Dhaka ne.
Hukumar lafiya ta duniya (WHO) ta bayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa kamfanin dillancin labaran kasar Anatoliu cewa, Darakta na hukumar yaki da cin hanci da rashawa ta bangalore, Jalal Saypur Rahman, wanda ke kula da shi a asibitin Kuwait Maidri, yana daya daga cikin wadanda suka mutu.
A wani bidiyo na yau da kullum da aka fitar a ranar Asabar, Ministan Sufuri da Bridges na Bangladesh, Obayedul Gwadar ya bayyana cewa za a dakatar da zirga-zirgar jama'a har zuwa ranar Asabar, fiye da yadda aka shirya.
An fara shirin dakatar da zirga-zirgar jiragen sama a ranar 26 ga Maris kuma an shirya a ranar Asabar, 4 ga Afrilu.
Har ila yau, ana ba da izinin jigilar kayayyakin da ake bukata - magani, man fetur da abinci.
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, tare da biyu da suka dawo daga Italiya da matar daya daga cikinsu,
A ranar 19 ga watan Maris, dukansu uku sun dawo.
SARS-CoV-2 ya kai kamuwa da cutar fiye da miliyan a duniya
Jami'ar Johns Hopkins ta ruwaito cewa, jimlar adadin masu kamuwa da cutar SARS-CoV-2 ta wuce miliyan daya a duniya a ranar Alhamis.
Akalla mutuwar dubu 52 za ta kasance sakamakon cutar COVID-19 da ke haifar da cutar coronavirus.
Wannan muhimmin batu ya zo a daidai ranar da Malawi ta tabbatar da annobar cutar ta farko, wato, mutuwar ta farko da ta shafi cutar korona a Zambia.
Koriya ta Arewa ta ce, a ranar Alhamis, ita ce daya daga cikin 'yan kasashen da ba su da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta yi rikodin kamuwa da cutar 1,051,635, wanda ya haɗa da sabbin shari'o'i 79,332 a cikin awanni ashirin da hudu kafin 10 na safe na 4 ga Afrilu.
An samu karin kamuwa da cutar ta Corona a Amurka fiye da 244,000, wanda ke da alaƙa da mutuwar akalla 5,900.
Labarin CBS News ya bayyana cewa, a ranar Laraba, an samu mutuwar mutane sama da 1,000 a Amurka sakamakon kamuwa da cutar coronavirus, yana mai da hankali kan bayanan da Jami'ar Johns Hopkins ta bayar.
Kasashen duniya sun sanar da daukar matakan dakile yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow, Sergei Zopyan, ya sanar da cewa an kara wa birnin rufewa har zuwa 1 ga watan Mayu.
A kasa, Shugaba Vladimir Putin ya sanar da cewa Rasha za ta ba da albashin da ba za ta je aiki ba har zuwa 30 ga Afrilu.
A majalisar dokokin Portugal an yi kuri'a don tsawaita dokar ta baci ta kasa har kwana 15, inda aka amince da dokar da aka amince da ita da kuri'u 215 a baya, 10 a baya da kuma daya a baya.
Saudiyya ta tsawaita dokar hana fita na kwana daya a cikin biranen Makka da Madina, alhali a baya dokar hana fita ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya yin dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike Dwayne, ya sanar da cewa an kara dokar hana fita zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya suna rage yawan takardar bayan gida don ma'amala.
A ranar Lahadi da kuma ranar Asabar da yamma, shagunan da ke cikin jerin shaguna na Australiya, Woolworths da Coles, sun kawo tsarin sayan kayayyaki a duk shagunan su na kasa, a kan ma'amala guda biyu da kuma kaya daya, bi da bi.
A ranar Litinin, ALTD ta gabatar da ma'anar kawai kunshin daya ga mutum.
An sanya waɗannan iyakokin a matsayin labarai a cikin shafukan yanar gizo da kuma shafukan Facebook na sarƙoƙi.
Idan mutane suka yi zaman kansu, ana san cewa masu amfani suna sayen kayayyaki saboda tsoron COVID-19.
A ranar Laraba, kamfanin Woolworths ya rage sayan takardar wanka don rarraba gidaje a matsayin fakiti don kyauta.
Waɗannan canje-canjen sun biyo bayan dokar da ta gabata, wanda aka gabatar da ita ta hanyar Woolworths da Coles a ranar 4 da 5 ga Maris, bi da bi.
"A cikin sanarwarsa ta 8 ga Maris, Coles ya bayyana cewa, "ma'aikatun da yawa suna ci gaba da zama marasa sayarwa a cikin sa'a daya bayan an rarraba su, kuma wannan bukatar ba ta taba faruwa ba", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ta kira shi ""ba zato ba tsammani".
"Wani kakakin kamfanin Woolworths ya ce tallace-tallace a makon da ya gabata sun karu da "mai tsanani".
Kayan Kostago a Canberra ma ya rage adadin da aka ba shi a makon da ya gabata zuwa fakiti biyu.
Don kara rage matsalar, Koles bai ba da izinin bayar da gudummawa ga manyan fakitoci daga masu samarwa ba, amma ya kara lokutan bayarwa. Woolworths ya ba da izinin bayar da gudummawa ga karin tanadi, yayin da ALDI ta shirya tanadi don siyarwa ta musamman a ranar Laraba.
Russell Zimmerman, darektan zartarwa na kungiyar 'yan kasuwar Australiya, ya ce yayin da 'yan kasuwar ke kokarin tara kudade, takunkumin da majalisar ta kafa kan lokacin isar da kaya na gida suna sanya shi wuya.
Ya ce, yayin da masu samar da kayayyaki ke kokarin biyan bukatar, farashin samarwa zai karu saboda karancin kayan da ake bukata.
A ranar Talata, ALDI ta sanar da cewa wasu shaguna ba za su iya aiwatar da ranar Laraba ta Musamman ba, saboda an riga an saki kayayyakin ajiya.
A cikin rahoton News.com.au, Dr. Gary Mortimer, masanin kasuwanci na kiri a Jami'ar Fasaha ta Queensland, ya ce shagunan suna cike da kayayyaki a kowace dare.
Ya ce, takardar bayan gida abu ne mai kiba wanda ke haifar da karancin kayayyaki, sannan bayan an sayar da komai, idan aka ga cewa duk manyan ɗakunan ajiya sun kasance marasa komai, za a kara samun rashin.
"Goli da Woolworths sun yi imanin cewa idan an ajiye abubuwa masu yawa a cikin ɗakunan ajiya, wato, kayan wanka da kayan tsabtace ruwa, da kuma kayan da za a iya saya, za a iya rage yawan tsoro", in ji Russell Zimmerman a wata hira da aka yi da ABC News.
A ranar Laraba, masana'antar kera takardar gidan wanka da aka sake amfani da ita, Who Gives a Crab, sun ce za su rasa kayayyakin su.
Kamfanin Kimberly-Clark, wanda ke samar da takardar gidan wanka na Clenex, da kuma kamfanin Solaris, wanda ke samar da sorbent, sun ce suna aiki 24/7 don kula da rarraba, in ji rahoton News.com.au.
Wani dandalin sayar da gidaje da gidaje na yanar gizo, Domain.com, ya ruwaito cewa wasu masu sayar da dukiya sun gabatar da takarda na gidaje kyauta ga masu neman kayan aiki a farkon gwanjon da aka yi a Melbourne.
A cikin jaridar N.T. News da ake buga a yau Alhamis a Darwin, an yi ta daɗaɗaɗa da shafi takwas da za a iya amfani da su a matsayin takarda ta gidan wanka.
A wani rahoto da ABC Australia ta bayar a ranar 3 ga watan Maris, an ce da farko, shaguna sun yi jinkirin sanya takunkumi, kuma an ce ba su da shirin yin takunkumi kan sayayya.
Russell Zimmerman ya ce akwai bukatar wasu abubuwa da suka hada da masks, disinfectants, dryers, handwashes da kuma gari.
Hakazalika, a waje da Australia, taron da ya faru a ranar Lahadi da yamma ya rage sayan takardun wanka na Octavo Andrews, wani kantin sayar da kayayyaki na Burtaniya, zuwa fakitin 12 na kwalliya.
Hukumar lafiya ta duniya ta bayyana COVID-19 a matsayin annoba.
Hukumar lafiya ta duniya WHO ta bayyana COVID-19 a ranar Laraba a matsayin annoba, wanda ke haifar da cutar SARS-CoV-2
Ko da yake kalmar "mutu" tana nufin yadda cutar ta yadu, ba yadda cutar ta musamman take da haɗari ba, saboda haka Hukumar Lafiya ta Duniya (WHO) ta nuna bukatar gwamnatoci su dakatar da aiki:"
"Dukkanin kasashe na iya canja yanayin annobar a yanzu".
"Ya kamata ƙasashe su gano, gwada, bi da su, ware su, gano su, kuma su haɗa kan al'ummarsu", in ji Darakta Janar na Hukumar Lafiya ta Duniya (WHO) Tetros Adhanom Gabreyes.
"Yana da matukar damuwa game da yadda cutar ta yadu da kuma yadda ta yi tsanani da kuma yadda ba a dauki mataki ba".
"Daga cikin bayanin da Dokta Tom Freedman, tsohon darektan cibiyoyin kula da cututtuka a Amurka ya bayar, annobar ta kasance ""ba a taɓa gani ba".
A wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce, "Babu wani cutar da ta shafi numfashi da aka lura da ita, banda mura mai tsanani, daga bayyanar zuwa ciwon duniya".
"Gabreus ya yi irin wannan ra'ayin, yana cewa, ""Ba mu taɓa ganin annoba da ta taso daga kwayar cutar coronavirus ba".
"Ya ce, ""Ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba.
Bayan da Hukumar Lafiya ta Duniya (WHO) ta yanke shawarar a watan Janairu ta ayyana yaduwar cutar a matsayin dokar ta baci ta kiwon lafiya ta duniya, an sake sanya ta a matsayin annobar annoba.
"Darakta Anthony Fauci, darektan cututtuka na allergy da cututtuka na kasa na Amurka, ya ce game da yaduwar, ""ainihin, zai kara muni".""
A cewar Associated Press, a ranar Alhamis, adadin mutanen da suka kamu da COVID-19 a duniya ya kai 126,000, kuma ya haifar da mutuwar 4,600.
Cutar COVID-19 ta 2019 ta kasance cutar COVID-19 da ke haifar da cutar ta COVID-19 wanda ke haifar da cutar ta COVID-19 ta COVID-19 wanda ke haifar da cutar ta COVID-19 ta COVID-19 wanda ke haifar da cutar ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID-19 ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta XNUMX ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta XNUMX ta XNUMX ta XNUMX ta hanyar da aka gano cewa an cutar da cutar ta cutar da cutar ta cutar da cutar ta cutar ta cutar da cutar ta cutar ta cutar da cutar ta cutar ta cutar da ta cutar ta cutar ta cutar da ta cutar ta cutar ta cutar da ta cutar ta cutar ta cutar ta cutar ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta COVID ta XNUMX ta XNUMX ta XNUMX ta XNUMX ta XNUMX ta hanyar da da da da da da da da da da aka cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar
An gano cutar a Wuhan, China, a watan Disambar 2019. An bayyana ta a matsayin dokar ta baci ta kiwon lafiya ta duniya a ranar 30 ga Janairu, 2020.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210 da suka yi fama da cutar, wanda ya haifar da mutuwar kusan mutane 97,000.
Kusan mutane 364,000 ne suka warke.
A kasar Sin, yawan mutuwar mutane daga cutar ya kai kashi 4 cikin 100, yayin da a duniya, ya kai kashi 13.04 cikin 100 a Aljeriya zuwa 0.08 cikin 100 a New Zealand.
Alamu na kowa da za a iya gani a ciki su ne zazzabi, tari, da kuma numfashi.
Abubuwan da ke tattare da matsaloli na iya zama pneumonia da kuma rashin lafiyar huhu mai tsanani.
Lokaci na bayyanar cututtuka daga kamuwa da cuta, yawanci kwanaki biyar ne, amma zai iya ɗaukar kwanaki biyu zuwa goma sha huɗu.
Babu wani magani ko kuma maganin rigakafi na musamman.
Maganin farko shine maganin bayyanar cututtuka da kuma maganin hanawa. Hanyoyin rigakafi da aka ba da shawarar sun haɗa da wanke hannu, rufe baki yayin duka, kiyaye nesa daga wasu, saka idanu da kuma ware kai daga mutanen da ake zargi da yiwuwar kamuwa da cuta.
Hukumomi a duk faɗin duniya sun amsa ta hanyar aiwatar da takunkumin tafiye-tafiye, killacewa, aiwatar da kulle-kulle, kula da haɗari a wuraren aiki da rufe wuraren aiki.
Rashin cin hanci da rashawa ya haifar da mummunan rikici na zamantakewa da tattalin arziki na duniya, jinkirta ko soke abubuwan da suka shafi wasanni, addini, siyasa da al'adu, da kuma yawan rashin wadatar kayayyaki da ke tattare da tashin hankali.
A cikin kasashe 193, makarantu da jami'o'i sun rufe a kasa ko a gida, wanda ya shafi kusan kashi 99.4 cikin dari na yawan daliban duniya.
Labarai marasa kyau game da cutar sun bazu a Intanet. An kuma sami wasu abubuwan da ke nuna tsoron baƙi da nuna bambanci ga mutanen Sin, waɗanda suka fito daga gabashin da kudu maso gabashin Asiya, da kuma waɗanda suke da kama da su, da kuma waɗanda suka fito daga wasu yankuna inda cutar ta fi fama da su.
Saurin tafiye-tafiye da rufe manyan masana'antu sun rage yawan gurɓataccen iska da kuma iskar carbon dioxide.
A ranar 31 ga watan Disamba na shekarar 2019, mutane da dama sun kamu da cutar ta numfashi, ba tare da sanin dalilin ba, kuma an fara bincike a kan cutar a farkon watan Janairu na shekarar 2020, a cewar jami'an lafiya a Wuhan, China.
Wadannan marasa lafiya galibi suna da alaƙa da kasuwar sayar da abincin teku ta Hunan, saboda haka ana tsammanin cutar tana da asalin cutar dabba.
An gano cewa cutar SARS-CoV-2 (wanda ake kira SARS-CoV-2) ne ke haifar da yaduwar cutar, wanda ke da alaƙa da cutar coronavirus ta hanyar ƙuƙwalwa, cutar coronavirus na tururuwa da SARS-CoV. An gano cewa mutumin da aka fara gano alamun cutar ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019 kuma mutumin bai san komai ba game da kayan masarufin nama.
A cikin farkon gwajin gwajin a watan Disamba na 2019, kashi biyu bisa uku na wadanda suka kamu da cutar sun kasance suna da alaƙa da kasuwa.
Wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya bayyana a ranar 13 ga Maris, 2020 cewa mai shekaru 55 da haihuwa daga lardin Hubei zai iya zama mutum na farko da ya kamu da cutar, kuma hakan zai iya faruwa a ranar 17 ga Nuwamba, 2019. Duk da cewa sabon kamuwa da cutar a China ya ragu, amma da sauri ya karu a Italiya, Iran da Koriya ta Kudu, a ranar 26 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta ce adadin sababbin marasa lafiya da ke zuwa magani a waje da China ya fi yawan waɗanda ke zuwa magani a China a karon farko.
Akwai yiwuwar cewa an yi rahoto kadan game da kamuwa da cuta, musamman a tsakanin mutanen da ke da alamun rashin lafiya.
A ranar 26 ga Fabrairu, an samu ƙananan ƙananan marasa lafiya, kuma a duniya, kashi 2.4% ne kawai na marasa lafiya da shekarunsu suka kai 19 ko ƙasa da haka. Patrick Vellance, babban mai ba da shawara kan kimiyya na Ingila, ya kiyasta cewa kashi 60% na mutanen Ingila za su iya kamuwa da cutar kafin su sami rigakafin garken da ke da tasiri.
Waɗannan suna nuna yawan mutanen da aka gwada don COVID-19 kuma an tabbatar da gwajin a cikin ƙa'idodin hukuma.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da 3% na yawanta, kuma akwai wasu ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland da ke da manufofi na hukuma na kada su gwada waɗanda ke da alamun rashin lafiya.
Wani bincike da aka wallafa a ranar 16 ga watan Maris ya nuna cewa, har zuwa 23 ga watan Janairu, kashi 86 cikin dari na kamuwa da cutar COVID-19 da aka samu a kasar Sin ba a gano su ba, kuma an gano cewa, wadannan kamuwa da cutar da ba a gano ba sun yada cutar ga kashi 79 cikin dari na marasa lafiya da suka kamu da cutar.
A cikin nazarin kididdigar da aka fitar a ranar 30 ga Maris, an kiyasta cewa akwai yiwuwar kamuwa da cutar a Italiya fiye da yadda aka bayyana a fili.
Matsayin farko na asali na haihuwa (R0) don COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da cibiyar kula da cututtuka ta Amirka ta wallafa ya nuna cewa hakan zai iya zama 5.7.
Mutane da yawa da suka kamu da cutar COVID-19 suna samun sauki.
Ga wadanda ba su yi hakan ba, lokaci daga bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, wanda shine mafi yawan kwanaki 14.
A ranar 10 ga Afrilu, 2020, an yi kusan mutuwar 97,000 sakamakon COVID-19.
A kasar Sin, kamar yadda aka gani a ranar 5 ga Fabrairu, kashi 80% na mutuwar sun wuce shekaru 60 kuma kashi 75% na marasa lafiya sun riga sun sami cututtukan cututtuka, ciki har da cututtukan zuciya da ciwon sukari.
Yawan mutuwar da COVID-19 ta haifar na iya zama mafi girma, saboda ba za a iya haɗa waɗanda suka mutu ba tare da an gwada su ba - a cikin gidajen kulawa, gidajen kulawa, da sauransu.
Bayanai na bangare daga Italiya sun gano cewa yawan mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar cutar ta coronavirus ta hukuma ta hanyar kashi 4-5x.
"Shugaban kula da cututtuka na Amurka (CDC) ya yarda cewa, ""[Mutanen da suka mutu] sun san an yi musu rahoto", wata sanarwa da aka tabbatar da ta hanyar ƙarancin rahotanni na bayanai a Amurka. Irin wannan raguwa yana faruwa ne a lokutan cututtuka, kuma ya faru ne a lokacin annobar 2009 H1N1 swine flu. Mutuwar farko da aka tabbatar ta faru ne a Wuhan a ranar 9 ga Janairu, 2020".
Mutuwar farko a waje da kasar Sin ta fara a Philippines a ranar 1 ga watan Fabrairu, kuma mutuwar farko a waje da Asiya a Faransa a ranar 14 ga watan Fabrairu.
A cikin watan Fabrairu, mutane 12 ne suka mutu a kasashen waje, kamar Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, an ruwaito cewa an samu mutuwar a cikin kasashe da yankuna sama da arba'in a duk nahiyoyi sai dai Antarctica.
Yawan ya bambanta a tsawon lokaci dangane da yankin, kuma ya bambanta ta hanyar yawan mutane, kamar su yawan da ake gwadawa, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da cutar ta fara zuwa yanzu, shekaru, jinsi, da kuma lafiyar gaba ɗaya.
Bisa ga bayanan jami'ar Johns Hopkins, yawan mutuwar kamuwa da cutar a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Yawan ya bambanta bisa ga yankuna.
A China, ƙididdigar yawan marasa lafiya da waɗanda suka mutu sun ragu daga 17.3% (mutanen da ke da alamun cutar a tsakanin 1 -10 ga Janairu 2020) zuwa 0.7% (mutanen da ke da alamun cutar a bayan 1 ga Fabrairu 2020). Sauran matakan sun haɗa da yawan mutuwar marasa lafiya (CFR-CFR), wanda ke nuna yawan waɗanda suka kamu da cutar (masu kamuwa da cutar da waɗanda ba a gano su ba) da kuma yawan mutuwar kamuwa da cutar (IFR-IFR).
Wadannan kididdigar ba su da iyaka kuma hanyar da za a iya yin maganin ita ce bin wani rukuni na mutane da suka kamu da cutar.
Yawancin cibiyoyin ilimi sun yi ƙoƙari su ƙidaya wannan adadi ga wani yanki na jama'a.
A lokacin annobar, cibiyar magunguna ta jami'ar Oxford ta kiyasta cewa yawan mutuwar da ake samu daga kamuwa da cutar zai kasance tsakanin kashi 0.1 zuwa 0.39%.
Matsakaicin kimantawa na wannan zangon ya dace da sakamakon gwajin farko na bazuwar COVID-19 a Jamus da kuma nazarin kididdiga wanda ke nazarin tasirin gwajin akan kimantawar CFR.
Hukumar lafiya ta duniya ta ce za a iya hana annobar.
Matsakaicin lokaci da kuma lokacin da za a iya kamuwa da cutar ba su da tabbas, kuma suna iya bambanta ta wurin wurin.
"Magij Boni na Jami'ar Jihar Penn ya ce, ""Idan ba a tabbatar da cewa cutar ta kai wani matakin da ba a saba gani ba, sai dai idan an fara samun karuwar cutar a cikin gidajen da ke dauke da cutar".
"Amma a yanzu, ba shi yiwuwa a yi wani shiri mai kyau game da lokacin da zai faru".
"Zhang Nanshang, babban mai ba da shawara kan harkokin likitanci na gwamnatin kasar Sin, ya yi kira ga dukkan kasashe su yi aiki tare don bin shawarar da Hukumar Lafiya ta Duniya (WHO) ta bayar game da matakan hana yaduwar cutar, idan za a iya yin hakan, ""za a kammala shi a watan Yuni".
"A ranar 17 ga watan Maris, Adam Kucharsky, na makarantar kiwon lafiya da kiwon lafiya ta London, ya ce SARS-CoV-2" Tabbas zai kasance a cikin yaduwar, zai kasance har shekara guda ko biyu, ""
"A cewar wani bincike na Imperial College karkashin jagorancin Neil Ferguson, ""za a bukaci kauce wa jiki da sauran matakan da za su iya ɗauka har sai an samu rigakafi (yana iya ɗaukar watanni 18 ko fiye) ".
"Ba zan iya tunanin cewa cutar za ta ɓace ba domin tana da saurin yaduwa", in ji William Shaffner na Jami'ar Vanderbilt, "kuma za ta iya zama wata cuta ta zamani da za ta sake dawowa kowace shekara".
Idan cutar ta sake barkewa, ƙarfinta zai dogara ne akan rigakafin yawan jama'a da kuma girman kwayoyin cutar.
A cewar wani rahoto, an gano cewa cutar COVID-19 ba ta da alamun bayyanar cututtuka, kuma ana iya gano cewa mutane da suka kamu da cutar suna da alamun bayyanar cututtuka.
Alamun da suka fi kowa sune zazzabi (88%) da kuma tari (68%).
Alamomin da aka fi gani sun hada da gajiya, yawan shan numfashi (matsananci), rashin fahimtar abin da ake ci, numfashi, ciwon tsoka da na'ura, ciwon wuya, ciwon kai, ciwon hanci, haushi, zubar da jini, ciwon ciki ko kuma ciwon haushi. Hukumar lafiya ta duniya (WHO) ta ce mutum ɗaya cikin shida yana fama da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Rigakafin Amurka (CDC) ta lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji ko matsa lamba, rikicewar farkawa, wahalar tashi, da kuma fuska ko lebe mai launin shuɗi. Idan akwai waɗannan alamun, ana ba da shawarar samun magani na gaggawa.
Saboda wasu daga cikin wadanda suka kamu da cutar ba su da wata alama, kuma ba su da wata alama ta asibiti, kuma sakamakon gwajin ya tabbatar da cewa sun kamu da cutar, masu bincike sun ba da shawarar cewa a sanya ido sosai da kuma gwada waɗanda ke da kusanci da waɗanda suka kamu da cutar don su kasance masu tsira daga kamuwa da cutar.
China ta kiyasta cewa yawan rashin alamun cutar ya kai kashi 44 cikin dari.
Wani misali na rashin tabbas shine, a cikin COVID-19 an fara kimantawa na rasa rashin jin daɗi a kashi 30% daga baya ya ragu zuwa 15%.
Har yanzu ana yin bincike a kan yadda cutar take yaduwa.
Ana ganin cewa cutar tana yaduwa ne ta hanyar kusantar da kai, ta hanyar tari ko kuma ta hanyar magana, wanda ke nuna cewa yana da nisa daga mita 1 zuwa mita 2 (daga 3 zuwa 6 feet).
Bincike ya nuna cewa idan ba a rufe bakinsu ba, saukad da za su iya tafiya daga mita 4.5 zuwa mita 8.2 zuwa 27.
Wasu sun ce ƙarancin saukad da ruwa da ake fitarwa yayin magana suna iya zama a cikin iska na dogon lokaci kuma suna iya yin yaduwar cutar ta hanyarsa. Ko da yake ba a yawan samun wannan cutar ta iska, saukad da numfashi na iya fita a lokacin da ake numfashi, har ma a lokacin magana.
Za a iya samun ruwa a bakin ko a cikin hanci ko kuma a numfasa shi cikin huhu.
Ana iya yin amfani da wasu hanyoyin likita kamar allura da kuma bugun zuciya (CPR) don yin fesa ta hanyar numfashi, wanda zai iya haifar da yaduwar cutar a cikin iska.
Idan mutum ya taɓa wani gurɓataccen yanki, har da fata, to zai iya yaduwa idan ya taɓa idanunsa, hanci ko bakinsa.
Ko da yake akwai damuwa game da yiwuwar yaduwar cutar ta hanyar ƙazanta, an yi imanin cewa akwai ƙananan haɗarin irin wannan haɗarin.
Gwamnatin kasar Sin ta musanta cewa SARS-CoV-2 ba zai iya yaduwa daga kwayar cutar ta bakin ba. Ana iya samun kamuwa da cutar a cikin kwanaki uku na farko na bayyanar cututtuka, amma ana iya samun kamuwa da cutar kafin bayyanar cututtuka da kuma bayan kamuwa da cutar.
Wasu sun tabbatar da cewa cutar ta kamu ne kwanaki uku kafin bayyanar bayyanar cututtuka, saboda haka yana nuna cewa akwai yiwuwar kamuwa da cutar kafin bayyanar bayyanar cututtuka.
Wasu daga cikin rahoton sun kasance marasa alamar cutar da aka tabbatar da su a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano cewa an yi musayar cutar ba tare da alamun cutar ba a lokacin binciken ganowa.
Cibiyar Tsaro da Kula da Cututtuka ta Turai (ECDC) ta ce, ko da yake babu cikakken bayani game da yadda cutar take yaduwa, mun san cewa mutum zai iya yaduwa zuwa mutum biyu zuwa uku.
A cikin polypropylene da kuma 304 grade steel, an gano cewa cutar tana rayuwa har zuwa kwana uku, kwana daya a kan allon kwali da kuma sa'o'i hudu a kan tagulla.
Wannan, duk da haka, zai bambanta dangane da zafi da zafin jiki. An tabbatar da tasirin COVID-19 a cikin dabbobi da sauran dabbobi.
Ko da yake babu wata hujja da ta nuna cewa dabbobi za su iya kai cutar ga mutane, jami'an Birtaniya sun ba da shawarar wanke hannuwan mutum bayan ya taɓa dabbobi kamar yadda zai yiwu masu kamuwa da cutar sun taɓa su bayan sun tuntubi wasu farfajiyoyi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Dukkanin halaye na sabon SARS-CoV-2 suna faruwa a cikin kwayoyin cutar coronavirus da suka danganci. Ta hanyar narkar da suturar kariya a waje da jikin mutum, an kashe kwayar cutar ta sabulu na gida.
An yi zaton cewa an fara yaduwar cutar daga dabba zuwa mutum.
An gano cewa kwayar cutar Corona, beta corona, tana da filaye biyu na kwayar cutar Sarpeco (Cyrrhoidea B) wanda ya samo asali daga ƙwayoyin cuta a cikin nau'in al'ada.
Wannan ya dace da sauran kwayoyin cutar Corona (RDG13) a cikin jimlar kwayoyin halitta na 96% na kwayoyin halitta.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a cikin takamaiman sassan jerin kwayoyin halitta tsakanin kwayoyin cutar da aka samo daga tururuwa da kuma wadanda suka yada su zuwa mutane.
Ya zuwa yanzu, yawan kwayoyin da ke cikin ƙwayar cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta ta cuta da ta cuta da ta cuta da ta cuta da da da ta cuta da da da da ta cuta da da da ta cuta da da da ta cuta da da da da ta cuta da da da ta cuta da da da da da ta cuta da da da da da da ta cuta da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da
Ana iya gano cutar ta wucin gadi ta hanyar bayyanar cututtuka, amma ana iya tabbatar da kwafin rigakafin ne kawai ta hanyar kwafin kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta.
Wani binciken da aka gudanar a Wuhan, wanda ya kwatanta PCR da CT, ya nuna cewa CT na iya nuna sakamako mai kyau fiye da PCR, duk da cewa wasu siffofin CT sun fi ƙarfin sauran cututtukan huhu da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
"Kamar yadda aka yi a watan Maris na 2020, Kwalejin Nazarin Radiology ta Amurka ta bada shawarar cewa kada a yi amfani da tsarin CT (CTC) a matsayin "gwajin farko ko gwajin tantancewa don gano COVID-19".
Hukumar Lafiya ta Duniya (WHO) ta fitar da ka'idojin gwaji na RNA (RNA) don cutar SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Kwafin gwajin ya yi amfani da tsarin kwafin kwayoyin halitta (RRT-PCR) a ainihin lokacin.
Ana iya gwada shi a cikin samfurori na numfashi ko jini.
Sakamakon zai kasance a cikin 'yan sa'o'i kaɗan zuwa kwanaki kaɗan.
Ko da yake ana iya amfani da ƙuƙwalwar ƙuƙwalwa, a mafi yawan lokuta ana yin wannan gwajin ne a kan ƙuƙwalwar ƙuƙwalwar ƙuƙwalwa. Yawancin dakunan gwaje-gwaje da cibiyoyin bincike suna haɓaka hanyoyin gwajin nakasa don gano ƙuƙwalwa.
A ranar 6 ga Afrilu, 2020, ba a tabbatar da cewa duk waɗannan sun isa ga daidaito don karɓar amfani da yawa ba.
An amince da tsarin gwajin ilimin lissafi da Cellex ya samar don amfani da gaggawa kawai ta hanyar dakunan gwaje-gwaje masu inganci a Amurka.
Abubuwan da ke nunawa na radiographic maps da radiographic sketches (CTs) akan mutane masu alamun sun hada da rashin daidaituwa na waje na waje da kuma ba-blaral fluids.
Kungiyar Radiology ta Italiya ta samar da wani dandalin yanar gizo na kasa da kasa na bayanan da ke nuna alamun da aka tsara don mutanen da suka kamu da cutar.
Saboda haɗuwa da sauran cututtukan cututtuka kamar Adenoids, yin kwayar halitta ba tare da tabbatar da PCR ba yana da ƙwarewar gano COVID-19.
Wani babban binciken da aka gudanar a kasar Sin ya nuna cewa, yayin da sakamakon CT na kirji ba shi da tabbas na gano cutar daidai da PCR, ana iya ganin cewa CT na iya zama kayan aiki na gano tasirin cutar.
An kirkiro hanyoyin sadarwa na jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyajuya.
Kula da lafiyar mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko bakinka da hannayen da ba a wanke ba, da kuma yin ayyuka kamar tari ko kumburi a cikin wani nama, da kuma saka wannan nama kai tsaye a cikin shara, sun haɗa da dabarun hana yaduwar cutar.
An shawarci wadanda suka riga sun kamu da cutar su sa abin rufe fuska a cikin jama'a.
Ana kuma ba da shawarar yin amfani da tazara ta jiki don hana yaduwar cutar. Gwamnatoci da yawa sun hana tafiya zuwa ƙasashe da yankuna da ke fama da cutar da duk wasu tafiye-tafiye marasa mahimmanci.
Duk da haka, a yawancin duniya, cutar ta kai matakin da ta shafi al'umma.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi kuma wasu 'yan al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar yin amfani da matakan tsaro na yau da kullun, na tuntuɓar mutum, da kuma kula da idanu yayin kula da waɗanda za su iya kamuwa da cutar. Kula da hulɗa da su shine babban hanyar da jami'an kiwon lafiya ke amfani da su don tantance asalin asalin kamuwa da cutar da kuma hana yaduwar cutar.
Amfani da bayanan wurin da gwamnatoci ke bayarwa ta wayoyin hannu don wannan dalili ya haifar da rikice-rikice game da keta sirrin, kuma Amnesty International da sauran hukumomi sama da 100 sun ba da rahoto suna neman a hana amfani da irin wannan sa ido.
An kunna ko kuma an gabatar da aikace-aikacen wayar hannu daban-daban don amfani da kai, kuma kamar yadda aka yi a ranar 7 ga Afrilu, 2020, ƙungiyoyi sama da goma sha biyu na ƙwararrun suna aiki akan mafita mai ladabi, gami da yin rikodin kwanan wata mai amfani tare da wani wayar hannu ta amfani da Bluetooth.
Masu amfani za su karɓi saƙon rubutu idan sun kasance a kusa da wanda aka gano yana da kamuwa da COVID-19 a cikin gwajin. Ana yada ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar; misali, wanke hanci da kuma wanke bakinka ba zai amfane ba.
Babu maganin COVID-19, amma kungiyoyi daban-daban suna aiki don samar da irin wannan.
Don hana yaduwar cutar, ana ba da shawarar wanke hannu sosai.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da yawa tare da ruwan sha da kuma ruwan sha na akalla na ashirin na biyu. An ba da shawarar cewa mutane su wanke hannuwansu aƙalla bayan sun je bayan sun dawo bayan sun shiga gidan wanka, ko kuma idan sun kasance marasa tsabta yayin kallon hannuwan; kafin cin abinci; bayan sun shafa hanci, bayan sun yi kumburi ko sun yi kumburi.
Domin a waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ke lalata makamashi.
A lokacin da babu sabulu da ruwa, Cibiyar Kula da Cututtuka da Rigakafin ta ba da shawarar yin amfani da kayan tsabtace hannu na giya wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya.
Hukumar lafiya ta duniya (WHO) ta shawarci mutane da su guji taɓa idanu, hanci ko baki ba tare da wanke hannu ba.
Ana iya tsabtace farfajiya ta hanyar wasu magunguna (a cikin minti daya bayan an sanya maganin kashe kwayoyin cuta a saman karfe) ciki har da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochloride, 0.5% hydrogen peroxide, da 0.2-7.5% bovidone-iodine.
Sauran abubuwa masu narkewa kamar benzodiazepine chloride da kuma chlorohexidine gluconate suna da ƙananan tasiri.
A wuraren da ake zargin akwai cutar ko kuma ofishin da aka tabbatar da kamuwa da cutar ko kuma cibiyar kula da mutane a lokacin rana, za a yi amfani da ofisoshin ofishi, dakunan wanka, da wuraren da mutane ke amfani da su.
Hukumomin kiwon lafiya sun ba da shawarar cewa a cire duk wani nama da ke cikin baki da hanci da sauri, idan mutane suka sunkuyar da gwiwoyinsu ko kuma suka rufe bakinsu da hancinsu da ƙwayoyin cuta a lokacin tari ko kuma tari.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata ga waɗanda ke fama da cutar, saboda saka abin rufe fuska zai iya rage yawan ruwa da kuma nisan tafiya yayin da ake magana da kuma numfashi yayin da ake yin tawaye da kuma yin tawaye.
Hukumar lafiya ta duniya (WHO) ta fitar da umarnin kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar Stephen Griffin, masanin ilimin cututtuka a jami'ar Leeds, ""rashin tsabtace hannu na yau da kullum shine babban dalilin da ya sa cutar ke yaduwa, kuma sanya abin rufe fuska zai rage yawan mutanen da ke so su taɓa fuskarsu ta hanyar sanya abin rufe fuska. "" Ana kuma ba da shawarar cewa masu kula da waɗanda ke da yiwuwar kamuwa da cutar su sanya abin rufe fuska".
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa masu lafiya su sa abin rufe fuska ne kawai idan suna cikin haɗari kamar kula da wani wanda ke da COVID-19, duk da haka sun yarda cewa sanya abin rufe fuska zai taimaka wa mutane su guji taɓa fuska.
Kasashe da dama sun fara inganta amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska wanda ba a yi amfani da shi ba a aikace na likita na masana'anta. China ta ba da shawarar musamman ga masu lafiya su yi amfani da abin rufe fuska na likita, musamman lokacin da suke hulɗa da wasu a kusa (1 m (3 ft) ko ƙasa da haka).
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata lokacin amfani da sufuri na jama'a ko kuma a wuraren da ke da yawan jama'a.
Hukumomin lafiya na Thailand suna ƙarfafa mutane su yi amfani da takalma masu rufe fuska a gida kuma su wanke su kullum.
Jamhuriyar Czech da Slovakia sun haramta fita a fili ba tare da yin abin rufe fuska ba ko rufe hanci da bakinsu.
A ranar 16 ga watan Maris, Vietnam ta bukaci duk wanda ya je wuraren jama'a ya sa abin rufe fuska don kare kansa da kuma wasu.
Gwamnatin Austria ta tilasta wa duk wanda ya shiga kantin sayar da kayayyaki sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasar su sa abin rufe fuska a lokacin da suke cikin jama'a.
Taiwan, wadda ta samar da fuska miliyan 10 a rana tun daga watan Maris, ta ba da umarni ga fasinjoji su sa fuska a kan jiragen kasa da bas na gari tun daga 1 ga Afrilu.
Panama ta tilasta yin amfani da abin rufe fuska a duk lokacin da ta fita waje, yayin da ta ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya saya shi ba.
An kuma yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Tsare-tsare na zamantakewa (wanda aka fi sani da tsare-tsare na jiki) yana nufin matakan hana kamuwa da cuta wanda ke jinkirta yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Ka'idoji sun hada da killacewa; takunkumin tafiye-tafiye; da kuma rufe makarantu, wuraren aiki, gidajen wasan kwaikwayo, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Mutane za su iya yin amfani da hanyoyin nisantar jama'a ta hanyar kasancewa a gida, ta hanyar hana tafiya, ta hanyar guje wa wuraren da mutane suke da yawa, ta hanyar yin amfani da gaisuwa ba tare da aikawa ba, ta hanyar ware kansu daga wasu.
Gwamnatoci da dama suna tilasta ko kuma bayar da shawarar yin nesa da jama'a a yankunan da ake kamuwa da cutar.
An rage yawan adadin da aka ba da shawarar a cikin gidajen gwamnati da kuma na kiwon lafiya na Amurka daga 250 (idan an san cewa babu yaduwar COVID-19 a wani yanki) zuwa 50 sannan 10 daga baya.
"A ranar 22 ga Maris, 2020, Jamus ta haramta kada mutum biyu su zauna a wuraren jama'a. CDC ta ba da umarni cewa tsofaffi da waɗanda ke da cututtukan jiki na dogon lokaci, ciki har da ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da rashin ƙarfi, suna da haɗarin rashin lafiya mai tsanani da matsaloli, kuma a wuraren da ke da kewaye da zamantakewar jama'a, irin waɗannan mutane su kasance a gida har ya yiwu. A ƙarshen Maris, 2020, Hukumar Lafiya ta Duniya (WHO) da kungiyoyin kiwon lafiya sun fara amfani da "harkar lafiya" don amsa irin wannan tambayar, "rashin yin amfani da fasaha", don sauya ma'amala ta hanyar sadarwa ko kuma ta hanyar sadarwa ta nesa, don sauya ma'amala ta jiki a cikin wannan yanayin.
"Amfani da kalmar ""rashin zamantakewa"" ya haifar da ra'ayin cewa mutane su kasance a ware daga al'umma, maimakon ƙarfafa su kasance tare da juna ta hanyar maye gurbin juna. Wasu hukumomi sun kuma wallafa tsarin kula da lafiyar jima'i da za a yi amfani da su yayin da cutar ta yadu".
Wannan ya haɗa da yin jima'i da mutumin da ba shi da cutar ko kuma wanda ba shi da alamun cutar.
An ba da shawarar cewa waɗanda suka kamu da COVID-19 da waɗanda ake zargin sun kamu da cutar su keɓe kansu a gida.
Hukumomin lafiya sun ba da cikakkun umarni game da tsarin keɓe kai. Gwamnatoci da yawa sun tilasta ko kuma sun ba da shawarar yin keɓe kai ga dukan mutanen da ke zaune a yankunan da ke fama da cutar.
An ba da umarnin yin ƙawancen kai ga ƙungiyoyin da ke da haɗarin yaduwar cutar.
Wadanda suka yi la'akari da yiwuwar tuntuɓar wani wanda ke da cutar COVID-19 kuma suka yi tafiya zuwa ƙasar ko yanki da cutar ta yi yawa kwanan nan, an shawarce su da su yi zaman keɓewa na kwanaki 14 daga ranar da suka kasance a cikin yanayin.
Dakatar da cututtuka ko kuma hana su da kuma rage su ne dabarun da za su iya hana cutar.
Ana gudanar da matakan hana cutar a farkon matakan da ta fara, da nufin gano masu kamuwa da cutar da sanya su a cikin kadaici, da kuma gabatar da wasu matakan hana cutar da kuma alluran rigakafi don hana cutar yadawa ga sauran al'umma.
Lokacin da ba za a iya sarrafa yaduwar cutar ba, ana yin ƙoƙari don rage yaduwar: Ana yin aiki don rage yaduwar da kuma rage tasirinsa a tsarin kiwon lafiya da kuma al'umma
Ana iya yin duka matakan rigakafi da na dakilewa a lokaci guda.
Ana buƙatar ƙarin aiki mai ƙarfi don matsar da matakan da za a iya ɗauka don kawar da cutar ta hanyar rage yawan haihuwa zuwa ƙasa da 1. Wannan ƙoƙari ne don rage ƙaruwa ta cutar a matsayin ɓangare na gudanar da yaduwar cutar, wanda ake kira flattening the epidemic curve.
Wannan yana rage haɗarin da ba za a iya magance shi ba ta hanyar sabis na kiwon lafiya kuma yana ba da ƙarin lokaci don samar da alluran rigakafi da magani.
Abubuwan da ke hana yaduwar sun hada da matakan hanawa mutum kamar tsabtace hannu, sanya abin rufe fuska da kuma ware kansa; ayyukan zamantakewa da ke nufin nisantar jiki kamar rufe makarantu da soke taron da jama'a ke taruwa; shigar da jama'a don karfafa karbuwa da shiga cikin irin waɗannan tsangwama; da ayyukan muhalli kamar tsabtace farfajiyar. An aiwatar da wasu matakai masu tsauri da ke nufin hana yaduwar, kamar ware dukan birane da kuma sanya tsauraran takunkumin tafiya a kasar Sin, yayin da aka san yadda mummunan yaduwar cutar yake.
Sauran ƙasashe sun ɗauki matakai don hana yaduwar cutar.
Koriya ta Kudu ta kaddamar da gwaje-gwaje da yawa da kuma sanya a cikin gida, da kuma yin gargadi game da motsi na wadanda suka kamu.
Singapore ta ba da tallafi ga waɗanda suka sami rauni kuma suka ware kansu, da kuma manyan tarar waɗanda suka kasa yin hakan.
Taiwan ta kuma yi wa masu sayar da kayan magani da ke kara yawan samar da abin rufe fuska tarar da tarar da su. Simulations ga Great Britain da Amurka sun nuna manyan kalubale a cikin rage (wanda ke hana yaduwar cutar, amma ba ya dakatar da ita) da kuma hana (wanda ke canza ci gaban cutar).
Ingantaccen tsarin rigakafi zai iya rage bukatun kula da lafiya ta kashi biyu cikin uku da mutuwar kashi biyu cikin uku, amma hakan zai haifar da mutuwar dubbai da kuma lalata tsarin kiwon lafiya.
Za a iya ba da fifiko ga dakile, amma dole ne a kiyaye shi har sai cutar ta bazu cikin yawan mutane (ko kuma har sai an sami allurar rigakafi, duk abin da ya fara zuwa) domin idan aka sassauta matakan, za a iya sake samun saurin yaduwa.
Matsayi mai tsawo na dakile cutar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19, amma ana ƙoƙari don ƙirƙirar ta, gami da gwajin magunguna na yanzu.
Shan magungunan shan magani da shan ruwa da kuma yin hutu a kantin magani na iya taimakawa wajen rage alamun.
Dangane da tsanani, ana iya buƙatar maganin rigakafi, narkewa da kuma taimakon numfashi.
Yin amfani da steroids zai iya sa sakamako ya zama mafi muni.
Ana binciken wasu sinadarai da aka ba da izini don magance COVID-19 kafin a yi amfani da su wajen magance wasu cututtukan cututtuka.
"Ƙungiyar Lafiya ta Duniya (WHO) ta kuma ce wasu 'yan'uwanci da kuma hanyoyin gida na iya taimakawa wajen kawar da alamun SARS-CoV-19".
Hukumar lafiya ta duniya (WHO) ta bayyana cewa, karfafa aiki da kuma inganta kiwon lafiya don biyan bukatun marasa lafiya na COVID-19 a matsayin wani mataki na mayar da martani ga kamuwa da cutar.
Ofishin Yankin Turai na ECTC (ECDC) da kuma Hukumar Lafiya ta Duniya (WHO) sun fitar da jagororin don sauya albarkatu a matakai da yawa, gami da mayar da hankali ga ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke ayyukan da ba dole ba kamar yadda ya kamata, warewa da keɓe marasa lafiya masu COVID-19 da horo ga ma'aikatan, da kuma ƙara yawan kayan numfashi da gado da ake samu.
Akwai ra'ayoyi daban-daban game da inda mutum (wanda ake kira mai cutar Zero) ya fara kamuwa da cutar.
An gano kamuwa da cutar ta farko a Wuhan, wani yanki na Hubei, China, a ranar 1 ga Disamba, 2019.
A cikin wata daya, adadin masu kamuwa da cutar korona a Hubei ya karu.
Wadannan galibi suna da alaƙa da kasuwar Hunan Seafood wholesale, wanda kuma ya sayar da dabbobi masu rai. Wani ka'idar kuma ita ce, cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko, a wata ma'anar, ta samo asali ne daga dabbobi. An gano wani nau'in cutar huhu wanda ba a san dalilinsa ba a ranar 26 ga Disamba kuma Likitan asibitin lardin Hubei Zhang Jixian ne ya kula da shi. Ya ba da rahoton Wuhan Jiangsan CDC (CDC) a ranar 27 ga Disamba.
"A ranar 30 ga watan Disamba, wani rukuni na likitoci a babban asibitin Wuhan ya gargadi abokan aikinsa game da "Coronosaurus irin na SARS".
'Yan sanda sun yi gargadin takwas daga cikin wadannan likitoci, ciki har da Lee Wenliang, saboda yada jita-jita na karya, kuma wani likitan mai suna Ai Feng ya yi wa'azi saboda ya yi gargadin.
Hukumar Lafiya ta Wuhan ta fitar da sanarwar a ranar 31 ga watan Disamba, inda ta sanar da Hukumar Lafiya ta Duniya (WHO).
A farkon watan Janairu, jami'an lafiya a Wuhan sun sanar da marasa lafiya da ke fama da cutar pneumonia da ba a gano su ba, wanda ya isa a fara bincike. A farkon farkon farkon kamuwa da cutar, yawan marasa lafiya ya ninka kusan sau bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta yada zuwa sauran lardunan kasar Sin, saboda yiwuwar Wuhan ta kasance cibiyar tafiye-tafiye da sufuri da kuma babban taro na jerin abubuwan da suka faru a lokacin Sabuwar Shekarar Sin.
A ranar 20 ga watan Janairu, kasar Sin ta samu kusan sabbin kamuwa da cutar 140 a rana guda, ciki har da biyu a Beijing da daya a Shenzhen.
Bayanai na baya sun nuna cewa mutane 6,174 sun riga sun kamu da cututtuka a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta riga ta gabace kasar Sin da Italiya a matsayin ƙasa da ke da yawan adadin masu kamuwa da cutar a duniya.A watan Afrilu, 2020, an sami kamuwa da cutar miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu, kuma sama da mutane 364,000 sun warke.
Akwai aƙalla kamuwa da cutar guda ɗaya a cikin kasashe da yankuna kusan 200.
Saboda yaduwar annobar a Turai, kasashe da dama a yankin Schengen sun hana 'yancin motsi tsakanin su kuma sun kafa takunkumin kan iyakoki.
Sakamakon haka ya nuna cewa an yi amfani da dokar hana fita ta hanyar hana mutane yin aiki a gida. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na jama'a, a Amurka suna ƙarƙashin wani irin dokar hana fita, fiye da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun shiga wani irin kulle-kulle, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu, wato kashi daya bisa uku na yawan duniya.
A Wuhan, an fara tabbatar da mutum da COVID-19 a ranar 1 ga Disamba, 2019; wani kuma wanda ba a tabbatar da shi ba ya nuna cewa an fara tabbatar da cutar a ranar 17 ga Nuwamba.
A ranar 26 ga watan Disamba, Dr. Zhang Jixian ya gano wani rukuni na marasa lafiya da ke fama da cutar pneumonia da ba a san dalilinsa ba.
A gwajin farko na samfurori na marasa lafiya a ranar 27 ga Disamba, 2019, ya nuna cewa akwai cutar coronavirus kamar SARS.
A ranar 31 ga watan Disamba, Hukumar Lafiya ta Wuhan ta fitar da sanarwar.
A wannan rana ne aka sanar da Hukumar Lafiya ta Duniya (WHO).
"Da zarar an sanar da wadannan sanarwa, 'yan sanda sun gargadi likitoci a Wuhan da cewa sun "yaɗa jita-jita" game da cutar".
"A lokacin da aka fara gabatar da shi, Hukumar Lafiya ta Kasa ta kasar Sin ta ce babu "babban shaida" na yaduwar cutar daga mutum zuwa mutum".
"A ƙarshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri, wanda Sakatare Janar na jam'iyyar kwaminis ta kasar Sin, Xi Jinping, ya bayyana a matsayin "yaƙin jama'a" na hana yaduwar cutar".
"A cikin abin da aka bayyana a matsayin "babban warewar da aka yi a tarihin 'yan Adam", an sanar da dokar hana fita ta dakatar da zirga-zirga a cikin Wuhan da wajenta a ranar 23 ga Janairu, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57 a duniya".
An haramta amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Jami'ai sun ce asibitin Huoshen Shan na wucin gadi ya kammala aikin a cikin kwanaki 10.
An gina wani asibiti da ake kira Lichenshen Hospital don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, China ta maida wasu wurare 14 a Wuhan kamar cibiyoyin taro da kuma wuraren wasanni zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakan hana yaduwar COVID-19, ciki har da fitar da sanarwar lafiya ga matafiya da kuma tsawaita hutun biki a Ilwan.
An rufe makarantu da jami'o'i a duk faɗin ƙasar.
An gudanar da ayyuka da dama a yankunan Hong Kong da Macau, musamman a wuraren da ake gudanar da ayyukan da suka shafi makarantu da jami'o'i.
An kafa ayyukan aiki na nesa a yankuna da yawa na kasar Sin.
An sanya takunkumin tafiye-tafiye a cikin gida da waje na Huawei.
An yi amfani da hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi a duk faɗin China.
"Da zarar an sanya dokar hana zirga-zirga a birane da yawa, an kiyasta cewa kusan mutane miliyan 760 (sama da rabin yawan jama'a) sun fuskanci wasu takunkumi na waje. Bayan da cutar ta shiga cikin duniya a watan Maris, jami'an kasar Sin sun dauki matakai masu tsauri don hana cutar daga "ƙaddamarwa" daga wasu ƙasashe".
Alal misali, gwamnatin Beijing ta sanya dokar killace dukkan matafiya na kasa da kasa da suka shigo birnin na tsawon kwanaki 14. A ranar 23 ga watan Maris, a yankin kasar Sin, har zuwa kwanaki biyar da suka gabata, mutum daya ne kawai ya kamu da cutar a cikin gida, wanda kuma ya kamu da cutar ta hanyar matafiyi daga Istanbul zuwa Guangzhou.
A ranar 24 ga watan Maris, 2020, Firayim Ministan kasar Sin, Li Keqiang, ya bayyana cewa an hana yaduwar cutar a cikin gida kuma an hana ta a kasar Sin.
A ranar 26 ga watan Maris, 2020, ma'aikatar harkokin wajen kasar Sin ta sanar da dakatar da izinin shiga masu riƙe da biza ko izinin zama daga ranar 28 ga Maris. Babu wani bayani game da lokacin da wannan manufar za ta ƙare.
Masu neman shiga kasar Sin dole ne su nemi takardar visa a ofisoshin jakadancin kasar Sin ko kuma a wasu ofisoshin jakadancin kasar.
A ranar 30 ga watan Maris, gwamnatin kasar Sin ta karfafawa kasuwanni da masana'antu su sake budewa, kuma ta ba da tanadi na kudi ga kamfanoni. A ranar 4 ga watan Afrilu, ta sanar da fara ranar makoki tare da minti uku na shiru a kasa a karfe 10:00 na dare. Wannan ya kasance daidai da bikin Kingming.
An tabbatar da cewa COVID-19 ya bazu daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar lafiya ta kasar ta ce, an samu karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ake ganin an yi ta ne a Teku saboda wani taro da aka yi a wani sabon addini da ake kira Shinzoonji Jesus Church.
Shinzoonji masu zuwa daga Wuhan zuwa Taiko suna da shakku cewa za su iya kamuwa da wannan yaduwar.
A ranar 22 ga watan Fabrairu, an samu alamun cutar a cikin mutane 9,336 da ke bin cocin, wanda ya kai 1,261, ko kuma kashi 13 cikin dari. Koriya ta Kudu ta ba da sanarwar gargadi mai girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu karin kamuwa da cutar 2,000 a Koriya, amma a ranar 29 ga watan Fabrairu, an samu karin kamuwa da cutar 3,150.
An rufe dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da cewa akwai wasu sojoji uku da suka kamu da cutar.
An kuma yi wa jadawalin jiragen sama rauni, saboda haka an sauya su. Koriya ta Kudu ta ƙaddamar da shirin da ake ganin shi ne mafi girma da kuma mafi kyau a duniya don gano ko akwai cutar a tsakanin jama'a, ware su idan akwai kamuwa da cutar, gano waɗanda suka yi hulɗa da su, da kuma ware su.
Abubuwan bincike sun hada da tilasta wa sabon matafiyin kasa da kasa sanar da alamun cutar ta hanyar wayar hannu, gwajin motsa jiki wanda ke gwada tasirin cutar ta hanyar sakamakon da aka samu a rana ta gaba, da kuma kara yawan gwajin da zai iya gwada mutane 20,000 a kowace rana.
Ko da yake ba a keɓe biranen gaba ɗaya ba, ana ganin shirin Koriya ta Kudu ya yi nasara wajen hana yaduwar cutar. Tun da farko, an yi ra'ayoyi biyu a cikin al'ummar Koriya ta Kudu game da ayyukan Shugaba Moon Jae-in wajen magance matsalar.
Mutane da yawa a Koriya sun sanya hannu kan takardun neman cewa a yi wa Muno murabus saboda yadda gwamnatin ta yi amfani da cutar ba daidai ba, ko kuma cewa aikinsa yana da kyau.
A ranar 23 ga watan Maris, an samu rahoton cewa Koriya ta Kudu ta samu karamin adadin kamuwa da cutar a cikin makonni hudu.
A ranar 29 ga watan Maris, an sanar da cewa, za a yi wa duk wanda ya zo daga kasashen waje na farko a cikin makonni biyu a cikin killacewa daga ranar 1 ga Afrilu.
A ranar 1 ga watan Afrilu, kafofin yada labarai sun ce, Koriya ta Kudu ta samu buƙatu daga kasashe 121 don neman taimako wajen gwada cutar.
Iran ta sanar da cewa an tabbatar da kamuwa da cutar SARS-CoV-2 a Guam a ranar 19 ga Fabrairu, inda mutane biyu suka mutu a ranar, a cewar ma'aikatar kiwon lafiya da ilimin likitanci ta kasar.
Matakan farko na hanawa da gwamnati ta sanar sun hada da soke kide kide da sauran al'adu, wasanni da kuma ibada a ranar Juma'a, tare da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya sanar da cewa babu wani shiri na keɓe wuraren da cutar ta shafa kuma za a keɓe mutane ne kawai.
Ko da yake an sanar da shirye-shiryen rage tafiye-tafiye tsakanin birane a watan Maris, har zuwa Nuwamba ta Farisa, an ci gaba da samun karin zirga-zirga tsakanin birane.
Shaidu na Shi'a a Kome sun kasance a bude ga mahajjata har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A tsakanin da'awar da ake yi na rufe adadin yaduwar cutar a Iran, fiye da kasashe goma sun gano cewa kamuwa da cutar ta fara ne daga Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa wannan na iya zama sama da kamuwa da cutar 388 da Iran ta sanar a wannan ranar.
An rufe majalisar dokokin Iran, inda aka ce an kamu da cutar a ranar 3 ga Maris, 23 daga cikin mambobi 290 da ke cikinta.
A ranar 12 ga watan Maris, kungiyar kare hakkin bil adama ta Iran ta bukaci jami'an gidan yari da su saki 'yancin bil adama da aka tsare da su saboda yin zanga-zangar lumana ba tare da wani sharadi ba, kuma su bada 'yancin' yancin 'yancin bil adama da suka cancanta.
An ruwaito cewa akwai haɗarin yaduwar cutar a wuraren da ba a kula da su sosai ba, kamar cibiyoyin tsare-tsare.
A ranar 15 ga watan Maris, gwamnatin Iran ta ce an samu mutuwar mutane 100 a rana daya, wanda ya zama mafi yawan mutuwar da aka samu a kasar tun lokacin da cutar ta fara.
Aƙalla 'yan siyasar Iran da jami'an gwamnati 12 da suka kasance a cikin mulki ko kuma a baya sun mutu daga cutar har zuwa 17 ga Maris.
A ranar 23 ga watan Maris, mutane 50 ne ke kamuwa da cutar a Iran a kowace awa, kuma mutum daya ke mutuwa a kowane minti 10.
Jami'an Hukumar Lafiya ta Duniya (WHO) sun ce, mutane da yawa a Iran sun kamu da cutar sau biyar fiye da yadda aka ruwaito.
An kuma ce, saboda takunkumin da Amurka ta dauka kan Iran, za a iya yin kasafin kudin Iran a kan matakan hana yaduwar cutar.
Babban Kwamishinan kare hakkin bil adama na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin da ake sanyawa kasashe da suka fi fama da cutar, ciki har da Iran.
Bayan an gano cewa wasu matafiya biyu 'yan kasar Sin sun kamu da cutar SARS-CoV-2 a Rome, an tabbatar da cewa cutar ta yada zuwa Italiya a ranar 31 ga Janairu.
Yawan masu cutar ya fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen sama da ke China da kuma sanar da dokar ta baci.
An gano wani rukunin marasa alaƙa na COVID-19 da aka fara da 16 da suka kamu da cutar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, kwamitin majalisar ya sanar da sabon dokar kotu don hana yaduwar, gami da killace mutane sama da 50,000 daga 11 garuruwa daban-daban a arewacin Italiya
"Prime Minister Quecep Conte, a wuraren da cutar ke yaduwa, ba za a ba da izinin shiga ko fita ba", in ji shi.
"An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna. "A ranar 4 ga Maris, Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, yayin da ƙasar ta kai mutuwar 100".
Duk manyan wasannin wasanni, gami da wasannin kwallon kafa na Serie A, an shirya su ne a bayan gida har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dage dukkan wasannin gaba daya na akalla wata daya.
A ranar 11 ga watan Maris, Firayim Minista Kante ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai kantuna da kantunan magani. A ranar 6 ga watan Maris, Kwalejin Italiya ta Cire Zuciya da Maganin Cutar (SIAARTI) ta fitar da takardun shaida na likita game da shawarwari game da maganin da ya shafi rashin lafiyar, wanda ya hada da rage damuwa, kawar da ciwo, dawo da motsin zuciya da kuma gaggawa.
A ranar 19 ga watan Maris, kasar Italiya ta kaddamar da kasar Sin a matsayin kasar da ta fi yawan mutuwar mutane a duniya bayan da aka samu mutuwar mutane 3,405 a cikin annobar.
A ranar 22 ga watan Maris, an ruwaito cewa Rasha ta tura jiragen saman soja tara zuwa Italiya tare da kayan aikin likita.
A ranar 5 ga watan Afrilu, adadin wadanda suka kamu da cutar a Italiya ya kai 128,948, mutuwar 15,887 da kuma murmurewa ya kai 21,815, yawancinsu a yankin Lombardy.
Rahoton CNN ya nuna cewa yawan tsofaffi a Italiya da rashin iyawar tantance kowa da kowa da cutar ya haifar da yawan mutuwar.
A cikin kasashen da cutar ta shafa, Birtaniya ce ta fi mayar da martani da ta fi dacewa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta aiwatar da wani nau'i na warewar jama'a ko matakan keɓewa mai yawa a kan 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci sukar rashin saurin da kuma gaggawa wajen magance matsalolin da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawara game da duk balaguro da kuma hulɗar jama'a ba, yana ba da shawarar cewa mutane su yi aiki daga gida kamar yadda ya kamata kuma su guji wuraren shakatawa, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, Gwamnati ta sanar da rufe wuraren nishaɗi kamar gidajen shakatawa da kuma wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin bayar da kashi 80 cikin dari na albashi ga ma'aikata har zuwa £2,500 a kowane wata don kauce wa matsalar rashin aikin yi. A ranar 23 ga watan Maris, Firayim Minista ya kafa takunkumi kan tsauraran matakan nisantar zamantakewa da hana mutane fiye da biyu haduwa tare da su, da kuma hana ayyukan waje da ke buƙatar tafiya da tilastawa.
Ba kamar matakan da suka gabata ba, an aiwatar da waɗannan ƙuntatawa ta hanyar 'yan sanda ta hanyar ba da tarar da tarurruka da kuma soke taro.
"An umarci rufe yawancin sauran cibiyoyin kasuwanci, ban da kasuwancin da ake ganin ""ba su da mahimmanci"" ciki har da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin man fetur, da wuraren gyara motoci".
A ranar 20 ga watan Janairu, an tabbatar da wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu a jihar Washington, a Pacific Northwest.
An kafa tawagar White House Task Force on Coronavirus a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a, kuma ta sanya takunkumi kan shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, wata babbar hukumar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta kirkiro kayan aikin gwajin ta.
Duk da haka, Amurka ta fara gwajin a hankali, wanda ya ɓoye ainihin adadin kamuwa da cutar a lokacin.
An yi watsi da gwajin saboda rashin ingancin kayan aikin gwaji da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan aikin gwaji na gwamnati (ta hanyar makarantu, cibiyoyi da asibitoci) har zuwa karshen Fabrairu, da kuma matakan da mutane ke bukata don cancanta don gwaji har zuwa farkon Maris.
A ranar 27 ga watan Fabrairu, Washington Post ta ruwaito cewa, an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
A ranar 13 ga Maris, The Atlantic ta ba da rahoton cewa an yi fiye da gwaje-gwaje 14,000.
"A ranar 22 ga Maris, Associated Press ta ruwaito: ""Mutane da yawa da ke da alamun sun jira sa'o'i ko kwanaki don a gwada su da kuma umarnin likita". Bayan an samu mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna J. Insley ya sanar da dokar ta baci, kuma nan da nan sauran jihohi suka bi wannan matakin".
Makarantun yankin Seattle sun soke darussan a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masu ilimin cututtukan cututtuka daga Kwalejin Imperial ta London, sun ba da umarnin Amurka game da tsinkaya game da tasirin sabon coronavirus a cikin ƙasar.
A wannan ranar, Shugaba Trump ya ba da dala biliyan 8.3 na kudaden gaggawa ga hukumomin tarayya don magance yaduwar cutar don sanya hannu kan Dokar taƙaitaccen shiri da kuma maganin cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikatan su, sun soke taron bita, kuma sun karfafa ma'aikatan su yi aiki daga gida.
An soke wasanni da yanayi a ranar 11 ga Maris. Trump ya sanar da takunkumin tafiye-tafiye na kwanaki 30 daga 13 ga Maris zuwa ga yawancin Turai, banda Ingila.
Kashegari, ya faɗaɗa takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, wanda hakan ya ba da damar amfani da kudaden tarayya don rikicin.
Tun daga ranar 15 ga Maris, an rufe masana'antu da yawa ko kuma an rage lokutan aiki don rage yaduwar cutar a duk faɗin Amurka.
A ranar 17 ga watan Maris, an tabbatar da cutar a duk jihohi 50 da kuma gundumar Columbia. A ranar 23 ga watan Maris, an sanar da kamuwa da cutar coronavirus 10,700 a New York City, wanda ya fi yawan kamuwa da cutar a Koriya ta Kudu.
Gwamnan ya ce a ranar 25 ga watan Maris, an fara ganin an samu amfanin nisantar zamantakewa kuma an kiyasta cewa an rage lokacin yin ninka cutar daga kwanaki 2.0 zuwa 4.7.
A ranar 28 ga watan Maris, an samu karin adadin masu kamuwa da cutar a New York City, wanda ya kai 32,308. Mutane 672 ne suka mutu sakamakon cutar. A ranar 26 ga watan Maris, an samu karin adadin masu kamuwa da cutar a Amurka fiye da kowace kasa a duniya, ciki har da China da Italiya.
A cewar wani rahoto da aka fitar a ranar 30 ga watan Maris, Shugaba Trump ya yanke shawarar tsawaita dokar ta hana jama'a har zuwa 30 ga watan Afrilu.
A wannan rana, wani asibiti mai suna Comfort, wanda ke dauke da gado kusan 1,000, ya sauka a birnin New York.
A ranar 3 ga watan Afrilu, mutane 884 ne suka mutu a cikin 24 hours a Amurka sakamakon cutar coronavirus.
A ranar 3 ga watan Afrilu, adadin marasa lafiya a jihar New York ya wuce 100,000. An zargi fadar White House da rage barazanar, ta hana labarai, da kuma umarci jami'an lafiya da masana kimiyya su yi aiki tare da ofishin mataimakin shugaban kasa Mike Pence kafin ya fitar da sanarwa da wallafe-wallafen game da cutar.
Akwai ra'ayi dabam-dabam a tsakanin masu goyon bayan yadda gwamnatin Trump ta bi da matsalar.
Wasu jami'an Amurka da masu sharhi sun soki Amurka kan dogaro da shigo da kayayyaki masu mahimmanci daga China, ciki har da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin hanyoyin tafiye-tafiye na iska don tsarawa da hango ko hasashen yanayin yaduwar cutar kuma an buga shi a cikin mujallar asibiti ta tafiye-tafiye a tsakiyar watan Janairu 2020.
A cewar rahoton da hukumar jiragen sama ta kasa da kasa ta bayar a shekarar 2018, an samu karin fasinjoji daga Wuhan zuwa Bangkok, Hong Kong, Tokyo da kuma Taipei.
Dubai, Sydney da Melbourne sun zama shahararrun zabi ga mutanen da ke tafiya daga Wuhan.
A cikin shahararrun biranen yawon bude ido 20, an ba da rahoton cewa Bali ta kasance mafi ƙarancin shirye-shirye don magance cutar, yayin da biranen Ostiraliya suka kasance cikin shiri sosai. Ostiraliya ta sanar da shirin gaggawa na gaggawa game da cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya ce akwai abubuwa da yawa da za a sani game da COVID-19 kuma Australia za ta inganta kula da iyaka da sadarwa ta nesa don hana annobar.
A ranar 21 ga watan Maris, an bayyana dokar ta baci ta kare rayukan mutane a Australia.
Saboda yadda aka yi amfani da shi wajen ware zirga-zirgar jama'a a Wuhan da Hubei, kasashe da dama suna shirin fitar da 'yan ƙasarsu daga yankin ta hanyar jiragen sama na kwangila na farko.
A cikin Amurka, Kanada, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, Thailand sun fara shirin fitar da 'yan ƙasarsu.
Pakistan ta ce ba za ta fitar da wani dan kasar daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kori 'yan Poland hudu da kuma wasu 'yan Brazil 34 ko kuma danginsu, ban da dan kasar Sin da kuma dan kasar Indiya.
Jirgin kasar da ke zuwa Brazil ya tashi a Poland kafin ya ci gaba da tafiya, kuma 'yan kasar Poland, China da Indiya sun sauka daga jirgin.
An ware 'yan ƙasar Brazil da suka je Wuhan a wani sansanin soja kusa da Brazil.
A wannan ranar, an kwashe 'yan Kanada 215 (na farko 176 daga jirgin Amurka, na biyu kuma 39) daga Wuhan zuwa CFP na Trenton inda aka killace su na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama daga Wuhan da ke dauke da 'yan Kanada 185 ya sauka a CFP Trenton.
Jami'an Australia sun tura 'yan ƙasa 277 zuwa Cibiyar Kula da Tsibirin Kirsimeti a ranar 3 da 4 ga Fabrairu, wanda aka sake mayar da shi a matsayin wuri mai keɓewa, inda suka zauna na kwanaki 14.
Wani jirgin sama na New Zealand ya sauka a Auckland a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da wasu daga Australia da Pacific) a wani sansanin jiragen ruwa a Bangaborowa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kori Amurkawa a kan jirgin ruwan na Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama daga ƙasar Kanada da ke dauke da fasinjoji 129 da aka kora daga Diamond Princes ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara fitar da 'yan kasar daga Iran. A ranar 14 ga Maris, gwamnatin Afirka ta Kudu ta yi yarjejeniya da jirgin saman South African Airways na 112 da ya mayar da 'yan kasar ta Kudu zuwa gida.
An yi gwajin asibiti kafin tashi kuma an bar wasu mutane hudu daga Afirka ta Kudu da ke da alamun kamuwa da cutar coronavirus don rage haɗarin yaduwar cutar.
Sai dai mutanen Afirka ta Kudu da suka kamu da cutar ne kawai aka mayar.
Sakamakon binciken ya nuna cewa babu wani dan Afirka na kudu da ya kamu da cutar, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan gida, 'yan sanda da sojoji masu aikin agaji, dukansu sun kasance cikin keɓewa da ke cikin gidan kwana 14 a matsayin matakin tsaro.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki a wani bangare saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun tura tallafi ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka da suka taru don aikawa da taimako zuwa yankunan da cutar ta shafa a kasar Sin, tare da wani rukuni na hadin gwiwa a yankin Birnin Chicago, sun aika da masks na N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da cewa za su ba da kyautar dala miliyan 100 ga Hukumar Lafiya ta Duniya (WHO) don kare "mutanen da ke cikin haɗari a Afirka da Kudancin Asiya" da kuma tallafawa bincike da kuma gudanar da bincike kan allurar rigakafi.
Interaksion ta ce a ranar 6 ga watan Fabrairu, gwamnatin kasar Sin ta ba da kyautar 2,00,000 ga Philippines bayan da wani dan majalisa mai suna Richard Garden ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar Red Cross ta Singapore ta sanar da cewa za ta tura tallafi mai kimanin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da kyautar masks miliyan daya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da fiye da tan 13 na kayan magani ga Wuhan, Malaysia ta ba da sanarwar bayar da kyautar safofin hannu miliyan 18 ga China, Jamus ta ba da kayayyakin magani da dama, ciki har da tufafi 10,000 na Hasmat, Amurka ta ba da kayayyakin magani tan 17.8 ga China, kuma ta yi alkawarin bayar da ƙarin tallafin kuɗi na dala miliyan 100 ga kasashen da suka kamu.
A watan Maris, kasar Sin da Cuba da Rasha sun tura kayan aikin likita da kwararrun masana zuwa Italiya don magance yaduwar cutar.
Wani dan kasuwa, Jack Ma, ya aika da kayan gwaji miliyan 1.1 da kuma kayan rufe fuska miliyan 6 da kuma kayan tsaro 60,000 zuwa Addis Ababa, Ethiopia don a rarraba su ta hanyar kungiyar Afirka.
Daga nan sai ya tura kayan gwaji 5,000, masks 100,000 da kuma na'urorin shan numfashi 5 zuwa Panama.
Ya kuma ba da kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Czech Republic sun nuna damuwa game da masks da kayan gwaji da aka yi a China.
Alal misali, Spain ta dawo da kayan aikin gwaji 58,000 da aka yi a kasar Sin, saboda kawai kashi 30% na daidaito, yayin da Netherlands ta dawo da kayan kwalliyar kayan kwalliyar da ke da lahani 600,000.
Belgium ta mayar da masks 100,000 da aka yi zaton sun fito ne daga kasar Sin, amma a gaskiya sun fito ne daga Colombia.
A gefe guda kuma, wasu sassan Latin Amurka da Afirka sun yi maraba da taimakon da kasar Sin ta bayar. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da shirye-shiryen gaggawa na taimakon gaggawa ga kasashe masu tasowa.
Hukumar lafiya ta duniya (WHO) ta yaba da kokarin da jami'an kasar Sin ke yi na sarrafawa da kuma hana yaduwar cutar.
"A lokacin annobar SARS ta 2002-2004 da aka yi a ɓoye, jami'an kasar Sin sun hana yin bayani, Hukumar Lafiya ta Duniya (WHO) ta nuna cewa akwai babban canji tsakanin halin da ake ciki da halin da ake ciki a yanzu, wanda ya hana hana gudanar da ayyukan rigakafi da na sarrafawa. A lokacin rikicin da ke faruwa, gwamnatin tarayya ta "ba da sabuntawa lokaci-lokaci don kauce wa firgita kafin hutun Sabuwar Shekara ta Watan".
"A ranar 23 ga watan Janairu, game da shawarar da hukumomin tarayya suka dauka na aiwatar da dokar hana zirga-zirga a Wuhan, wakilin Hukumar Lafiya ta Duniya (WHO), Gauden Galeya, ya ce, "duk da cewa ba a ba da shawarar hakan ba ne ga Hukumar Lafiya ta Duniya (WHO) " wannan shi ne babban alamar sadaukarwa ga hana cutar a yankin da cutar ta fi fama da ita. "Wannan ba a taɓa gani ba a tarihin kiwon lafiya ta jama'a. Wannan shi ne gaggawa na farko da aka bayyana a duniya (WHO) tun bayan an sanar da cutar ta gaggawa a duniya (HEPHEP) a watan Janairu 2009 (March 30), saboda dalilai na karuwar yawan mutanen da ke fama da cutar.
"Darakta Janar na Hukumar Lafiya ta Duniya (WHO), Tetros Adhanom, ya ce, "Harancin yaduwar cutar a duniya, musamman ga ƙasashe masu karamin da matsakaitan kudade, ba su da tsarin kiwon lafiya mai ƙarfi, ne ya sa aka sanar da PHEIC".
"Domin ya nuna cewa an yi amfani da takunkumin tafiye-tafiye, Tetras ya ce, ""ba lallai ba ne a yi amfani da matakan da ba su dace ba wajen yin tafiye-tafiye da kasuwanci a duniya"" kuma ""World Health Organization (WHO) ba ta bada shawarar rage cinikayya da motsi ba".
"A ranar 5 ga watan Fabrairu, Hukumar Lafiya ta Duniya (WHO) ta yi kira ga al'umma ta duniya da ta nemi tallafin dala miliyan 675 don tallafawa shirye-shiryen dabarun a ƙasashen da ke da ƙananan kuɗaɗe, don nuna gaggawa ga ƙasashe da ba su da tsarin gano waɗanda suka kamu da cutar ko da ta bayyana".
"A cikin wasu rahotanni da Tedros ya yi, ya kara da cewa """Muna da karfi kamar yadda muke da rauni a cikin haɗin kanmu"" kuma al'ummar duniya sun ce ""yi kokarin yau ko kuma ka rasa fiye da haka daga baya""". A ranar 11 ga Fabrairu, WHO ta kafa COVID-19 a matsayin sunan cutar a taron manema labarai".
A wannan ranar, Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya ce Tetras ya amince da samar da ""ikon ga dukan Majalisar Dinkin Duniya don magance wannan"."
"A sakamakon haka, an kafa Kwamitin Gudanar da Rikicin Majalisar Dinkin Duniya wanda zai haɗa bayanan da dukan Majalisar Dinkin Duniya ke bayarwa. Wannan zai taimaka wajen mayar da hankali ga bayanan kiwon lafiya yayin da sauran kungiyoyi ke ba da kwarewarsu don magance tasirin da cutar ke yi wa zamantakewa, tattalin arziki da ci gaba, in ji Hukumar Lafiya ta Duniya (WHO). "
"A ranar 14 ga Fabrairu, an kafa wani kwamitin aiki na hadin gwiwa da WHO da China don taimakawa kasar Sin a cikin gida da gudanar da bita da taro da manyan hukumomin kasa da kasa don tantance ""karfin cutar da yaduwarta"" da kuma gudanar da wani bincike na fili don tantance tasirin matakan hana yaduwar cutar a larduna da jihohi, ciki har da kungiyoyin birane da na karkara"" da kuma ba da taimako ga masana na WHO da na duniya a kasar Sin. A ranar 25 ga Fabrairu, WHO ta ce, "Duniya dole ta kasance a shirye don yiwuwar yaduwar cutar coronavirus a matsayin cuta", duk da cewa har yanzu akwai lokacin da za a kira cutar, kuma WHO ta ce dole ne kasashen duniya su kasance a shirye don yiwuwar yaduwar cutar".
"A ranar 28 ga watan Fabrairu, jami'an Hukumar Lafiya ta Duniya (WHO) sun ce za a kara yawan barazanar cutar coronavirus daga ""babba"" zuwa ""babba"" a duniya, wanda shine mafi girman matakin gargadi da kimantawa".
"Darakta mai kula da shirin gaggawa na kiwon lafiya na Hukumar Lafiya ta Duniya (WHO), Mike Ryan, ya yi gargadin a cikin wata sanarwa cewa, ""Wannan gwaji ne na gaskiya ga kowace gwamnati a duniya: dole ne ta farka".
"Cutar za ta iya kasancewa a nan gaba, don haka dole ne ku kasance a shirye", in ji shi, yana mai cewa, matakan da suka dace na hana cutar za su taimaka wa duniya ta kauce wa "masu muni".
"Ryan ya kara da cewa babu bukatar a bayyana wannan a matsayin annoba ta duniya da ke tattare da cutar ta annoba ta hanyar jami'an lafiya na jama'a, kuma idan aka bayyana hakan, to, yana nufin cewa ""mun yarda cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta bayyana cutar korona a matsayin annoba.
"Dokar Hukumar Lafiya ta Duniya (WHO) tana da matukar damuwa da "karamin matakin yaduwar cutar da kuma mummunan aiki da kuma rashin aiki mai tsanani", in ji Darakta Darakta. Hukumar Lafiya ta Duniya (WHO) ta fuskanci muhimman zargi game da rashin wadatar magance cutar, ciki har da jinkirta sanar da dokar ta baci ta kiwon lafiya da kuma sanya cutar a matsayin annoba".
Wani ɓangare na wannan koma baya shi ne takardar da mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu don neman murabus na Daraktan Janar na Hukumar Lafiya ta Duniya (WHO), Tedros Adnanom.
A ranar 26 ga Maris, 2020, masana kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada cewa a lokacin annobar COVID-19, ya kamata a girmama hakkokin kowane mutum.
Kwamitin ya ce kowa yana da hakkin samun hanyoyin kare rayuka kuma gwamnati ta yi aiki da shi.
Kwamitin ya jaddada cewa rashin albarkatu ko inshorar lafiya ba za a iya la'akari da nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin samun kiwon lafiya, gami da nakasassu, ƙalilan, tsofaffi, masu gudun hijira, marasa gida, waɗanda ke rayuwa cikin matsanancin talauci, waɗanda ke tsare da tsare, 'yan gudun hijira da sauran kungiyoyin marasa iyaka da ke bukatar tallafin gwamnati.
Hukumomin duniya sun fara aiki don magance tasirin tattalin arziki da zamantakewar al'umma da rikicin COVID-19 ya haifar.
Kungiyar Tattalin Arziki da Ci gaban ta kaddamar da dandamali wanda zai ba da cikakken bayani game da manufofin da aka aiwatar, ra'ayoyi da shawarwari a cikin ƙasashe a duniya, wanda zai taimaka a kan lokaci.
Daga tsarin kiwon lafiya da manufofin karfafa tattalin arzikin duniya zuwa magance tasirin kulle-kulle da takunkumin tafiye-tafiye, Cibiyar Digital ta ƙunshi mai lura da manufofin ƙasa, kuma tana nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe haɗin gwiwar duniya don magance ƙalubalen cutar coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar yadda ta bi da annobar da ta barke a lardin Hubei na kasar Sin, wanda aka fara da shi a Amurka da ofishin majalisar ministocin kasar Amurka, Michael Gove da kuma dan shugaba Jar Bolsonaro a Brazil.
An kori wasu jami'an jam'iyyar ta Communist Party of China (CPC) a lardin kasar Sin saboda yadda suka bi da kokarin warewa a tsakiyar kasar, wanda ake ganin alamar rashin jin dadin matakin da jami'an jam'iyyar suka dauka kan yaduwar a yankunan.
Wasu masu sukar sun yi imanin cewa an yi wannan ne don kare Sakatare Janar na jam'iyyar Sin ta kasar Sin, Xi Jinping, daga fushin da ke tattare da yaduwar cutar.
Wasu jami'an kasar Sin sun musanta yarda da cewa cutar ta korona ta fara a Wuhan, a goyon bayan ka'idodin hadin gwiwa cewa cutar ta COVID-19 ta fito ne daga Amurka ko Italiya.
"Shugaban gwamnatin Donald Trump na Amurka ta yi amfani da kalmar coronavirus a matsayin ""Cinese pathogen"" ko ""Wuhan pathogen"", wanda ya nuna cewa China ta "ƙaddamar da tsarin da ya zama cutar da ta zama annoba ta duniya", wanda wasu masu sukar suka soki a matsayin wariyar launin fata da kuma "juya tsarinsa na rashin nasarar sarrafa cutar".
"The Daily Beast ta samu wata sanarwa daga gwamnatin Amurka, wadda ta bayyana shirin sadarwa daga Majalisar Tsaro ta Kasa, cewa, ""dukkanin kasar Sin ne ke da alhakin wannan dabarar".
"An ce dole ne mu samu wannan sakon ta kowace hanya, har da taron manema labarai da kuma fitowar ta talabijin. "Manyan kafofin yada labarai kamar su Politico, Foreign Policy da Bloomberg sun ce kokarin da kasar Sin ke yi na tura tallafi ga kasashen da cutar ta shafa na daga cikin wani labari da ke damun duniya".
"Shugaban harkokin wajen Tarayyar Turai (EU) Joseph Borel ya yi gargadin cewa, ""akwai wani bangare na siyasa da kasa, ciki har da gwagwarmayar tasiri ta hanyar yin amfani da 'yanci' da kuma 'yancin siyasa.'"
"Ba kamar Amurka ba, kasar Sin tana da matukar sha'awar cewa ita ce mai daukar nauyin da kuma amintacciyar hadin gwiwa", in ji Borel.
Kasar Sin ta yi kira ga Amurka ta cire takunkumin da ta yi wa Siriya da Venezuela da kuma Iran, yayin da ta tura tallafi ga kasashe biyu da suka rage.
An dakatar da rufe fuska 100,000 da Jack Ma ya ba Cuba a ranar 3 ga Afrilu saboda takunkumin Amurka.
An kuma zargi jami'an Amurka da mayar da kudaden da aka ba wasu kasashen zuwa nasu kasashe.
An samu rahotanni daga kasashe kamar Jamus, Austria da Switzerland; Jamhuriyar Czech da Italiya da ke tattaunawa kan batun rufe fuska.
Bugu da ƙari, Turkiyya ta kama daruruwan kayan numfashi da za a tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki tarayyar Turai game da rashin alhakin da ta yi wa Italiya da ke fama da cutar coronavirus.
"Majalisa na Italiya a Tarayyar Turai, Maurizio Masari, ya ce, "China ce kadai ta amsa wannan matakin na biyu".
"Ba shakka, wannan ba alama ce mai kyau na haɗin kai na Turai ba".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya, Giuseppe Conte, Shugaban Rasha Vladimir Putin ya umarci sojojin Rasha da su tura likitocin soja, da na'urorin kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
"Littafin Italiya na La Stampa ya yi magana game da wani "babban matakin siyasa mai zurfi", wanda ba a san shi ba, inda ya ce kashi 80 cikin dari na taimakon da Rasha ta ba shi "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Wannan hujja ta zargi Rasha da yin kamfen na "duniya siyasa da diplomasiyya".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da bayanan da aka yada a kafofin watsa labarai, suna nuna godiyarsu.
Rasha ta tura wani jirgin sama mai dauke da kayayyakin kiwon lafiya zuwa Amurka.
"Idan muka zo ga bayar da taimako ga 'yan'uwanmu na Amurka, [Putin] yana tsammanin cewa idan ya cancanta, Amurkawa za su mayar da irin wannan taimako, idan aikin samar da kayan aiki da kayayyaki a Amurka ya yi sauri", in ji Dmitry Peskov, mai magana da yawun Kremlin.
"Wasan NATO na "Defender 2020", wanda shi ne babban atisayen NATO na bayan Cold War, za a yi a Jamus, Poland da Baltic States a wani karamin matakin".
"Sakatare Janar na Kamfen din rage makaman nukiliya, Kate Hudson, ta soki Defender 2020: ""A halin yanzu na rikicin kiwon lafiya na jama'a, yana shafar ba kawai rayuwar sojojin Amurka da na kasashen Turai da ke cikin taron ba, har ma da mutanen kasashen da lamarin ya faru. Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kusan 'yan majalisa biyu da goma sha biyar da ke cikin yanzu ko kuma tsoffin' yan siyasa".
Shugaban Iran Hassan Rouhani ya rubuta wani sako a bude a ranar 14 ga watan Maris na 2020 inda ya nemi taimakon shugabannin kasa da kasa, inda ya bayyana cewa kasarsa na fuskantar matsalar rashin samun damar shiga kasuwannin duniya sakamakon takunkumin da Amurka ta sanya wa Iran.
Masu sharhi kan harkokin siyasa na ganin hakan zai iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020.
"Koriya ta Kudu ta soki Japan da 'ƙoƙarin killace mutane da ba a san su ba da gangan ba,' bayan Japan ta sanar da cewa za a yi wa masu zuwa daga Koriya ta Kudu 'yan kwanaki biyu a cikin keɓewa a kan wuraren da gwamnati ta nada".
Tun da farko, al'ummar Koriya ta Kudu sun rabu biyu saboda shawarar da Shugaba Moon Jae-in ya yanke game da magance matsalar.
Wasu 'yan Koriya sun sanya hannu kan takardun neman a gudanar da bincike kan Moon bisa ga zargin da suka yi cewa gwamnati ta yi da rashin kula da cutar, wasu kuma sun ce amsa da ta bayar abin yabo ne.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya ba gwamnatoci damar karfafa su.
A Hungary, majalisa ta amince da izinin firaminista Viktor Orbán na tsawaitawa, dakatar da majalisa da zaɓen, da kuma hukunta waɗanda ake zargi da yada labaran karya game da cutar da kuma yadda gwamnati ke magance matsalar.
Rashin wadatar kayayyaki, yawan amfani da kayan aiki a duniya don yaki da kamuwa da cuta, yawan sayen kayayyaki da rashin tsoro, da kuma wasu lokuta da suka hana masana'antu da ayyukan logistics.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadi game da karancin magunguna da kayan aikin likita da ke tasowa saboda karuwar bukatar masu amfani da kuma matsalolin samar da kayayyaki.
Akwai karancin wadata saboda yawan yankuna suna cikin fargaba, da kuma cire kayan abinci masu mahimmanci kamar abinci, takarda ta gida da ruwan sha.
Ma'aikatar fasaha ta yi gargadin cewa za a yi jinkiri a fitar da kayayyakin lantarki.
Darakta Janar na Hukumar Lafiya ta Duniya (WHO), Tetros Adnanom, ya ce bukatar kayan kariya ta mutum ta karu da sau 100.
Wannan bukatar ta sa farashin ya karu da sau 20 na farashin da aka saba samu, kuma hakan ya haifar da jinkirin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan kuma ya haifar da karancin kayan aikin kare lafiyar mutum a duniya, wanda zai iya zama barazana ga ma'aikatan lafiya, a cewar Hukumar Lafiya ta Duniya (WHO).
A Australia, annobar ta ba da sabuwar dama ga 'yan kasuwa da ake kira TYCOW su sayar da kayayyakin Australiya zuwa China.
Gwamnatin Ostiraliya ta dakatar da wannan aikin saboda rashin abinci ga yara a wasu manyan kantunan sayar da kayayyaki. Duk da cewa COVID-19 ya yi tasiri sosai a arewacin Italiya da yankin Wuhan, kuma ana buƙatar abinci mai yawa, dukansu sun tsira daga mummunan rashin abinci.
Matakan da kasar Sin da Italiya suka dauka kan haramtacciyar safarar kayayyaki masu mahimmanci da kuma cinikayya sun ci gaba da yin nasara, suna kawar da matsanancin karancin abinci da ake tsammani a Turai da Arewacin Amurka.
A arewacin Italiya, inda ake samun yawan amfanin gona, ba a samu raguwar samar da kayayyaki ba, amma masana'antun sun yi imanin cewa farashin zai iya tashi.
Har ma a birnin Wuhan, an yi watsi da abinci na ɗan lokaci. Jami'an gwamnatin Sin sun fitar da adana naman alade don tabbatar da cewa an sami isasshen abinci ga jama'a.
A Italiya ma, akwai dokokin da ke bukatar masu samar da abinci su riƙa ajiye kayayyaki don irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a China: A cewar wani rahoto da aka fitar a wata jarida a ranar 16 ga Maris, sakamakon matakan da gwamnati ta dauka na hana yaduwar cutar, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na shekarar 2020 kuma sayar da kayayyaki ya ragu da kashi 20.5 cikin dari.
Kasar Sin tana da babbar cibiyar tattalin arziki da masana'antu, saboda haka ana ganin yaduwar cutar a matsayin babbar barazana ga dorewar tattalin arzikin duniya.
Akade Demaris na Economic Intelligence ya yi hasashen cewa kasuwannin za su kasance masu rashin daidaito har sai an bayyana sakamakon da zai iya faruwa.
A watan Janairun 2020, wasu masu bincike sun kiyasta cewa koma bayan tattalin arzikin da ke tattare da annobar ta yanzu zai fi na SARS a shekarar 2002 zuwa 2004.
Wani masanin daga Jami'ar Washington a St. Louis ya kiyasta cewa, fiye da dala biliyan 300 na iya shafar jerin kayayyakin duniya a cikin shekaru biyu.
A sakamakon raguwar farashin mai da kasar Sin ta samu, an tura kungiyar kasashen da ke fitar da man fetur zuwa kasar OPEC cikin mawuyacin hali.
Kasashen duniya sun fadi a ranar 24 ga Fabrairu saboda yawan kamuwa da cutar COVID-19 a waje da yankin China.
A ranar 27 ga Fabrairu, saboda damuwa da ke ƙaruwa game da kamuwa da cutar coronavirus, wasu manyan alamun kasuwar Amurka, ciki har da NASDAQ 100, S&P 500 (S&P) da Dow Jones Industrial Average, sun yi saurin faɗuwa a karon farko tun bayan 2008, da Dow ya faɗi da maki 1,191, wanda shine mafi girman faɗuwa na kwana ɗaya bayan rikicin kuɗi na 2007-08.
Dukkanin shafuka uku sun fadi sama da kashi 10 cikin dari a karshen mako.
A ranar 28 ga watan Fabrairu, kamfanin kimanta darajar SCOB, GmbH, ya tabbatar da kimantawar kudin kasar Sin, amma ya kara da cewa ba zai yiwu ba.
Kasuwancin ya sake faɗuwa saboda tsoron cutar coronavirus, wanda ya kai ga mafi girman faɗuwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a iya samun ci gaba a tattalin arziki.
Masanin tattalin arziki Mohammad El-Arian ya yaba da gaggawa da manyan bankuna da kuma gwamnatin kasar suka dauka a kan lokaci.
Babban bankin tarayya yana aiki da sauri fiye da yadda ya amsa a lokacin koma bayan tattalin arziki na 2008.
Kasuwancin yawon bude ido yana daya daga cikin bangarorin da suka fi fama da matsalolin da suka shafi hana tafiya, rufe wuraren jama'a, gami da wuraren tafiya, da kuma shawarwarin gwamnatoci game da duk wani tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, Sina Eastern Airlines da kuma Guandace sun soke jiragen saboda karancin bukatar, yayin da kamfanin jirgin saman yankin na Burtaniya, Flybe, ya yi ta fama da koma baya.
Wannan shi ne babban tasiri a kan masana'antar jirgin ruwa.
An rufe tashoshin jiragen ruwa da kuma tashoshin jiragen ruwa.
Wannan annoba ta dace da sunnyun, wani muhimmin lokacin tafiya da ya shafi hutun sabuwar shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke abubuwa da yawa da suka shafi manyan taro, gami da bukukuwan Sabuwar Shekara na shekara-shekara, kamfanoni masu zaman kansu da shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland sun rufe kansu.
An rufe wasu abubuwan da ake yi a sabuwar shekara da wuraren yawon bude ido don kauce wa taron jama'a, ciki har da wuraren da aka hana birnin da aka hana a Beijing da kuma wuraren da aka gina haikalin gargajiya
A cikin kananan hukumomi 24 da yankuna 24 a larduna 31 na kasar Sin, jami'ai sun kara hutun sabuwar shekara har zuwa 10 ga Fabrairu, inda suka shawarci mafi yawan wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Waɗannan yankuna suna wakiltar kashi 80 cikin 100 na GDP na ƙasar da kuma kashi 90 cikin 100 na fitarwa.
Kasar Hong Kong ta rufe makarantu har zuwa watan Maris, lokacin da ta yi sanarwar gaggawa, da kuma soke bikin Sabuwar Shekara, inda ta kai matakin da ya fi dacewa da annobar, kuma ta yi watsi da bukukuwan Sabuwar Shekara.
Kasuwancin da ke zuwa ga masu siyarwa a Turai da Latin Amurka ya ragu da kashi 40%.
Kasashen Arewacin Amurka da Gabas ta Tsakiya na da raguwa da kashi 50-60%.
Wannan ya nuna cewa, a watan Maris, yawan masu amfani da kayayyaki a wuraren sayar da kayayyaki ya ragu da kashi 33 da 43 bisa dari idan aka kwatanta da watan Fabrairu.
Masu gudanar da shagon a duk faɗin duniya sun ɗauki ƙarin matakan kamar ƙara matakan kiwon lafiya, shigar da masu duba zafin jiki na masu zuwa shagon, da soke abubuwan da suka faru, kuma an kiyasta cewa, a cewar kimantawar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da annobar ta haifar, zai iya sa tsakanin miliyan 14 da miliyan 22 a Latin Amurka su shiga matsanancin talauci idan aka kwatanta da yanayin da ba a da annobar ba.
A cikin watan Janairu da Fabrairun 2020, a lokacin da annobar ta yi fice a Wuhan, kimanin mutane miliyan 5 ne suka rasa ayyukansu a kasar Sin.
Fiye da ma'aikata 'yan gudun hijira miliyan 300 na kasar Sin sun makale a gidajensu a lardunan cikin gida ko kuma sun makale a lardin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimar da bankin tarayya na St. Louis, cutar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka kuma rashin aikin yi zai iya kaiwa kashi 32%. Rashin aikin yi a Indiya ya sa dubban dubban ma'aikatan baƙi na Indiya (ma'aikata masu biyan kuɗi na yau da kullun) ba su da aiki. Wani binciken da aka gudanar da kamfanin Ares Reed ya gano cewa kashi 44% na iyalai na Kanada sun sami rashin aikin yi na wani nau'i. Kimanin ma'aikata 9,00,000 sun rasa aikin yi a Spain tun lokacin da suka shiga cikin yanayin rashin aikin yi a tsakiyar watan Maris 2020.
A lokacin rabin watan Maris, ma'aikata 4 miliyan na Faransa sun nemi amfanin rashin aikin yi na wucin gadi, kuma ma'aikata 1 miliyan na Burtaniya sun nemi a karkashin shirin Credit Universel. Kusan rabin miliyan kamfanoni a Jamus sun tura ma'aikatansu a karkashin shirin gajeren lokaci na tallafi na gwamnati da aka sani da Cusafed.
Faransa da Birtaniya suna bin tsarin biyan kuɗin aiki na gajeren lokaci na Jamus.
Masana'antu na fasaha da al'adun gargajiya sun sha wahala sosai daga annobar, yana shafar ayyukan kamfanoni da kuma mutane a duniya - masu aiki na dindindin da masu zaman kansu.
Cibiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (galibi na jama'a) don samun damar al'adun al'adu ga al'umma, kula da lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha kamar yadda ya yiwu.
A cikin watan Maris na 2020, a duk faɗin duniya da kuma a matsakaita, gidajen tarihi, dakunan karatu, gidajen wasan kwaikwayo da sauran cibiyoyin al'adu suna soke ko kuma rufe abubuwan da suka faru da abubuwan da suka faru ba tare da an tsai da lokaci ba.
A sakamakon haka, an yi ƙoƙari sosai don samar da sabis na musanya ta hanyar dandamali na dijital. Wani sabon abu kuma mai saurin faruwa shine soke ayyukan addini, manyan wasanni, tare da su, kide-kide da kide-kide, tarurruka na fasaha da kuma kayan ado.
A cikin watan Litinin, Vatican ta sanar da cewa an soke bukukuwan mako mai tsarki a Rome a makon ƙarshe na lokacin Lenten na Kirista.
Yawancin majami'u sun ba da shawarar cewa tsofaffin Kiristoci su zauna a gida maimakon halartar taron addu'a na ranar Lahadi; wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shirye na kai tsaye ko talabijin, wasu kuma suna ba da sabis na ibada ta hanyar drive.
Bayan da Roman Katolika ta rufe majami'un ta kuma fitar da Kiristocin masu bautar gumaka daga St. Peter's Square, wasu kungiyoyin addini kamar majami'u, masallatai, majami'u, haikali da gurdwara sun soke ayyukansu da kuma hana jama'a taruwa.
Ma'aikatar lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma daga bisani aka rufe wuraren ibada. Saudiyya ta haramta masu bautar baƙi da kuma 'yan ƙasarsu shiga wuraren tsarki a Makka da Madina.
Wannan annoba ta haifar da babbar matsala ga gudanar da wasanni a duniya bayan yakin duniya na biyu.
Yawancin manyan wasanni da suka faru sun soke ko an dakatar da su, ciki har da 2019 UEFA Carrier Association, 2019 UEFA Euro 2020, 2019 NBA Season, da kuma 2019 NHL Season.
"Wannan yaduwar ta rushe shirye-shiryen gasar Olympics ta bazara ta 2020 da aka shirya a farkon watan Yuli; a ranar 24 ga Maris, Hukumar Olympic ta Duniya ta sanar da cewa za a sake sabunta taron zuwa wani kwanan wata bayan shekarar 2020, amma ba bayan lokacin bazara na 2021 ba". Cibiyoyin caca da sauran wuraren wasanni a duniya za su rufe kuma za a dage ko kuma a soke wasannin karta na rayuwa".
Wannan ya sa yawancin masu caca suka koma Intanet, kuma yawancin shafukan yanar gizo na caca sun ƙara yawan kuɗin shiga ga sababbin shiga. An kuma shafi masana'antar nishaɗi.
Yawancin manyan gidajen wasan kwaikwayo kamar su Broadway sun dakatar da duk abubuwan da suka faru.
"Wasu masu fasaha sun gano sababbin hanyoyi na samar da abubuwan da za a yi a yanar gizo, kamar su shirya abubuwan da za a raba a kan layi, a maimakon yin wasan kwaikwayo na yau da kullum, wato, waƙoƙi da aka watsa a kai tsaye ko kuma ƙirƙirar abubuwan da za a yi amfani da su a yanar gizo don yin aiki, rarraba da kuma tallata ayyukan su".
A kan layi, yawancin abubuwan da ke tattare da cutar ta coronavirus na intanet sun haifar da juyayi da kuma juyayi ga mutane da yawa a cikin rashin daidaito.
Tun lokacin da COVID-19 ta fara yaduwa, mutane daga China da kuma Gabashin Asiya sun kasance na gargajiya. Kuma, tsattsauran ra'ayi, tsoron baƙi da nuna bambanci da kuma nuna bambanci ga mutanen Turai, Amurka da sauran ƙasashe da cutar ta fi tasiri.
Abubuwan da ke haifar da tsoro, shakku da ƙiyayya sun faru a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da kuma yankin Asiya-Pacific.
Rahotanni da aka fitar a watan Fabrairu (da ya fi tasiri a kasar Sin) sun yi rikodin nuna bambancin launin fata da aka nuna wa kungiyoyin 'yan kasar Sin a fadin duniya, kamar yadda ake cewa, za su iya kamuwa da cutar, ko kuma a ce, hukuncin da ya dace ne.
Wasu kasashen Afirka ma sun samu karuwar rashin amincewa da kasar Sin.
Mutane da yawa a Wuhan da Hubei sun koka cewa an nuna musu wariya saboda asalin su.
A cikin yankin da cutar ta shafa, an samu taimako ta hanyar Intanet da kai tsaye daga China.
Yayin da yaduwar cutar zuwa sabbin wurare masu zafi, mutanen Italiya, wanda ya fara yaduwar COVID-19 a Turai, za su fuskanci shakku da nuna bambanci. Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun da ke hana Sin shiga ƙasashensu don hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a cikin Twitter.
A cikin Amurka da Birtaniya, da kuma wasu kasashen Asiya, an samu karuwar hare-haren nuna wariyar launin fata da hare-haren da ake yi wa kansu.
"Hukumar shugaban Amurka Donald Trump ta bayyana coronavirus a matsayin "Cinese virus" an yi ta sukar ta, kuma masu sukar suna ganin cewa yin hakan abu ne na wariyar launin fata da kuma adawa da kasar Sin".
'Yan zanga-zangar da ke Ukraine sun kai hari kan motocin da ke dauke da 'yan kasashen waje da suka zo Nuwi-Sansari daga Ukraine da Wuhan.
Dalibai daga jihohin arewa maso gabashin Indiya da ke zaune a wasu manyan biranen Indiya kuma suna karatu a kan iyakar da ke da iyakar da Sin sun sami labarin cewa suna fuskantar matsalar kamuwa da cutar.
"Shai'anan sun lalata yanayi, "in ji shugaban jam'iyyar Bharatiya Janata Party ta West Bengal State Committee, Dillip Ghosh.
"Sa'an nan kuma ofishin jakadancin kasar Sin a Kolkata ya yi tir da irin wannan ra'ayin, ya ce "ba daidai ba ne". A kasar Sin, tsoron baƙi da kuma nuna bambanci ga wadanda ba 'yan kasar Sin ba ya ƙaruwa saboda cutar cin hanci da rashawa.
Wasu jaridu sun cire tsarin nuna wasiƙun imel ga masu biyan kuɗi kawai a kan shafukan yanar gizon su don karanta labarai game da cutar ta coronavirus a wani ɓangare ko gaba ɗaya.
Yawancin masu wallafa kimiyya sun ba da damar karanta takardun kimiyya game da kamuwa da cuta ga kowa.
Wasu masana kimiyya sun zaɓi su raba sakamakon su da sauri a kan sabobin da suka gabata kamar bioRxiv.
Cutar da ke tasowa - Cutar da ke tasowa ta ƙwayoyin cuta, sau da yawa sabon abu ne a cikin iyakar yaduwar cutar ko yanayin watsawa
Duniya da Cututtuka - Bayani na Duniya da Cutar Cutar
Jerin annoba da annoba - yawan mutanen da suka mutu saboda annoba
Cin hanci da rashawa da cututtukan da ke tattare da shan dabbobi  Hadarin kiwon lafiya da ke tattare da cinikin dabbobi na kasashen waje
Gwaje-gwajen gwaje-gwaje na SARS-CoV-2 da ake yi a cikin dakin gwaje-gwaje na respiratory coronavirus disease 2019 (COVID-19) da kuma SARS-CoV-2 da ke da alaƙa sun haɗa da hanyoyin gano yanayin cutar da kuma gano wasu kwayoyin da ake samarwa a cikin amsawa ga kamuwa da cuta.
An tabbatar da cewa akwai kwayoyin cutar a cikin samfurin RT-PCR wanda ke gano RNA (RNA) na kwayar cutar.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtukan cututtuka na kwanan nan ko na yanzu.
Ana iya amfani da tsarin gano kwayoyin halitta (biology) don tantancewa da kuma lura da mutane.
Wasu gwajin rigakafi na nuna yawan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Ana iya tantance ainihin mutuwar da cutar ta haifar da ita da kuma rigakafin garken daga sakamakon gwajin.
Saboda iyakancewar gwajin, babu wata ƙasa da ke da tabbataccen bayanai game da kamuwa da cutar a cikin yawan jama'arta a watan Maris na 2020.
Har zuwa 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin 100 na yawan jama'ar ƙasar, kuma yawan mutanen da aka gwada ya bambanta sosai daga ƙasa zuwa ƙasa.
Wannan bambancin na iya shafar yawan adadin mutuwar da aka sanar, kuma yana iya zama mai yawa a wasu ƙasashe.
Ana iya gwadawa a cikin samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasopharyngeal pancreatic ko chicken samfur, ta amfani da ainihin lokacin bayanan transcription polymerase chain query (RRT-PCR).
Sakamakon zai kasance a cikin 'yan sa'o'i zuwa kwanaki biyu.
Gwajin RT-PCR da aka yi ta hanyar swap zai ba da tabbataccen sakamako ne kawai a makon farko na cutar.
Bayan haka, cutar ta ɓace a cikin wuyansa, amma ta kai ga huhu kuma ta ci gaba da ƙaruwa.
A lokacin gwajin da aka yi a mako na biyu a cikin waɗanda suka kamu da cutar, ana iya amfani da wani samfurin maye gurbin da aka yi da su ta hanyar wani ruwa mai narkewa daga cikin hanyar numfashi ko kuma daga cikin ciwon kumburi.
Daya daga cikin gwajin PCR na farko an yi shi ne a cikin Janairu 2020 a Saradij, Berlin, ta amfani da ainihin lokacin bayanan bayanan bayanan polymerase chain query (RRT-PCR), kuma ya samar da tushen kayan aiki 250,000 don rarrabawa ta WHO.
A ranar 23 ga Janairu, 2020, Birtaniya ta samar da tsarin gwaji kamar yadda ta kasance a lokacin. Kamfanin Koriya ta Kudu, GoGenbiotech PCR, wanda ke da tushen PCR, na asibiti, mai gwajin SARS-CoV-2 (Powercheck Coronavirus) a ranar 28 ga Janairu, 2020.
"Wannan yana nufin kwayar halitta ""E"" da dukkan kwayoyin cutar beta suka raba da kuma RdRp (RdRp) da ke da alaƙa da SARS-CoV-2 (SARS-CoV-2). A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami amincewa na farko daga Hukumar Kula da Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Kayan Aikin Aikin Kayan Aikin Kayan Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin Aikin
Gwaje-gwaje a CDC a Atlanta sun sami matsala saboda gwajin da aka yi a cikin wasu nau'ikan kayan gwaji guda uku ya ba da sakamako mai ban mamaki saboda kayan gwaji marasa kyau; sakamakon haka, an samu nasarar aiwatar da samfurori sama da 100 a kowace rana a matsakaici a cikin Fabrairu 2020.
Har zuwa 28 ga Fabrairu, 2020, ba a tabbatar da gwajin da ya yi amfani da abubuwa biyu ba, kuma ba a ba da izinin gudanar da gwaje-gwaje ga dakunan gwaje-gwaje na jihar da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin dokar ta baci. Labs masu kasuwanci a Amurka sun fara gwajin a farkon Maris 2020.
LabCorp ta sanar da cewa, a ranar 5 ga Maris, 2020, ana samun hanyoyin gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
A ranar 9 ga Maris, 2020, Quest Diagnostics ta ba da damar yin gwajin COVID-19 a duk faɗin ƙasar.
Babu wani iyakance-yankin da aka sanar; dole ne a tattara samfurin da kuma sarrafa shi bisa ga yanayin da CDC ta ba da shawarar.
A Rasha, an kirkiro kuma an samar da tsarin gwajin COVID-19 ta hanyar Vector, Cibiyar Nazarin Jihar Na'urar Kwayar cutar da Kayan Gida (VECTOR).
An sanar da cewa Clinic Mayo ta kirkiro tsarin gwaji don gano kamuwa da COVID-19 a ranar 12 ga Maris, 2020. An amince da Roche Diagnostics daga Hukumar Abinci da Magunguna (FDA) a ranar 13 ga Maris, 2020 don ingantaccen tsarin gwaji don yin gwaji mai yawa a cikin awanni 3.5, wato, inji don yin gwaji mai yawa na kusan gwaje-gwaje 4,128 a cikin tsawon awanni 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna (FDA) ta ba da izinin gaggawa na gaggawa (EUA) ga Labs na Abbot don yin gwaji tare da tsarin Abbot M2000; kuma a baya, Hukumar Abinci da Magunguna (FDA) ta ba da irin wannan izinin ga Hologic, LabCorp da Thermophyser Scientific.
A ranar 21 ga Maris, 2020, an ba da izinin gaggawa na gaggawa (EUA) daga Hukumar Abinci da Magunguna (FDA) don gwajin gwaji wanda zai ɗauki minti 45.
FDA ta amince da gwajin da ke amfani da fasahar karuwa ta sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sin
Ba a buƙatar juyawa na zafin jiki na madadin don haka, ana iya samar da sakamako mai inganci a cikin minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin injuna 18,000 a Amurka, kuma Abbott na sa ran bunkasa samarwa zuwa gwaje-gwaje 50,000 a rana. Wani gwaji na musamman da ke amfani da kwayar halitta guda daya da ke dauke da kwayar cutar coronavirus (N-protein) da ke hade da kwayar cutar a Taiwan. Idan ya yi nasara, akwai tabbacin cewa zai iya samar da sakamako a cikin minti 15 zuwa 20 kamar gwajin Rapid Syndrome.
"Binciken wata kasida a watan Maris na 2020 ya ce ""ana iya samun rashin yiwuwar ganewar asali ta hanyar hotunan kirji a farkon lokaci, yayin da sakamakon CT [CT-computed tomography] na iya nuna cewa an riga an nuna alamun bayyanar".
Abubuwan da ke tattare da CT sun haɗa da binary polyhedral surface-glass optics tare da waje, asymmetrical, da kuma back-distributed.
Yayin da cutar ta yi tsanani, ana samun ciwon subclavian vein, numfashi mai zurfi da kuma taurin kai.
Wani bincike da aka gudanar a Wuhan inda cutar ta fara, ya nuna cewa PCR ya fi CT kyau, ko da yake wasu siffofin CT sun fi sauran cututtukan huhu da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
"Kamar yadda aka yi a watan Maris na 2020, Kwalejin Nazarin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin "gwajin farko ko gwajin farko don gano COVID-19". Kamar yadda aka yi a watan Maris na 2020, Cibiyar Kula da Ciwon Cutar da Cututtuka (CDC) ta ba da shawarar yin amfani da PCR don gwajin farko".
Wani ɓangare na aikin rigakafin rigakafi don kamuwa da cuta shine samar da antibodies, gami da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane waɗanda ke da kwanaki 7 ko fiye bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma sa ido kan mutane. Ana iya yin kimantawa a cikin manyan dakunan gwaje-gwaje (CLT) ko wuraren gwajin kulawa (PoCT-POCT).
Ana iya yin waɗannan kimantawa ta hanyar tsarin sarrafa kai mai inganci a cikin dakunan gwaje-gwaje da yawa, amma kasancewa da su ya dogara da yawan aikin kowane tsarin.
Ana amfani da samfurin jini guda ɗaya na jini don CLD, duk da haka ana iya amfani da jerin samfurori don bin tsarin rigakafi.
Ana yin gwajin PoCT ne ta hanyar yin jini a cikin fata.
A ranar 26 ga Maris, 2020, Hukumar Abinci da Magunguna (FDA) ta fitar da sunayen kamfanoni 29 da aka tabbatar da cewa za su iya rarraba gwajin rigakafin su a halin yanzu, saboda suna ba da bayanai ga kamfanin idan aka buƙata.
Kamar yadda aka yi a ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani na gaggawa. Kamfanonin EuroImmun Medical Laboratory Diagnostics da Enidop Diagnostics, waɗanda ke samar da kayan gwaji don taimakawa gano IgG da IgA masu aiki da ƙwayoyin cuta daga samfurin jini, sun sami amincewar Turai a ƙarshen Maris 2020 don kayan aikin gwajin su.
Da yake yana iya gwada ɗaruruwan samfurori a cikin 'yan sa'o'i, mai cutar zai iya ba da sakamako da sauri fiye da yadda ake yin kimantawa na PCR na yau da kullum na RNA.
A farkon watan Afrilu, sun gano cewa babu wani kayan gwajin rigakafi da aka saya a Burtaniya da ya dace da amfani.
"Hong Kong ta kafa shirin da zai sa marasa lafiya masu shakku su zauna a gida, su "sanya samfurin bututun da sashen gaggawa ke ba marasa lafiya", su kuma dawo da shi bayan an aika da shi. Hukumar NHS ta Burtaniya tana gudanar da shirin gwajin marasa lafiya masu shakku a gida don kawar da haɗarin kamuwa da cutar ga wasu idan marasa lafiya suka zo asibiti ko kuma an yi amfani da maganin rigakafi.
A ranar 2 ga watan Maris, kungiyar likitocin inshorar doka ta kasa da ke Jamus ta ce, "Koriya ta Kudu ta samu damar gudanar da gwajin da ya kai kimanin 12,000 a rana ta hanyar tsarin tafiyar da ta kai, kuma an gudanar da gwajin 10,700 a makon da ya gabata".
Idan likita ya ba da umarnin a yi masa gwaji, asusun inshorar zai biya kuɗin.
A cewar shugaban kamfanin Robert Koch, Jamus na da damar gudanar da bincike na mako-mako 160,000.
A ranar 19 ga watan Maris, an gudanar da gwajin a manyan birane da dama.
A ranar 26 ga Maris, 2020, ba a san adadin gwajin da aka yi a wurin ba saboda Jamus ta ba da rahoton adadin sakamakon gwajin da aka tabbatar da cutar.
"A cikin binciken farko na dakin gwaje-gwaje, masu bincike a asibitin Technion da Rampam na Isra'ila, sun kirkiro da kuma gwada wata hanya don gwada samfurori daga marasa lafiya 64 a lokaci guda, kawai idan an gano cewa samfurori sun kasance masu kyau, masu karɓar samfurori da aka haɗa sun bayyana cewa samfurori sun kasance masu kyau. A nan ne aka buɗe wani dakin gwaje-gwaje mai suna "Iron Billion" (GIB) da aka kira "Iron Billion" a ranar 5 ga watan Mayu 2020.
Idan ba a aiwatar da tsarin gwajin da aka kirkira a cikin kwanaki 5 ba tare da jagorancin Wang Jian, wanda ya kafa BGI, za a iya samun karin kashi 47 cikin 100 na masu cutar a Hubei kuma farashin yin amfani da shi don magance keɓewa zai ninka.
A cikin birnin Shenzhen da Tianjin da Beijing da Shanghai a kasar Sin, cibiyoyin bincike na Hu-Yan sun bi tsarin da Wuhan Lab ke yi.
A ranar 4 ga Maris, 2020, aikin yau da kullun ya kai gwaji 50,000 a rana. An buga samfurori masu yawa, masu yawa, waɗanda aka buga ta Oregami ratings, waɗanda zasu iya gwada samfuran marasa lafiya 1122 don COVID19 ta amfani da ƙididdiga 93 kawai. Waɗannan samfurori masu daidaituwa za a iya gudanar da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar sarrafawar robotic fluid ba.
A watan Maris, karancin kayan gwaji da rashin wadataccen ajiya sun zama abin hana gudanar da gwaji mai yawa a cikin EU, UK da Amurka.
Wannan ya haifar da wasu masu kirkiro su binciko ka'idojin samar da samfurin don yin dumama samfurori zuwa 98 ° C (208 ° F) na minti 5 don sakin kwayoyin halittar RNA (RNA) don gwaji. A ranar 31 ga Maris, an sanar da cewa UAE tana gwada yawan mutanen ta fiye da sauran ƙasashe kuma tana kan hanyar ƙara yawan gwajin don yin gwaji ga yawancin yawanta.
"Wannan ana yin sa ne ta hanyar sayen wata dakin gwaje-gwaje mai karfin gaske dangane da yawan jama'a (wanda ya dogara da dakin gwaje-gwaje na gaggawa na ""Hu-Yan"" a China") daga Gungu na 42 da BGI".
An gina shi cikin kwanaki 14 kuma yana da ikon gudanar da dubban gwajin RT-PCR a kowace rana kuma shine dakin gwaje-gwaje na farko a duniya da ke aiki a waje da China da irin wannan damar.
An kirkiro hanyoyin gwaji daban-daban a China, Faransa, Jamus, Hong Kong, Japan da Amurka don magance sassa daban-daban na bayanan kwayoyin cutar.
Hukumar lafiya ta duniya ta amince da girke-girke na Jamus don samar da kayan aiki da za a tura wa ƙasashen da ba su da albarkatun da za su iya yin kayan aiki a kansu.
An fitar da tsarin bin Jamus a ranar 17 ga Janairu 2020; an jinkirta gwaji a Amurka saboda babu wata hanyar da cibiyoyin kula da cututtuka na Amurka suka samar har zuwa 28 ga Janairu. Saboda wasu matsaloli game da amincin kayan aikin gwaji a farkon lokacin kamuwa da cutar, Amurka da China sun kasa samar da isasshen kayan aiki don biyan gwaji da bukatun da aka ba su ta hanyar shawarwarin masu ilimin kiwon lafiya.
A maimakon haka, masana sun ce, Koriya ta Kudu ta yi amfani da gwaji mai yawa don rage yaduwar cutar coronavirus.
A yawancin lokuta, a cikin dakunan gwaje-gwaje na masu zaman kansu, an gina gwajin ne ta gwamnatin Koriya ta Kudu na tsawon shekaru.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta ba da shawarar cewa hanya mafi kyau ta rage yaduwar cutar COVID-19 ita ce hanzarta shirye-shiryen gwaji. Saboda bukatar yin gwaji mai yawa saboda yaduwar cutar, daruruwan dubban gwaje-gwaje a cikin dakunan gwaje-gwaje na masu zaman kansu a Amurka sun kasance a kan gungumen azaba.
A watan Maris na shekarar 2020, kasar Sin ta sanar da cewa tana da matsaloli game da daidaito na kayan aikinta na gwaji.
"A Amurka, kayan aikin gwajin da CDC ta samar sun kasance da ""rashin daidaituwa""; bayan haka gwamnati ta kawar da takunkumin da ke hana gwaji na sirri. Spain ta sayi kayan aikin gwaji daga kamfanin Shenzhen Bioeci Biotechnology Co., Ltd. na kasar Sin, amma sakamakon ya bayyana ba daidai ba".
Kamfanin ya bayyana cewa sakamakon sakamakon kuskuren da aka samu a tattara samfurori ko kuma amfani da kayan aikin daidai ne.
Ma'aikatar ta Spain ta ce ta dawo da kayan aikin da suka ba da sakamako mara kyau kuma ta maye gurbin su da wani kayan aikin gwaji na Shenzhen BioEC. 80% na kayan aikin gwajin da Czech Republic ta saya daga China sun ba da sakamako mara kyau.
"Prime Minister Madoviq ya bada shawarar a jefa su cikin Danube. Turkiya ta ce kayan aikin gwajin da ta sayi daga China suna da "ƙimar kuskure" kuma ""ba za a iya amfani da su ba". Birtaniya ta sayi kayan aikin gwaji miliyan 3.5 daga China amma ta bayyana cewa ba su dace da amfani ba a farkon watan Afrilu 2020".
An gano wadanda suka kamu da cutar SARS-CoV-2 da kuma wadanda suka yi hulɗa da su a cikin gwaji da kuma keɓancewa.
Masu binciken kankara a garin Vo-Ville, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a cikin kwanaki 10 a wurin da ke da yawan mutane 3,400.
Rabin wadanda aka tabbatar da cutar ba su da wata alama. Dukkanin wadanda aka tabbatar da cutar an killace su.
An hana tafiya zuwa majalisa ta gari, wanda ya kawar da sabon kamuwa da cuta gaba ɗaya.
Duk da rashin tsauraran dokoki kamar rufe gidajen cin abinci da shagunan sayar da kayayyaki, cutar ta COVID-19 ta bazu a Singapore a cikin 2020 a cikin sauri fiye da sauran ƙasashe masu tasowa saboda tsananin saurin bin sawu, ƙuntatawa kan tafiya mai shigowa, gwaji da keɓewa.
An soke wasu bukukuwa, kuma a ranar 28 ga watan Maris ne Singapore ta fara umarci mazaunan ta su zauna a gida, amma a ranar 23 ga watan Maris ne makarantu suka sake budewa a kan lokaci bayan hutu.
Kasashe da dama kamar Iceland da Koriya ta Kudu sun bi dokar hana fita mai tsanani, yayin da suka yi aiki tuƙuru wajen sarrafa yaduwar annobar ta hanyar bin diddigin hulɗa, takunkumin tafiye-tafiye masu shigowa, gwaji da keɓewa
A wani binciken kididdiga, ƙasashen da suka yi gwaji sosai sun sami ƙarancin mutuwar idan aka kwatanta da yawan mutuwar, saboda an gano waɗanda suka kasance marasa lafiya ko marasa alamun cutar a waɗannan ƙasashe.
Hukumar ta bada shawarar cewa kasashen da ba su da ingantattun wuraren yin gwaji, da kuma dakunan gwaje-gwaje na kasa da ba su da kwarewa sosai a kan COVID-19, su aika samfuransu biyar na farko da aka tabbatar da cewa ba su da tasiri a kan COVID-19 da kuma samfurori 10 na farko don tabbatarwa zuwa ɗayan dakunan gwaje-gwaje na WHO (WHO)16 don gwaji.
Daga cikin dakunan gwaje-gwaje 16 da aka ba da shawarar, akwai 7 a Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka, da 1 a Ostiraliya.
"A cikin jadawalin da ke ƙasa, shafi na ""% tabbatarwa bisa gwaji"" yana shafar manufofin da ƙasar ke da shi game da tsarin gwaji".
Idan aka daidaita sauran, yawan marasa lafiya da aka tabbatar da gwaji a kasar da ke gwadawa da wadanda aka kwantar da su asibiti ne kawai zai kasance % fiye da na kasar da ke gwadawa da dukkan 'yan kasar ba tare da la'akari da ko mutane suna da alamun cutar ba
Yin wanka (ko kuma wanke hannu), wanda aka fi sani da tsabtace hannu, shi ne kawar da ƙasa, man fetur, ƙwayoyin cuta, ko wasu abubuwa marasa amfani daga hannun mutum.
"Tsabtace hannu a wasu 'lokaci masu muhimmanci' na rana yana hana yaduwar cututtuka da yawa, kamar kumburi da kuma cutar cholera, wanda ke yaduwa ta hanyar fitsari da kuma baki".
Mutane suna iya kamuwa da cututtukan numfashi kamar zazzabi ko kuma sanyi na yau da kullum. Idan ba a wanke hannu kafin a taɓa idanu, hanci, ko baki (wato, gashin gashi) ba, za su iya kamuwa da irin wannan cuta.
Abubuwa biyar masu muhimmanci da ake bukatar a yi a rana su ne wanke hannu da sabulu: kafin da bayan wanka, bayan wanke ƙasan yaron ko sauya labule, kafin a ciyar da yaron, kafin a ci abinci da kuma bayan dafa abinci ko kuma lokacin da ake amfani da naman naman da ba a dafa ba, kifi ko naman alade.
Idan babu ruwa da sabulu, za a iya wanke hannuwanka da toka.
Kafin ka shirya abinci, a lokacin da kake shirya shi, kuma bayan ka shirya shi.
Kafin ka kula da wani marar lafiya, da kuma bayan ka kula da shi.
Bayan an canja kayan shafa ko kuma an wanke yaro da ya yi amfani da gidan wanka.
Bayan ka sha hanci, ko kuma bayan ka ji tari ko kuma ka yi ciwon ciki.
Bayan ka taɓa dabba, gonar dabba ko kuma sharar dabba.
Hanyar lafiya ta hannu tana nufin ayyukan lafiya da suka shafi ayyukan likita.
Yin wanka da hannu kafin a ba da magani ko magani zai iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu shine tsabtace hannu daga ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta) da kuma sunadarai da zasu iya haifar da cutar ko cuta.
Wannan yana da mahimmanci ga mutanen da ke kula da abinci ko aiki a cikin likita, amma yana da mahimmanci ga jama'a.
Yin wanka da hannu yana da fa'idodi masu yawa na kiwon lafiya, gami da rage yaduwar kamuwa da cutar mura, coronavirus da sauran cututtukan da ke kamuwa da cuta; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan jiki; da rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar yara a cikin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa yin wanka a hannu a cikin yara 'yan shekara biyar da ƙasa zai iya taimaka musu su ƙara tsawo.
A kasashe masu tasowa, za a iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da na hanji ta hanyar gabatar da sauye-sauyen hali kamar wanke hannu da sabulu.
Wannan matakin mai sauki zai iya rage yawan mutuwar da ake samu daga wadannan cututtuka da kusan kashi 50.
Abubuwan da ke sa hannuwanmu su wanke hannuwanmu suna iya rage yawan cututtukan ciki da kashi uku, idan aka kwatanta da samar da ruwa mai tsabta a yankunan da ba su da isasshen kuɗi.
Ana iya danganta rage yawan abubuwan da ke faruwa a cikin ciki da kashi 48 cikin dari da wanke hannu da sabulu. Kamar yadda yake faruwa a gidaje, makarantu da kuma al'ummomi a duk faɗin duniya, wanke hannu da sabulu shine hanya mafi inganci da arha don hana ciwon ciki da cututtukan numfashi masu tsanani (ARI).
Rashin numfashi yana da mahimmanci a cikin cututtukan numfashi masu tsanani, kuma shine babban dalilin mutuwar yara a ƙarƙashin shekaru biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Rashin ciki da rashin numfashi suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, yin wanka da sabulu a hannu kafin cin abinci da bayan amfani da gidan wanka a matsayin al'ada na iya ceton rayuka fiye da kowane rigakafi ko magani, kusan rabin mutuwar da ke tattare da ciwon ciki, da kuma rage mutuwar da ke tattare da cututtukan numfashi masu tsanani.
Ana haɗa hannuwan hannu tare da sauran ayyukan inganta kiwon lafiya a matsayin wani ɓangare na ayyukan ruwa, tsaftacewa da tsaftacewa (wash).
Yin wanka a hannu yana kare ka daga cutar da ke tattare da kai tsaye.
Wani sakamako mai illa na wanke hannu shine cewa wanke hannu sau da yawa zai haifar da lalacewar fata saboda bushewar fata.
Wani bincike a Denmark a shekarar 2012 ya gano cewa yawan wanke hannu zai iya haifar da wani yanayi mai saurin lalacewa, wanda ake kira rashin lafiyar fata ko kuma cututtukan fata, wanda ya zama gama gari musamman tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin wanke hannu sau da yawa a matsayin alamar rashin tausayi mai tsanani (OCD).
Akwai lokatai guda biyar masu mahimmanci don wanke hannu da sabulu don rage yaduwar cutar ta bakin-baki: bayan amfani da gidan wanka (ƙananan ruwa, wanke), bayan wanke ƙananan jariri (canja tufafi), kafin ciyar da jariri, kafin cin abinci da kuma kafin / bayan / dafa abinci bayan cin nama marar dafaffen, kifi ko naman alade.
Sauran lokutan da ake bukatar yin amfani da wanke hannu don hana yaduwar cutar su ne kafin a yi maganin ciwo ko rauni; kafin a yi maganin ciwo ko rauni; bayan an yi maniyyi, tari ko hanci; bayan an taɓa sharar dabbobi ko kuma an yi amfani da dabbobi; da kuma bayan an taɓa shara.
A wasu ƙasashe, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike da aka gudanar a 2015 a kasashe 54 ya nuna cewa gidaje 38.7% suna wanke hannu da sabulu. A wani bincike da aka gudanar a 2014, Saudiyya tana da mafi yawan kashi 97%; Amurka tana da kashi 77%; China tana da kasa da kashi 23%. Akwai hanyoyin da za a iya canza halayyarsu don yin amfani da sabulu a lokutan da suka dace.
Shirin Kula da Lafiya na Muhimmanci da Ma'aikatar Ilimi ta Philippines ke aiwatarwa, misali ne na inganta lafiyar yara da ilimi.
A cikin shirin na kasa, ana yin amfani da maganin kwari sau biyu a shekara, da kuma wanke hannu da sabulu a kullum, da kuma brushing da fluoride a kullum.
An yi nasarar aiwatar da shi a Indonesia.
Ana iya samun karɓan ƙwayoyin cuta daga fata ta hanyar ƙara sabulu ko kayan wanki a cikin ruwa.
Babban aikin sabulu da kuma wanka foda shine rage matsalolin narkewa da kuma kara narkewa.
Ruwa shi kaɗai ba shi da amfani wajen tsabtace fata, saboda kitse da furotin da suke cikin ƙasa ba su narkewa cikin ruwa nan take.
Duk da haka, tsabtace ruwa yana taimakawa ta hanyar isasshen ruwa.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, na iya ƙunsar ƙwayoyin cuta daga aikace-aikacen da suka gabata.
Kadan daga cikin binciken da suka lura da yaduwar kwayoyin cuta daga sabulu mai ƙazanta ya kammala cewa ba za a iya yin yaduwar ba saboda an yi wa kwayoyin cuta bugun jini.
A cewar CDC, sabulu mai ruwa tare da iyakancewar hannayen hannu na da kyau".
Ana ba da shawarar sosai ga masu kula da lafiyar jama'a don amfani da sabulu masu hana kwayar cuta.
Har zuwa yau, babu wata hujja da ta nuna cewa kwayoyin antimicrobial suna zaɓar su a yanayi saboda amfani da maganin kashe kwayoyin ko maganin kashe cututtuka.
Duk da haka, sabulu na antibacterial suna da wasu kwayoyin antibacterial na yau da kullum kamar trichlosion, wanda ke da jerin jerin abubuwan da ke hana kwayoyin halitta.
Saboda haka, ko da yake ba a zaɓa maganin rigakafi a cikin sabulu mai ƙonewa ba, ba za su iya zama masu tasiri ba a lokacin da aka sayar da su.
Baya ga masu sarrafa farfajiyar jiki da kuma kare fata, tsarin da aka tsara na zamani na iya kasancewa acid (acetic acid, ascorbic acid, lactic acid), benzopeic acid wanda ke aiki a matsayin microorganism da kuma wasu masu sarrafa fata (ya'yan itace, biofuels, green pepper, plant extracts). Wani bincike mai zurfi daga Jami'ar O'okan'an School of Public Health ya nuna cewa sabulu masu amfani da su ne kamar su trichlorousine masu amfani da su don kare kwayoyin cuta, rigakafin cututtuka, da kuma cirewa daga hannayen mutum.
Ruwan da ke da kyau a wanke hannuwanmu ba shi da zafi sosai don kashe ƙwayoyin cuta.
A zafin jiki (37 °C), kwayoyin cuta suna girma da sauri.
Ruwan sabulu mai zafi ya fi ruwan sanyi da sabulu mai zafi amfani wajen rage ƙazanta da ƙwayoyin cuta.
Koyaya, sabanin abin da ake imani da shi, binciken kimiyya ya nuna cewa amfani da ruwan zãfi ba zai haifar da raguwar ƙwayoyin cuta a hannayenmu ba.
Masu tsabtace hannu ko masu hana hana hana shan magani suna da kayan aikin tsabtace hannu ba tare da ruwa ba.
A cikin ƙarshen 1990s da farkon karni na 21, abubuwan tsabtace hannayen hannu marasa giya (wanda aka fi sani da giya-based hand rubs, disinfectant hand rubs, ko hand sanitizers) sun fara zama sanannun.
Yawancin su suna yin amfani da isopropyl alcohol ko ethanol a matsayin gel, ko kuma a matsayin mai narkewa, ko kumfa, kamar glycerin don sauƙaƙe amfani da kuma rage tasirin bushewar giya, a hade da wani abu mai narkewa kamar carbohydrate (polyme na acrylic acid).
Ƙara hydrogen peroxide mai narkewa yana ƙara haɓaka aikin antimicrobial. Masu tsabtace ruwa da ke dauke da akalla 60 zuwa 95% barasa suna da ingantattun ƙwayoyin cuta.
Masu tsabtace barasa suna kashe kwayoyin cuta, suna kashe kwayoyin cuta masu ƙwayoyin cuta (MRSA da VRE) da kuma wasu ƙwayoyin cuta (HIV, herpes, RSV, rhinoceros, vaccinia, mura, da ciwon hanta) da kuma fungi.
70% na giya mai narkewa mai narkewa yana kashe ƙwayoyin cuta a cikin hannayen mutum 99.97% (3.5 ragewa, daidai da ragewa 35 decibels) a cikin dakika 30 da aka yi amfani da shi kuma yana kashe ƙwayoyin cuta a cikin minti 1 da aka yi amfani da shi 99.99% zuwa 99.999% (4 zuwa 5 ragewa).
Kayan tsabtace hannu na tushen barasa ba su da amfani ga ƙwayoyin cuta na Norovirus (ko Norvac) - wanda shine mafi yawan sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
A yi amfani da su a gaban da baya na hannayen hannu biyu da kuma a kan yatsunsu da kuma ƙwanƙolinsu na kusan dakika 30 har sai ruwa, kumfa ko gel sun bushe.
Dole ne a wanke yatsunsu sosai, musamman idan hannu ya zama mai tsabta, kamar yadda Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar.
Yawan amfani da waɗannan wakilai ya dogara ne da sauƙi da kuma hanzarta kashe su da ƙananan halittu; duk da haka, ba za su zama madadin wanke hannu ba idan babu sabulu da ruwa.
Idan ba a haɗa maganin kashe fuska da / ko na fata a cikin kayan aiki ba, idan ana amfani da kayan tsabtace hannu masu amfani da giya sau da yawa, fata za ta bushe.
Ana iya rage ko kawar da tasirin shan giya ta hanyar ƙara glycerin da / ko sauran magungunan matasa zuwa ga tsarin.
A cikin gwaji na asibiti, kayan tsabtace hannu na barasa sun rage yawan saurin fata da bushewa fiye da sabulu ko antibacterial washing powder.
Rashin hannu wanda ba a saba samu ba saboda rashin lafiyar fata, cututtukan fata na fata, cututtukan cututtukan fata na urticaria, ko rashin lafiyar fata ga barasa, ko kuma haɗuwa da giya.
Abin sha'awa shi ne cewa, idan aka kwatanta da wanke hannu da sabulu da ruwa, ba za a iya samun ƙarancin ƙwayoyin cuta da ke sa mutum ya yi fushi ba.
Duk da yadda suke da tasiri, abubuwa da ba na ruwa ba ba ne suke tsabtace kayan aiki a hannu, amma suna kawar da su daga kamuwa da cuta.
Wannan shi ne dalilin da ya sa sabulu da ruwa ba sa hana kamuwa da ƙwayoyin cuta da yawa, domin suna ci gaba da kasancewa a hannayenmu.
Ingancin tsabtace hannayen hannu na rashin giya ya dogara da yawa akan abubuwan da ke ciki da kuma tsarinsa, kuma a tarihi ya kasance da tasiri sosai, musamman ma giya da kayan shafawa.
Kwanan nan, ba kamar giya da aka nuna cewa yana da tasiri mai lalacewa saboda maimaita amfani ba, wanda zai iya haifar da mummunan tasirin fata, ba kamar sauran shirye-shiryen da aka nuna cewa sun yi amfani da benzodiazepine chloride suna da ci gaba da kuma aikin antibacterial gaba ɗaya bayan amfani.
Mutane da yawa a cikin al'ummomin da ke da ƙananan kuɗi ba za su iya sayen sabulu ba, amma za su yi amfani da toka ko ƙasa a maimakon haka.
Yana da amfani sosai fiye da amfani da toka ko ƙasa kawai, amma yana iya zama ƙasa da tasiri fiye da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko toka ta gurɓata da kwayoyin halitta, za su iya ƙara cutar maimakon rage yaduwar ta.
Kamar sabulu, toka yana aiki a matsayin mai kashe kamuwa da cuta domin idan ya yi hulɗa da ruwa, yana samar da wani abu mai ƙanshi.
Hukumar lafiya ta duniya ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin sabulu idan babu sabulu.
A cikin tsarin wanke hannu da cibiyoyin rigakafin Amurka ke ba da shawarar, akwai matakai masu zuwa don hana kamuwa da cutar:
Ka wanke hannãyenka da ruwa mai zafi ko sanyi.
Ana bada shawarar ruwa mai gudana, saboda ana iya gurɓata bututun da ke tsaye, kuma ba za a yi bambanci a yanayin zafin jiki na ruwa ba.
Ka wanke hannayenka da sabulu mai yawa, a bayan hannu, tsakanin yatsunsu, da kuma a ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannu sosai idan suna amfani da sabulu fiye da idan suna amfani da ruwa kawai.
Ka matsa kuma ka shafa na akalla dakika 20.
Dandami zai haifar da kumburi wanda zai taimaka wajen kawar da ƙwayoyin cuta daga fata, kuma dogon lokacin da aka matsa zai kawar da ƙwayoyin cuta.
Ka wanke kanka sosai a ƙarƙashin ruwa mai gudana.
Yin wanka a cikin kwanon rufi zai iya sake gurɓata hannayenmu.
Ka bar shi ya bushe da wani yanki mai tsabta ko kuma ka bar shi ya bushe a cikin iska.
Hannun da ke da danshi da kuma rigar suna da saukin kamuwa da cuta. Yawancin lokaci, wuraren da ba a tsabtace su ba daidai ba suna ƙarƙashin yatsunsu, wuyan hannu, yankunan da ke tsakanin yatsunsu, da ƙusa.
Naƙoƙi da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Ana yawan ba da shawarar yin amfani da kayan shafawa don hana bushewa da hannu; fata mai bushewa na iya haifar da lalacewar fata, wanda zai kara haɗarin yaduwar kamuwa da cuta.
Za a iya shirya zaɓuɓɓuka masu rahusa don wanke hannu a wuraren da babu ruwa mai ruwa da/ko sabulu. Misali, zuba ruwa ta hanyar ruwa mai dacewa daga fure mai rataye ko kuma shinge, da kuma/ko amfani da toka idan kasashe masu tasowa ne. A cikin yanayin da ake da karancin samar da ruwa (kamar makarantu ko yankunan karkara na kasashe masu tasowa) akwai hanyoyin adana ruwa, da zaɓuɓɓuka masu rahusa.
"Tape-tap wani fasaha ne mai sauki wanda ke amfani da rami wanda aka dakatar da shi a hankali ta hanyar igiya, kuma yana da lever da aka kunna da ƙafa don zuba ruwa mai yawa a hannayen hannu".
Yin aiki da kyau na bushe hannu yana da muhimmanci a cikin tsarin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe a cikin gidajen wanka na jama'a.
Wani bincike da ake yi a yanzu ya nuna cewa takarda tana da tsabta fiye da na'urorin wanka na lantarki da ake samu a cikin gidajen wanka.
A shekara ta 2008, wani binciken da Jami'ar Westminster ta London ta gudanar kuma aka tallafawa ta masana'antar kera takarda da kuma taron tarurruka na Turai, ya taimaka wajen kwatanta matakin kiwon lafiya da takarda, masu bushewar hannayen iska masu zafi da kuma masu bushewar hannayen iska na zamani ke bayarwa.
Bayan wanke hannuwanka a cikin mai bushewa mai zafi, adadin ƙwayoyin cuta a yatsunsu ya ƙaru da kashi 194% da kuma kashi 254% a cikin yatsunsu.
Drying hannayenku ta hanyar e-air dryer yana haifar da ƙaruwa da ƙwayoyin cuta a yatsunsu da kashi 42% da kuma 15% a cikin yatsunsu.
Bayan wanke hannu da kuma wanke su da wando, adadin ƙwayoyin cuta a yatsunsu ya ragu da matsakaita zuwa kashi 76 cikin ɗari da kuma kashi 77 cikin ɗari a cikin takalma. Masana kimiyya sun gudanar da gwaje-gwaje da yawa don ganin ko wasu masu amfani a cikin gidan wanka da kuma yanayin ɗakin suna iya kamuwa da cutar ta hanyar sakamakon kowane irin bushewa.
Jirgin sama mai bushewa yana fitar da iska a cikin iska mai gudu 180 m / s (650 km / h;400 mph), yana da ikon jefa ƙwayoyin cuta daga hannayensu da kayan aiki kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin wanka zuwa mita 2 .
Yin amfani da mai bushewa na hannayen hannu mai zafi yana iya yada kwayoyin daga mai bushewa zuwa mita 0.25.
A shekara ta 2005, TÜV Produkt und Umwelt ta gudanar da bincike da ya nuna cewa ana yin amfani da wasu hanyoyin bushewa.
Bayan an wanke hannayen, an lura da canje-canje a yawan kwayoyin:
Akwai masana'antun bushewa da yawa, kuma an kwatanta bushewa da bushewa da takarda.
Yin wanke hannu ta amfani da wanke hannu a lokacin tafiya yana da wani zaɓi idan babu sabulu da ruwa.
Dole ne a ƙunshe da akalla kashi 60% na giya a cikin wani kayan aikin tsabtace hannu mai gina jiki.
An tilasta shi ne bayan da likitan Hungary Ignaz Semmelweis ya gano (1846) cewa amfani da wanke hannu na likita wajen hana cutar a cikin asibiti.
Akwai na'urorin lantarki da ke ba da ra'ayoyi don tunatar da ma'aikatan asibiti lokacin da suka manta su wanke hannu.
Wani bincike ya gano cewa yawan kamuwa da cutar ya ragu da amfani da su.
Yin wanka na hannu na likita yana nufin wanke kowane ɓangaren hannu da sabulu da ruwa ko gel a cikin lokaci na aƙalla 15 seconds.
Ka yi wa hannunka ado kamar yadda aka saka su.
Idan akwai ƙura a ƙarƙashin yatsunsu, za a iya amfani da goga a cikin farantin don cire shi.
Tun da ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannayenku, yana da muhimmanci ku wanke su sosai kuma ku bushe su da tsabta.
Bayan an bushe, ya kamata a yi amfani da wanka don dakatar da ruwa (wanda zai iya buɗe ƙofar fitarwa idan ya cancanta).
Wannan zai hana hannuwan su sake gurbatawa daga waɗannan farfajiyar.
Yin wanka a cikin tsarin kiwon lafiya yana nufin kawar da ƙwayoyin cuta masu cutarwa da kuma hana su yadawa.
New England Journal of Medicine ta ce, rashin wanke hannu a yawancin yanayin kiwon lafiya ba shi da kyau, da kuma yawan likitoci da ma'aikatan jinya da suka manta su wanke hannu kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar ƙwayoyin cuta.
Wani bincike ya nuna cewa yin wanka da hannu da sauran ayyuka masu sauki na iya rage yawan cututtukan jini da ke tattare da fitsari da kashi 66 cikin dari. Hukumar lafiya ta duniya ta wallafa wani binciken da ya tabbatar da wanke hannu da kuma wanke hannu a fannonin kiwon lafiya.
An wallafa wannan jagorar kan tsaftace hannu a shafin yanar gizon kungiyar domin a yi wa jama'a tambayoyi.
Wani bincike mai dacewa da aka gudanar da shi shi ne WTP da Al.
Idan ana bukatar bayani game da yadda ake bin ka'idoji, kungiyoyin kasuwanci za su iya yin aunawa da kuma kimantawa game da lafiyar hannu.
"A cewar Hukumar Lafiya ta Duniya (WHO) akwai "Lokaci Biyar" na wanke hannu:
Bayan an fallasa shi ga jini / jikin ruwa
Kafin aikin da ake bukata na rigakafin kamuwa da cuta, da
Bayan kulawar mai haƙuri. Ƙara sinadarai masu maganin kashe kwayoyin halitta (" maganin rigakafi " ko " sabulu " na maganin rigakafi) a cikin sabulu yana ba da damar lalata ƙwayoyin cuta ga ruwan wanka na hannu.
Irin wannan aikin kashe kwayoyin cuta na iya zama da kyau kafin tiyata ko a cikin tsarin da ake samun ƙwayoyin antibiotic da yawa. Don tiyata yana da mahimmanci a sami bututun ruwa wanda zai iya 'yanke' hannayen mutum, ba tare da taɓa shi ba, buɗewa da rufewa. Waɗannan su ne wanke hannu, wanke wasu chlorhexide ko iodine, sassan sterile don bushewa da hannayen da aka wanke, da kuma goga mai sterile don wankewa da kuma wani kayan aikin sterile don tsabtace ƙarƙashin yatsunsu, da sauransu.
Dole ne a cire dukan kayan ado.
Don yin wannan aikin, dole ne a wanke hannayensu da goshin su daga gwiwa zuwa gwiwa na tsawon minti 2.
Ba a buƙatar tsawon lokacin shafewa (minti 10) ba.
Idan ka wanke hannuwanka, kada ka bar ruwa ya sake shiga hannunka.
Bayan an gama wanke hannu, za a yi wa hannuwansa wanka da kayan wankewa da kuma saka su a cikin wani tufafi mai tsabta.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannuwanku kafin kuma bayan kula da mai ciwo ko kuma a yi amfani da maganin kashewa.
Don hana kamuwa da cutar ta stephalococcal a asibitoci, mafi girman amfani da wanke hannu ya samo asali ne daga wanke 20% na farko, kuma mafi ƙarancin ƙarin amfani ya samo asali ne lokacin da yawan wanke hannu ya ƙaru fiye da 35%.
Yin wanka da wanka da sabulu mai tsabta ya ninka yawan adadin cututtukan cuta da ke yaduwa ta hanyar abinci fiye da sau uku. Wanke hannu da maganin hana kwayoyin cuta na tsawon dakika 30 ya rage yawan cutar kwayoyin cuta, wanda ya fi yawan wanke hannu da maganin hana kwayoyin cuta na 26% fiye da wanke hannu da sabulu mai hana kwayoyin cuta.
Sabulu da ruwa sun fi amfani da wanke hannu na tushen barasa wajen rage cutar H1N1 da kuma ƙwayar cuta mai wuya daga hannayenmu. Matsalolin inganta tsabtace hannu a cikin tsarin kiwon lafiya sun haɗa da ba da shawara ga ma'aikata game da wanke hannu, ƙara samun damar wanke hannu na tushen giya, da kuma ba ma'aikata tunatarwa ta rubutu da ta baki.
Akwai bukatar bincike kan abin da zai iya zama mafi tasiri a cikin tsarin kiwon lafiya daban-daban.
A kasashe masu tasowa, wanke hannu da sabulu ya zama sananne ga masu amfani da shi, kuma yana da muhimmanci ga samun lafiya da kuma abinci mai gina jiki.
Duk da haka, rashin wadatar ruwa mai inganci a gidajen mutane, makarantu da wuraren aiki, sabulu ko kuma wanke hannu yana kalubalanci cimma dabi'un wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, akwai ƙananan bututun wanka a kusa da gidajen wanka na sirri ko na jama'a, duk da cewa akwai yiwuwar samar da wuraren wanka.
Amma, yin wanka da hannu a ƙasa zai iya zama al'ada fiye da yin wanka da sabulu ko ruwa.
Tallafawa da kuma ba da shawara ga wanke hannu da sabulu zai iya shafar yanke shawara, ya haifar da wayar da kan jama'a game da fa'idodin wanke hannu kuma zai haifar da canjin halayyar mutane na dogon lokaci.
Wannan yana da mahimmanci don saka idanu da kimantawa don yin aiki da kyau.
Wani bincike na tsarin nazarin nazarin bincike 70 ya gano cewa hanyoyin da aka danganci zamantakewar al'umma suna da tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen ta hanyar kafofin watsa labarun ba su da tasiri. Misali shine "hanyar tauraro uku" ta UNICEF, shirin inganta wanke hannu a makarantu, wanda ke ƙarfafa makarantu su ɗauki matakai masu sauki, masu rahusa don tabbatar da cewa ɗalibai suna wanke hannu da sabulu, a tsakanin sauran bukatun kiwon lafiya.
Idan aka kai ga matsakaicin digiri, makarantu za su iya samun matsayi na taurari uku daga ɗaya zuwa ɗaya.
Gina wuraren wanke hannu wani bangare ne na kamfen din inganta wanke hannu don rage cututtuka da mutuwar yara.
Wani misali kuma na yakin neman wayar da kan jama'a game da kokarin samun sauyi a dabi'a shine Ranar wanke hannu ta duniya. A sakamakon annobar coronavirus ta 2019-20, UNICEF ta karfafa karɓar emojis na wanke hannu.
Wasu bincike sun nuna cewa a ƙasashen da ke tasowa da ke da alaƙa da dalibai, yawan kuɗin wanke hannu ya rage yawan amfani.
Koyaya, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu yana da tsada sosai fiye da sauran hanyoyin ruwa da tsabtace jiki.
"Babban mahimmancin wanke hannu ga lafiyar mutum - musamman ga waɗanda ke cikin yanayin da ba su da lafiya kamar uwayen da aka haifa a asibiti ko kuma waɗanda aka ji rauni a cikin sojoji - an fara gane su a tsakiyar karni na 19 ta biyu na farko na lafiyar hannu: Ignaz Semmelweis, likitan Hungary Vienna, Austria da Florence Nightingale, Turanci ""wanda ya kafa aikin jinya na zamani"."
A lokacin, mutane da yawa sun gaskata cewa cutar ta kamu da cutar ta hanyar cutar da ake kira miasma.
Bayan da aka samu cututtuka da ke tattare da abinci a shekara ta 1980, cibiyar kula da cututtuka da rigakafin cututtuka ta Amurka ta yi gagarumin ƙarfafa kula da tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cututtuka.
A shekarar 2009 ne aka kamu da cutar sankarar kwayar cutar ta PMS kuma a shekarar 2020 an kamu da cutar COVID-19, wanda ya haifar da wayar da kan jama'a game da muhimmancin wanke hannu da sabulu don kare kansu daga irin wannan cututtukan cututtuka a kasashe da dama.
"Misali, ana rataye wasu hotuna game da ""daidaitaccen hanyoyin wanke hannu"" a kusa da tankuna a cikin gidajen wanka na jama'a, gine-ginen ofis da kuma wuraren wanka a filin jirgin sama a Jamus".
"Fahimtar cewa ba za ka so ka ɗauki wani aiki ko kuma ka raba shi da wani abu ba, yana nufin "ka wanke hannuwan wani daga wani abu".
Wannan ya fito ne daga ayar Littafi Mai Tsarki a Matta, inda Bilatus Babunti ya wanke hannuwansa a kan gicciye Yesu Kristi, amma ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Turanci.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta da hauka yayin da take ƙoƙarin tsabtace wani ƙazanta mai ban mamaki, wanda ya bayyana cewa yana wakiltar jin laifi game da laifuffukan da ta aikata da kuma laifuffukan da ta sa mijinta ya yi.
An kuma gano cewa bayan tuna ko tunani game da ayyukan rashin ladabi, mutane suna wanke hannuwansu fiye da wasu, kuma suna daraja kayan wanke hannu sosai.
Kuma waɗanda aka ba da izinin wanke hannu bayan irin wannan tunani ba su da wata damar yin wasu ayyukan tsabtace jiki kamar ayyukan sadaukarwa.
Addinai suna ba da shawarar wanke hannu don dalilai na kiwon lafiya da alama. Yin amfani da ruwa na alama, amma ba tare da sabulu don wanke hannu ba, wani ɓangare ne na wanke hannu na al'ada da ke cikin addinai da yawa, ciki har da Baha'i a Yahudanci, Hindu, Devillah da Nethil Yadayam, Lavoobo a Kirkito, da kuma Buddha a Islama. Addinai suna ba da shawarar wanke hannu mai tsabta, musamman bayan wasu ayyuka.
Addinai kamar Hindu, Yahudanci da Musulunci sun tilasta wanke hannuwanka bayan ka yi amfani da gidan wanka.
Addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun bukaci a wanke hannu kafin da kuma bayan kowane abinci.
Ƙuntatawa a kan hadarin aiki dangane da COVID-19
Yin amfani da matakan tsaro da kiwon lafiya na aiki don hana cutar COVID-19 (COVID-19) shine matakan kiyaye haɗarin aiki na COVID-19.
Ana saita matakan haɗarin aiki na aiki bisa ga wurin aiki da yanayin aiki, tushen haɗarin kamuwa da cutar, yadda cutar ke da tsanani a cikin al'umma da kuma abubuwan haɗari na ma'aikatan mutum waɗanda zasu iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗari suna da ƙananan hulɗa da aiki tare da jama'a da sauran ma'aikata. A wannan yanayin, ana ba da shawarar matakan rigakafin cututtuka na asali, ciki har da wanke hannu, ƙarfafa ma'aikata su kasance a gida idan suna da rashin lafiya, bin tsarin numfashi, kula da tsabta a cikin yanayin aiki, da kuma ci gaba da ƙwayoyin cuta.
Ayyuka masu haɗari na matsakaici sun haɗa da aiki mai haɗari wanda ke buƙatar sau da yawa ko kuma kusanci da waɗanda ke da haɗari, waɗanda ba a sani ba ko kuma waɗanda ake zargi da cutar ta COVID-19 ko waɗanda ke tafiya a duniya, kamar su waɗanda ke da haɗari saboda yaduwar zamantakewar yanzu.
Wannan ya hada da ma'aikata da ke da alaƙa da jama'a kamar makarantu, wuraren aiki masu yawan jama'a da kuma wasu manyan kamfanonin sayar da kayayyaki.
Baya ga matakan rigakafin kamuwa da cuta na asali, matakan kula da haɗari ga wannan rukuni sun haɗa da ingantaccen iska ta amfani da matattarar iska mai inganci, toshewa da kuma kayan kariya na mutum wanda za a iya sawa idan mutum ya haɗu da COVID-19.
Hukumar Kula da Tsaro da Lafiya ta Duniya (OSHA) ta ce ma'aikatan kiwon lafiya da masu kula da lafiya da ke fuskantar wanda aka sani ko ake zargin cewa yana da tasiri na COVID-19 suna cikin haɗarin kamuwa da cutar. Ma'aikatan da ke yin samfurori ko aiki da mutum wanda aka sani ko ake zargin cewa yana da tasiri na COVID-19 suna cikin haɗarin kamuwa da cutar.
Abubuwan da ke cikin haɗarin haɗari ga ma'aikata sun haɗa da sarrafa injiniya kamar dakunan iska masu ƙarancin iska da kuma kayan tsaro na mutum masu dacewa da yanayin aiki.
Akwai wasu abubuwan da za su iya faruwa a wurin aiki saboda COVID-19.
Wasu ma'aikata ba sa iya zuwa aiki domin suna fama da rashin lafiya, suna bukatar su kula da wasu, ko kuma suna tsoron cewa za su kamu da cutar.
Abubuwan kasuwanci na iya canzawa saboda canje-canje a cikin hanyoyin samun kayan da ake buƙata da kuma kayan da ake buƙata (ta hanyar sayen kaya a lokacin da babu taron ko samun kaya ta hanyar bayarwa ko sabis na drive-through).
A ƙarshe, jigilar kayayyaki daga yankunan da COVID-19 ya fi shafa na iya zama abin takaici. Za a iya amfani da shirin shirye-shiryen annobar da kuma maganin cutar don jagorantar matakan tsaro.
Shirye-shiryen sun nuna matakan haɗari da suka shafi aiki da aiki, gami da tushen haɗari, haɗarin haɗari daga gida da ƙungiyoyin jama'a da haɗarin haɗari ga tsofaffi ko ma'aikata masu haƙuri na yau da kullun.
Sun bayyana matakan da za a bi don kauce wa haɗari da kuma shirye-shiryen da za a yi don ziyarar yanayin da zai iya haifar da cutar.
Shirye-shiryen shirye-shiryen annobar da kuma ayyukan amsawa na iya kasancewa ƙarƙashin shawarwarin ƙasa ko na ilimi.
Manufofin da ake da su na amsawa ga kamuwa da cutar sun hada da rage yaduwar cutar tsakanin ma'aikata, kare wadanda suke da matukar hadarin kamuwa da cutar tare da mummunan cututtukan lafiya, kula da ayyukan kasuwanci da rage mummunan tasiri ga sauran kamfanoni a cikin hanyoyin samar da su.
Matsayin da ake samu na cutar yana shafar yadda ake amsawa a cikin al'umma inda kasuwancin ke.
Tsarin tsarin kula da haɗari shine tsarin da aka yi amfani dashi sosai a cikin tsaro na gida da kuma fannoni na ilimin kimiyyar ruwa don tsara matakan haɗari ta hanyar aiki.
A inda ba za a iya kauce wa haɗarin COVID-19 ba, ingantattun matakan sarrafawa, sannan na gudanarwa, da kuma ƙarshe, amfani da kayan tsaro na mutum, sune hanyoyin sarrafawa masu tasiri.
A cikin aikin injiniya, an haɗa da keɓe ma'aikata daga haɗarin aiki ba kawai game da halin ma'aikata ba, amma kuma a cikin sauƙi mai sauƙi don aiwatar da shi.
Abubuwan da ke tattare da sauye-sauye a cikin ayyuka ko manufofi da ma'aikaci ko mai aiki ya yi aiki da su ne ake kira sarrafawa.
An yi la'akari da cewa kayan aikin kare mutum (PPE-PPE) ba su da tasiri sosai fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu matakan rashin tsaro.
Dole ne a zaɓi PPE (PPE) bisa ga haɗarin da zai iya faruwa ga ma'aikata, dole ne su dace da su (misali kayan numfashi), dole ne a sawa su daidai, dole ne a yi musu bincike na lokaci-lokaci, dole ne a kula da su kuma idan ya cancanta a maye gurbin su, dole ne a cire su yadda ya kamata, a tsabtace su, a adana su, ko kuma a cire su don kauce wa lalacewar tsabta.
A cewar Hukumar Kula da Lafiya da Lafiya a Amurka (OSHA), ayyukan da ke da haɗari mai ƙarancin haɗari suna da ƙarancin aiki tare da jama'a da sauran ma'aikata.
Yin wanka hannuwansu a kai a kai da kuma yadda ya kamata, ƙarfafa ma'aikata su kasance a gida idan suna rashin lafiya, kafa dokokin numfashi, ciki har da rufe baki da hanci lokacin da suke tari da tari, kafa tankuna na takarda da shara, gudanar da aiki na nesa ko kuma sa'o'i na aiki idan ya cancanta, ƙarfafa ma'aikata kada su yi amfani da kayan aiki da kayan aiki na wasu, da kuma tsabtace da kuma kawar da ƙwayoyin cuta a wuraren aiki a matsayin al'ada, sune matakan rigakafin cututtuka na asali da aka ba da shawarar ga dukkan wuraren aiki.
Ganowa da ke tattare da mutane da ke da damar kamuwa da cutar a wurin aiki yana da muhimmanci sosai wajen kare ma'aikata, abokan ciniki, masu kallo da sauransu.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke da alamun cututtukan numfashi masu tsanani su zauna a gida har sai sun sami mura, alamun mura, da wasu alamun cutar, bayan sun ƙi shan maganin rage mura ko wasu alamun cutar aƙalla awanni 24 kafin su ɗauki maganin da zai rage mura ko kuma maye gurbin wasu alamun. Manufofin izinin asibiti suna da sassauƙa, kuma bari ma'aikatan su zauna a gida don kula da wani dangin da ke ciwo, kuma su sanar da ma'aikatan game da waɗannan manufofin.
A cewar Hukumar Kula da Tsaro da Lafiya ta OSHA, ayyukan da ake buƙata a cikin 6 (1.8m) na nisa ko kuma a kusa da su tare da waɗanda suke da yiwuwar kamuwa da cutar SARS-CoV-2 (SARS-CoV-2), waɗanda ba a sani ba ko kuma ake zargin suna da cutar, waɗanda ke da COVID-19 marasa lafiya ko kuma waɗanda suka yi tafiya ta duniya kwanan nan zuwa yankin da COVID-19 ke yaduwa.
Waɗannan sun haɗa da ma'aikata da ke hulɗa da jama'a a wurare kamar makarantu, wuraren aiki masu yawan jama'a, da kuma wuraren sayar da kayayyaki masu yawa. Waɗannan ƙuntatawa na injiniya da aka kafa don ƙungiyoyi da ke aiki a cikin irin wannan yanayin haɗari mai girma na iya haɗawa da kafa matattarar iska mai ƙarfi, haɓaka yawan iska, kafa matattarar ruwa mai laushi, da kuma kafa matattarar ruwa mai laushi da kuma kafa matattarar ruwa. Waɗannan ƙuntatawa na iya haɗa da ƙarfafa ƙungiyoyin tsaro masu zaman kansu su zauna a gida, samar da isar da iska mai laushi, ko kuma ba da horo, da kuma ba da izini ga wasu matakan tsaro da suka shafi haɗari da kuma ba da izini ga ma'aikata.
Ma'aikatan da ke cikin wannan rukunin masu haɗari ba sa bukatar kayan numfashi.
A cikin jirgin akwai wasu takunkumin da ke kan hanya don kare ma'aikata da sauran fasinjoji, ciki har da ware mai rashin lafiya daga wasu mutane da kafa 6 da kafa, sanya wani memba na rukuni don bauta wa mai rashin lafiya, da kuma ba da abin rufe fuska ga mai rashin lafiya ko kuma gaya masa ya rufe mai rashin lafiya da hanci da hanci.
Dole ne ma'aikatan jirgin su sa sa safofin hannu na likita na amfani guda ɗaya yayin kula da mai tafiya mai rashin lafiya ko kuma taɓa farfajiyar da za ta iya zama ruwan jiki ko kamuwa da cuta. Dole ne kuma su sa ƙarin kayan kariya na sirri idan mai tafiya mai rashin lafiya yana da zazzabi, ciwon tari ko wahalar numfashi.
Dole ne a ajiye safofin hannu da sauran kayan da za a cire a cikin jaka mai haɗari na rayuwa, sannan a tsabtace kuma a kashe ƙwayoyin cuta. Idan akwai mura ko wasu alamomi a cikin jirgin, haɗarin da za a yi a kan jiragen ruwa na kasuwanci, gami da jiragen ruwa masu kyau da sauran jiragen ruwa masu jigilar mutane, ya ƙunshi jinkirta tafiya da kuma keɓancewa da kuma sanar da cibiyar likita a cikin jirgin nan da nan.
A cikin yanayi na musamman, dole ne a yi gwajin asibiti a cikin ɗakin don mutum a cikin gida. Cibiyar Kula da Cututtuka da Rigakafin (CDC) ta ba da shawarar rufe makarantu da wuraren kula da yara na ɗan gajeren lokaci don tsaftacewa ko ƙonawa idan wanda aka azabtar ya kasance a cikin ginin makaranta, ba tare da la'akari da yanayin watsawa ba.
A lokacin da akwai matsakaici ko ƙananan yaduwar jama'a, ana iya aiwatar da dabarun nisantar jama'a kamar soke tafiye-tafiye, soke taro da kuma ba da abinci a cikin rukuni na motsa jiki ko rukuni na mawaƙa ko gidan cin abinci, ƙara tazara tsakanin tebur, jinkirin ziyarar da kuma ɓoye lokaci, hana masu halarta ba dole ba, da kuma amfani da sararin samaniya na ofishin kiwon lafiya ga yara da ke da alamun kamar zazzabi.
A yayin da akwai yaduwar jama'a a cikin gida, ban da dabarun nisantar zamantakewa, ana iya ɗaukar tsawaitaccen rufe makarantu a matsayin dabara. Cibiyar hana cututtuka da tsaro (CDC) ta ce akwai ƙananan haɗarin lafiyar gaggawa ga ma'aikatan tsaro da ke fahimtar ayyukan yau da kullun.
An shawarci jami'an tsaro da ke hulɗa da mutanen da aka tabbatar ko ake zargin suna da tasirin COVID-19 su bi ka'idodin da masu aikin likita na gaggawa ke bi, gami da kayan kariya na sirri.
Idan akwai kusanci yayin kamawa, dole ne a tsabtace da kuma lalata kayan aiki da tufafi tare da mai tsabtace tsabtace gida da aka yi amfani da shi kafin amfani, kuma dole ne a bi ƙa'idodin aiki na musamman don warewa da cire kayan kariya na mutum (PPE) da aka yi amfani da su, warewa da wankewa.
Hukumar Kula da Tsaro da Lafiya ta Duniya (OSHA) ta rarraba wasu ma'aikatan kiwon lafiya da na kiwon lafiya a matsayin waɗanda ke cikin babban ko mafi girman haɗarin haɗari.
Masu ba da sabis na kiwon lafiya, masu ba da tallafi, masu ba da sabis na dakin gwaje-gwaje da ma'aikatan sufuri na likita waɗanda suka san ko kuma suna da shakkar cutar COVID-19 sun haɗa da waɗanda ke yin ayyukan da ke da haɗarin kamuwa da cutar.
Ana ɗaukar yanayin mafi girma na cutarwa idan ma'aikata suna yin ayyuka kamar tattarawa ko sarrafa samfurori daga waɗanda suka san ko kuma waɗanda ake zargi da cutar COVID-19.
Matakan da za su iya haifar da cutar sun haɗa da shigar da bututu a cikin numfashi, ayyukan da ke haifar da tari, gwajin huhu, wasu hanyoyin magani na hakori, da kuma tattara samfurori ta hanyar bincike ko kuma yin allura.
A cikin ayyukan gawawwakin da ke da haɗari mai yawa, gami da ma'aikata da ke aiki da ke shirya gawawwakin waɗanda suka san ko kuma ake zargi da cutar COVID-19 a lokacin mutuwa; idan aka bincika gawawwakin, waɗannan zasu zama mafi girman haɗarin bayyanar. Ƙarin ƙuntatawa na injiniya ga waɗannan rukunin haɗari sun haɗa da dakunan keɓewa don marasa lafiya da aka sani ko ake zargi da COVID-19, gami da lokacin da ake aiwatar da ayyukan samar da aerosol.
A wasu wuraren kiwon lafiya da kuma kula da lafiyar jiki, za a iya ba da iska mai iska mai kyau.
Dole ne a yi amfani da samfurori bisa ga matakan kiyayewa na 3.
Hukumar lafiya ta duniya (WHO) ta ba da shawarar cewa a kula da sababbin marasa lafiya a wuraren jiran mutane daban-daban dangane da yiwuwar COVID-19. WHO ta ba da shawarar cewa waɗanda aka sani da cutar ko waɗanda ake zargi da cutar SARS-CoV-2 su kasance a ƙasa da ƙafa 6 a can kuma su sa kayan numfashi, ban da PPE, a cikin yanayin da za a iya samun kwari.
A Amurka, dole ne a yi amfani da N95 mai tace fuska mai numfashi ko mafi kyau a cikin yanayin cikakken, rubutaccen shirin kiyaye numfashi wanda ya ƙunshi cancanta-gwaje, horo, da kuma gwaji na likita.
Ƙari ga haka, ana iya samun ƙarin tsaro a cikin kayan numfashi don sa ma'aikatan su kasance cikin kwanciyar hankali. WHO ba ta ba da shawarar yin ado a duk lokacin da COVID-19 ba ya yaduwa ta hanyar numfashi ba, amma ta hanyar jiki.
Hukumar lafiya ta duniya (WHO) ta bada shawarar cewa ma'aikatan da ke aiki a wuraren shiga da fita a kasar su kadai su saka abin rufe fuska a lokacin aikin tiyata.
Hukumar lafiya ta duniya ta ba da shawarar cewa a yi amfani da abin rufe fuska na tiyata, tabarau na kariya ko kuma rigar fuska, da kuma safofin hannu ga waɗanda ke tattarawa, kulawa ko ɗaukar samfurin numfashi daga marasa lafiya na COVID-19 ba tare da yin amfani da aerosol ba.
A cikin yanayin da za a iya samun cutar, ana amfani da N95 (N95) ko FFP2 respirator maimakon abin rufe fuska da ake amfani da shi a lokacin tiyata.
WHO ta ba da shawarar cewa a rage bukatar na'urorin kariya ta sirri ta hanyar saka idanu da kuma hada-hadar samar da kayan kariya ta sirri ta hanyar telemedicine, rashin isasshen wadatar kayan kariya ta sirri, da kuma hana mutane shiga dakin da ke cikin kulawa ta kai tsaye tare da mai cutar COVID-19, da amfani da kayan kariya ta sirri kawai da ake buƙata don takamaiman aiki, da kula da marasa lafiya da yawa tare da ganewar asali guda ɗaya, da ci gaba da amfani da wannan kayan numfashi ba tare da cirewa ba, da saka idanu da kuma haɗa kayan kariya ta sirri ta hanyar samar da sarkar samar da kayan kariya, da kuma ƙarfafa marasa lafiya su daina amfani da masks.
Mai aikawa: Catherine Maher, Shugaba, Wikimedia
Mai karɓa: Dukan ma'aikatan kamfanin Wikimedia
Labari: [COVID-19] Rage yawan aiki, shirya don nan gaba
Ranar aikawa / lokaci: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙoƙin haƙƙin mallaka
A wannan watan, muna fuskantar yanayi na musamman.
Cutar COVID-19 ta nuna yadda 'yan Adam ke da alaƙa da juna a duniya da kuma yadda muke da alhakin juna.
Ba mu da misali ga irin waɗannan kalubalen, amma mun san cewa mafi kyawun amsa shine a mayar da hankali ga sadaukarwa, haɗin kai da kuma tsarin zamantakewar duniya.
Abokantaka da kuma kulawar da muka samu daga dukkan abokan aikinmu ta hanyar imel, kira da tattaunawa, shaida ce mai ban mamaki na samun damar aiki tare da mutane masu ban mamaki.
Ba ni da abin da zan yi alfahari da shi fiye da ganin ku duka abokan aiki.
A makon da ya gabata, wani ya yi mini godiya game da aikinmu.
Sun tunatar da ni da muhimmancin yadda duniya take amfani da Wikipedia don samun bayanai, kuma yana da muhimmanci a ci gaba da samun damar yin amfani da waɗannan albarkatun a kan layi ga kowa.
Ko dai ka ci gaba da kula da dandamali a wurin aiki ko ka ba abokan aikinka kuɗi ko kuma ka taimaka wa al'ummominmu su kasance cikin aminci, aikinka ne zai sa hakan ya yiwu.
Yanzu duniya tana bukatar bayanai da Wikipedia ke bayarwa fiye da dā.
Lokaci ne da za mu yi aiki ba kawai ba, amma kuma yadda za mu yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, daga wannan makon za mu yi wasu canje-canje masu muhimmanci a yadda muke aiki tare.
Canje-canje a ayyukanmu da kuma ayyukanmu
Kamar yadda Robin ya ambata a baya, a daren jiya ne C-Committee ta gana da tattauna halinmu da tsare-tsarenmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna abin da muke ganin ya dace da yanayin da muke ciki da kuma hanya mafi kyau don ci gaba da kamfanin a wannan lokacin.
Mun yi matukar son mu kawar da damuwa kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana son rage karfinsa, to sai ka yi hakan.
Ga dukan ma'aikata, kwangilar kwangila da ma'aikata:
Muna fatan cewa za mu yi aiki na sa'o'i 4 a rana ko kuma 20 a mako.
Ba mu ba da izinin hutu ba - idan kana son yin aiki fiye da lokacin da kake aiki, aikin zai amfane ka sosai.
Duk da haka, a halin yanzu, duniya tana cikin yanayin da ba za a iya tsammani ba, kuma kuna iya son tallafawa ƙaunatattunku, ku sayi kayan ado, ko ku je likita, amma lafiyarku ita ce fifiko.
Ba mu lura da lokacinku ba.
Idan kana rashin lafiya, kada ka je aiki.
Ba za mu iya faɗi ba, amma muna faɗi.
Babu buƙatar izinin likita ko PTO - Taimaka wa ƙungiyar ku gyara kalandarku da shirye-shiryen aiki don tabbatar da cewa kun mai da hankali kan mahimman abubuwan aiki da kuma aikawa da bayanin ga manajan ku.
(Idan an tabbatar da cewa kana da COVID-19, don Allah ka sanar da Brian a T&C Ops, T&C zai taimaka maka ka sami tallafi da kake bukata kuma ka tabbata cewa kana samun kulawa mai kyau daga hukumar kula da matakinka).
Za a biya cikakken albashin ma'aikatan da ke aiki na tsawon sa'o'i.
Kamar yadda muka fada a baya, muna tabbatar wa masu kwangila da ma'aikatanmu cewa za su cika alkawarinmu na biyan albashi mai yawa bisa ga lokutan aiki.
Za a biya kowa a kan al'ada na aiki a cikin yanayi na yau da kullum.
Wannan ya ƙunshi rashin lafiya da kuma rashin iya aiki.
Idan kana son yin aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar kawar da damuwa da duniya kewaye da su.
Aikin da muke yi, musamman a irin wannan lokacin, zai iya kawo sakamako da ba mu zata ba.
Bugu da ƙari, yana nufin kare kanka.
Abin da muke roƙon ku shi ne ku tuntubi manajanku don mu san abin da za mu yi tsammani, kuma mu daidaita shi.
Wasu ayyuka suna da muhimmanci.
Akwai wasu ayyuka da za mu ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma kungiyoyin tara kudade (ciki har da wasu) suna yin aiki mai mahimmanci da ake buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan bangarorin don tantance manufofin da ke gudana da kuma mayar da hankalinmu ga tallafawa abin da ake buƙata don aikinmu.
Dukanmu muna da aiki da yawa da za mu yi, kuma za mu mai da hankali ga ayyukan da suka fi muhimmanci a yanzu.
A halin yanzu, jinkiri zai rage tasirin.
"Ba mu da niyyar yin aiki a matsayin ""lokaci biyu don kama abin da aka rasa"" a lokacin da annobar ta ƙare".
Ba a sa ran yin karin sa'o'i don biyan jadawalin aiki.
Mun yarda da canjin yanayi, kuma za mu yi aiki don kafa sabbin manufofi da jadawalin lokaci a inda ya dace.
Menene APP (Shekarar Shekara)
Don daidaitawa da sabon tsari da kuma tsammanin aiki na yau da kullun, mun yi niyyar sake tsara jadawalin don aiwatar da Shirin Shekararmu na 2020-2021.
Manufarmu ita ce, mu gabatar da wani karin tsarin shirin 2019-2020 wanda zai ba da karin lokaci a cikin 'yan makonni masu zuwa don tsarawa wanda zai ba ma'aikatan aiki mai mahimmanci, kula da kansu da kula da ƙaunatattun su, yayin da ya dace da waɗanda suke bukatarsa ko kuma waɗanda suke so.
Wannan tsawaitawa na lokaci yana rage yawan aiki da matsin lamba na yanzu a cikin kamfanin.
Za mu gabatar da shirinmu ga kwamitin gudanarwa a mako mai zuwa, kuma da zarar an tabbatar da hakan, za mu sabunta shi tare da wakilan da kungiyoyi game da matakai na gaba.
Ina godiya ga kwamitin APC da ya jagoranci wannan.
Aikin ofis, da kuma yin tsabtace jiki
A makon da ya gabata, mun samu labari cewa wani abokin aikinmu a San Francisco yana fama da cutar COVID-19.
Amma, a matsayin abin takaici, mun yi amfani da ƙungiyar tsabtace-kayan cuta don tsabtace dukkan farfajiyar da ke ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafi na asibiti don kashe kwayoyin cutar a saman, dakunan gida da kuma masu amfani da wutar lantarki da ke shiga shafinmu.
An kiyaye tsarin ɗabi'a ko doka game da amfani da kayayyakin da ke tabbatar da lafiyar mazaunan a cikin ginin.
Muna farin ciki cewa za mu iya samun ofishin a shirye don mu sa'ad da muka soma aiki.
Ofishinmu na DC yana cikin hanyar sadarwa wanda ya raba ka'idojin su na COVID-19 tare da mu da kuma dukkan ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma cikin cikakken tsarin nesa, daidai da jagororin da muka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, muna tattauna batun yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawa, amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki a nesa a karon farko.
Abokanmu na dogon lokaci sun san cewa wannan gyara ne, kuma suna so su ba ku wasu shawarwari:
Ka iyakance tsawon taro zuwa matsakaicin ƙara na awa ɗaya ko biyu.
Idan ana bukatar zaman na dogon lokaci, bincika yadda za a iya raba su zuwa zaman kwanaki da yawa.
Ka bayyana bukatar taron a fili, ka tsara shirin ayyuka, kuma ka aika abubuwan da za a koya a gaba.
Ka sa hoton hoton ta tsoho ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Wani don tsara tarurruka a gaba, wani don lura da tambayoyin da suka taso yayin hira da kuma wani don bin jerin masu magana da kuma wani don taimakawa wajen yin tsokaci (ko kuma yin tsokaci tare).
Idan kana bukatar wani mai kyau headset, ka aika da wani imel zuwa goyon bayan fasaha.
Ku yi amfani da kuɗin da aka ba ku don ku sayi abincin rana.
Ka shiga tashar #Remoteys a Slack don tattaunawa da abokan aikinka game da ayyukan da aka rarraba
Hukumar ta HR tana gudanar da ayyukan gudanar da ayyukan aiki na yanar gizo don tallafawa ingantaccen aikin da aka rarraba a duk faɗin kamfanin.
A makon da ya gabata, mun nemi duk masu karɓar tallafin zamantakewa su soke abubuwan da ake gudanarwa na jama'a kamar su editathons, wanda aka tallafa wa ta hanyar tallafin Wikimedia, har sai an sanar da WHO cewa an kammala lokacin annobar.
Mun sanar da su cewa mun fahimci cewa ba za a iya kammala matakan tallafi da suka ɗauka dangane da buƙatarmu na sokewa da sauran ƙuntatawa ba, kuma ba za a yi wa kowa hukunci ba saboda jinkiri ko canji a cimma waɗannan manufofin.
A wannan makon za mu bi wasu jagororin kan Wikimedia da sauran taron yanki da na al'umma.
Ga al'umma ta duniya, maimakon su taimaka wa jama'arsu, Wikipedia da sauransu su kasance masu hankali da kuma fahimtar cewa wannan rikici ya haifar da baƙin ciki a kullum
CRT tana aiki ne akan kafa shafi a kan Meta-Wiki don taimakawa al'umma su kula da tasiri da kuma bin diddigin sadarwa tare da hangen nesa.
Ci gaba da sanin matsalolin COVID-19
A ranar Alhamis mai zuwa, 14:00 UTC / 07:00 PT, za mu aika da gayyatar zuwa kalandarku don halartar taron ma'aikata na musamman.
Za ku iya amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ciyar da lokaci tare da juna.
Muna da tabbaci cewa za mu taimaka muku a wannan batun.
A halin yanzu, zaku iya samun wasu bayanai daga wannan imel ɗin kuma ku sami duk bayanan da suka dace game da COVID-19 a cikin Ofishin Wiki.
CRT zai sabunta waɗannan shafuka daga lokaci zuwa lokaci kuma zai sarrafa duk bayanan a wuri ɗaya.
Muna kuma ci gaba da sadarwa tare da ma'aikatan da ke zaune a ƙasashen da ke fama da cutar.
Idan kuna da tambayoyi game da tafiya, abubuwan da suka faru, manyan ayyukan aiki, ko ƙalubale game da inshora ko taimako da ake buƙata, don Allah kada ku yi jinkirin sanar da CRT ko aiki tare.
Mun zo nan ne don samar da tallafi da kuma goyon baya da ake bukata.
Idan kana da wasu bayanai masu sirri ko kuma masu mahimmanci, ka aika da imel zuwa Brian Judon, Daraktan Ayyukan Duniya na HR International.
Duk waɗannan canje-canjen ba za a iya ɗauka a matsayin watsi da aikinmu da alhakinmu ba.
Maimakon haka, sun nuna cewa a wannan lokacin, dole ne mu sake daidaita ayyukanmu da alkawuranmu yadda ba mu taɓa yi ba.
Muna ganin wadannan matakan suna da muhimmanci domin mu ci gaba da aiki, mu samar da goyon baya da muke bukata ga motsinmu, mu kuma ba wa juna sabis da duniya ke jiran su.
Ayyukan da muka shirya za su jira mu a lokacin da lokaci ya yi.
A yanzu, lokaci ne da za mu goyi bayan juna kuma mu yi aiki mai muhimmanci a cikin makonni ko wata-wata.
Muna bukatar ku duka don cimma wannan, don haka muna so ku kasance masu halartar taron a duk lokacin da za a iya, kuma a yanzu muna so ku kula da kanku da iyalanku yadda ya kamata.
Yanzu, don Allah ku wanke hannuwanku, kada ku taɓa fuskarku!
Catherine, CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da kuma sauran shugabannin kungiyar (Grand I, Heather W, Jaime V, Jane U, Lisa S, Robin A, Ryan M, da kuma Toby N).
B'angiodensin-transfering enzyme 2 (ACE2-ACE2) shine enzyme wanda aka haɗa a farfajiya (a cikin membranes na kwayoyin halitta) na ƙwayoyin a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE-2 yana magance aikin angiotensin-transforming enzyme (ACE) ta hanyar rage matakin angiotensin-II da kuma ƙara ang (1-7) wanda ya sa ya zama kyakkyawan magani mai mahimmanci don magance cututtukan zuciya. ACE-2 yana aiki a matsayin shigarwa a cikin ƙwayoyin halitta don wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
An fi kiran wani nau'in mutum na enzyme HACCE2.
Anjeodensin-transferent enzyme 2 shine enzyme mai ƙunsar ƙarfe wanda ke kan farfajiyar ciki da kuma saman sauran ƙwayoyin halitta.
Protein ACE2 yana da wani nau'i na N-terminal peptide M2 da kuma wani nau'i na renal amino acid mai karɓar mai karɓar C-terminal.
ACE2 shine nau'in furotin na farko da ke wucewa sau ɗaya wanda ke nuna wani ɓangare na enzymatically-active a saman ƙwayoyin cuta da sauran ƙwayoyin cuta.
Ƙungiyar ta ACE2 ta rabu da wani enzyme daga cikin yankin membrane mai suna shetacean, wanda ya haifar da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Anjeodensin-transforming enzyme - 2 yana cikin mafi yawan kwayoyin: Anjeodensin-transforming enzyme - 2 yana da alaƙa da ƙwayoyin cuta na ƙwayoyin cuta na huhu na alveolar cell type II, endocytes na hanji, endothelial cells na jijiya da hanci, da kuma ƙwayoyin tsoka na jijiya a cikin mafi yawan kwayoyin.
Ana samun murfin mRNA (ACE2) a cikin ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, da kuma ƙwayar cuta.
Babban aikin ACE2 shine aiki a matsayin ma'auni na ACE.
ACE tana raba hormone na antioetensin I zuwa vasogonistic antioetensin II.
ACE2 yana raba carboxyl-terminal amino acid phenylalanine daga anxiodenthin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana sanya shi cikin vasodilator anxiodenthin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
[Des-ARG9]-ACE2 na iya haifar da ɓarkewa tsakanin wasu sauran peptides kamar Pradicin, Apelin, Neurotensin, Dinorphine A, da Crelline.
ACE2 kuma yana tsara SLC6.A19, wanda shine tsaka tsaki amino acid mai karɓar karɓar furotin da manyan kwayoyin halitta a cikin ƙwayoyin halitta. An tabbatar da shi a cikin cutar Hardnap, wani nau'in amino acid mai saurin canzawa.
A matsayin furotin, ACE2 (ACE2), yana aiki a matsayin babbar hanyar shiga cikin kwayar cutar ta mutum-NL63 (HCoV-NL63), SARS-CoV-SARS, da kuma SARS-CoV-2 (SARS-CoV-2, COVID-19).
Musamman, ɗaurewar S1 na SARS-CoV da SARS-CoV-2 zuwa wani sinadarin sinadarin ACE2 a saman sel yana sanya endocytosis da kuma sanya duka sinadarin da sinadarin zuwa endosomes a cikin sel.
Wannan shigarwa yana nufin cewa yana da muhimmanci a kara yawan furotin na S.S.S.A. a cikin tsarin samar da jini, DMPRSS2. Ana gudanar da bincike kan ko ana iya yin maganin hana cutar.
Duk da haka, kungiyoyi da yawa da kungiyoyi masu kulawa sun bada shawarar ci gaba da maganin ACE mai tsauri da ARP.
"A cikin wani bincike da kuma bincike na yau da kullum da aka buga a ranar 11 ga Yuli, 2012, an gano cewa ""amfani da maganin hana cutar ACE yana da hadarin rashin lafiya mai yawa na 34% fiye da na rashin lafiya fiye da na hanawa""
"Bugu da kari, ""Abubuwan da aka yi amfani da su a cikin ACE sun rage hadarin kamuwa da cutar a tsakanin marasa lafiya da ke da haɗarin kamuwa da cutar, musamman waɗanda ke da haɗarin bugun jini da kuma bugun zuciya".
"Amfani da maganin hana cutar ACE yana rage mutuwar da ke tattare da cutar pneumonia, duk da haka sakamakon ya fi rauni fiye da hadarin cutar pneumonia gaba ɗaya".
Ana ganin cewa Flexible Fusion Human ACE2 (rhACE2) sabon magani ne ga mummunar cutar huhu, kuma ya bayyana yana inganta haɓakar jini da kuma haɓakar huhu a cikin aladu da ke da ciwon huhu mai tsanani wanda aka haifar da glucose.
RHACE2 yana da rabin rai na kimanin sa'o'i 10 a cikin mutane, kuma yana da minti 30 kafin a fara aiki, kuma yana da ƙarin sa'o'i 24 (lokaci) don amfanin.
Yawancin binciken sun nuna cewa RHACE2 na iya zama magani mai kyau ga mutanen da ba su da haƙuri ga tsarin Rhinin-angiotensin-restrictors (RAS inhibitors) ko kuma cututtukan da ke haifar da karuwa na angiotensin II. An kimanta RHACE2 a cikin gwaji na asibiti don magance cututtukan huhu mai tsanani.
"B'COVID-19 Apples app ne na wayar salula wanda aka tsara don taimakawa gano hulɗa a lokacin cutar COVID-19 ta 2019-20 wanda ke nufin tsarin gano mutane (""Sadarwa"") waɗanda zasu iya kasancewa cikin hulɗa da mutumin da ya kamu da cutar".
A wasu yankuna da yankuna an kirkiro ko kuma an gabatar da aikace-aikacen da yawa tare da goyon bayan gwamnati.
An inganta tsarin da yawa don ƙirƙirar aikace-aikacen bin diddigin sadarwa.
Akwai damuwa game da tsare sirri game da tsarin da ke dogara da bin diddigin yanayin masu amfani da app.
Zaɓuɓɓukan da ba su da yawa sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci ga mai amfani zuwa wasu wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan tallafi kai tsaye ga irin waɗannan masu sarrafawa na Bluetooth a cikin dandamali na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da kamfanin Alibaba, ta kirkiro wani app wanda zai ba da damar tabbatar da cewa 'yan kasar sun yi hulɗa da wadanda suka kamu da COVID-19.
Yana aiki a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da mai sarrafawa mai suna TraceDucether.
"Wannan app ta kasance ta hanyar al'ummar IT ta gida, an buga ta kyauta kuma za a ba ta gwamnati. An gabatar da app na Bluetooth na "Dakatar da Coronavirus!" a yammacin Macedonia, wanda ke gano bayyanar mutanen da suka kamu da cutar kuma yana ba da sanarwar gaggawa ga hukumomin lafiya".
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Lafiya sun kirkiro wannan app.
Kamar yadda aka bayyana a ranar 14 ga Afrilu, 2020, app din yana jiran amincewar Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnatin ta ce, app din na bin diddigin sadarwa yana cikin ci gaba, kuma za a fitar da shi cikin makonni kadan. Kuma ana shirin yin irin wannan app din a Ireland da Faransa (""StopCovid"").
Kasashen Australia da New Zealand na duba aikace-aikacen bisa tsarin da ake amfani da shi na Singapore's TrestCether App da kuma Bluetooth. Rasha na son gabatar da aikace-aikacen Geofencing ga marasa lafiya da ke fama da COVID-19 da ke zaune a Moscow, wanda aka tsara don hana masu cutar barin gida.
Farfesa Ross Anderson, mai koyar da aikin tsaro a Jami'ar Cambridge, ya lissafa wasu matsalolin da za su iya faruwa a tsarin da ke kan aikace-aikace, wanda zai iya zama da tasiri idan an yi amfani da shi don yin amfani da shi ga ƙananan ɓangaren jama'a.
"Domin magance damuwar game da yaduwar masu amfani da cutar coronavirus da ba daidai ba ko kuma cutarwa, Apple ya kafa iyaka ga irin kamfanoni da za su iya ƙara masu amfani da cutar coronavirus zuwa Shagon App ɗinsu, kuma ya ba da izini ga kawai ""masu amfani da"" ko kuma masu daraja".
Google da Amazon sun aiwatar da irin wannan takunkumin.
Masu fafutukar kare hakkin dan Adam sun nuna damuwa game da tasirin yin amfani da manhajar cutar ta coronavirus don yin amfani da sa ido kan jama'a, musamman ma game da ko za a kawar da wannan tsarin sa ido da aka gina don magance cutar ta coronavirus bayan an kawar da barazanar cutar.
Kungiyar Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa inda suka nemi a takaita irin wannan sa ido.
Kamfanoni sun sanar da sharuɗɗa guda takwas a cikin shirye-shiryen gwamnati:
Dole ne a yi sa ido a kan abin da ya dace, da abin da ya dace, da kuma yadda ya dace.
Dole ne tsawo na saka idanu da saka idanu su kasance da ƙa'idodin faɗuwar rana;
Dole ne a yi amfani da bayanan ne kawai don dalilai na COVID-19;
Dole ne a kare kare kare bayanai da rashin suna kuma a kare su bisa tushen shaida;
Dole ne a hana karuwar nuna bambanci da warewa ta hanyar bin diddigin;
Dole ne a ƙayyade shi a cikin doka game da raba bayanai tare da ɓangare na uku;
Dole ne 'yan ƙasa su sami' yancin kare kansu daga lalata da kuma magance lalata.
"Za a kuma buƙaci halartar dukan 'masu ruwa da tsaki,' ciki har da masu aikin kiwon lafiya na jama'a da kuma kungiyoyin da ke kan gado. Kungiyar Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan
Google / Apple shirin da aka gabatar yana so ya magance matsalar ci gaba da bin diddigin ta hanyar cire tsarin bin diddigin su daga tsarin aiki na na'urar idan ba a ci gaba da buƙatar bin diddigin ba.
Wasu ƙasashe sun maye gurbin aikace-aikacen da ke amfani da bin diddigin cibiyar sadarwa, yana kawar da buƙatar saukar da aikace-aikacen da ikon guje wa bin diddigin.
A Isra'ila, an amince da saka idanu kan yanar gizo.
Akwai yiwuwar samun damar hanyoyin sadarwa na tushen tushen da ke samun damar samun damar bayanan wuri na asali don samun matsalolin sirri.
Duk da haka, ba lallai ba ne ga dukkan tsarin da ke da sabobin tsakiya su sami damar samun bayanan wuri na sirri; an kirkiro tsarin tsare sirri da yawa waɗanda ke amfani da sabobin tsakiya don sadarwa kawai (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da wani tsarin da ba na aikace-aikace ba don gano mutanen da za su iya yin hulɗa da wanda ya kamu.
Maimakon amfani da aikace-aikacen da aka keɓe, tsarin yana tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, yana haɗa wannan bayanin tare kuma yana aikawa da shi ga mutanen da ke da rauni ta hanyar saƙonnin rubutu.
Ana amfani da wannan bayanin don faɗakar da yiwuwar tuntuɓar. Gwamnati ta kuma ba da bayanan wurin ga jama'a. Wannan ya yiwu ne saboda manyan canje-canje a dokokin tsare sirri game da bayanai a ƙasar tun lokacin da cutar ta fara yaduwa.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da kuma shafukan yanar gizo da yawa. Kasashe, ciki har da Jamus, ana ganin suna amfani da su duka a matsayin tsarin da ke tattare da tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Kula da sadarwa don kare sirrin sirri wani kyakkyawan ra'ayi ne wanda ya kasance a cikin wallafe-wallafen bincike tun daga kusan 2013. Kamar yadda aka yi a ranar 7 ga Afrilu, 2020, fiye da rukuni na masana suna aiki don hanyoyin da za su iya zama masu zaman kansu, kamar aikawa da yanayin kusanci na mai amfani zuwa wasu wayoyin hannu ta amfani da Bluetooth Low Energy (BLE).
Duk da haka, PEPP-PT wani shiri ne mai hadin gwiwa wanda ke da tsarin daidaitawa da rarraba hanyoyin, ba wata ka'ida ba. Ka'idojin rarraba sun haɗa da gano yiwuwar hulɗa a cikin tsarin tsare sirri na tsare sirri (TP-PPT/TP-3D), lambobin sadarwa na wucin gadi (TCN , FKA lamba lamba lamba, CEN), ka'idojin tsare sirri masu mahimmanci da kuma hanyoyin gano hanyoyin sadarwa na hannu (PACD) da sauran hanyoyin.
A cikin waɗannan ka'idoji, bayanan sirri da za a iya ganowa ba za su taɓa barin na'urar ba, kuma duk abubuwan da suka faru suna faruwa a cikin na'urar.
Kungiyar tsare sirri a MIT Media Lab na samar da SafeBaths, wani dandamali don amfani da fasahohin kare sirrin yayin tattarawa da amfani da bayanan gano wuri ko hanyar shiga tsakanin mutane don bin diddigin yaduwar COVID-19.
"Wannan ya dogara ne akan binciken da Whitepaper ya yi na ""Research: Maintaining Personal Privacy in a Pandemic" wanda aka buga a watan Maris na 2020 ta hanyar App's Can Rock. Wani irin wannan yunƙurin shine Safe Safe Treasury Platform na Enigma MPC, wani kamfani da ke haɓaka fasahar tsare sirri, wanda shine dakin gwaje-gwaje da MIT Media ta kafa".
Ba tare da yin jayayya da sirrin wannan bayanin ba, SafeTrade yana amfani da fasahar kayan aiki mai aminci don ba da damar masu amfani su raba mahimman bayanai na wuri da kiwon lafiya tare da sauran masu amfani da hukumomi.
A ranar 5 ga Afrilu, 2020, an kafa kungiyar CCN-Collective ta duniya, ta hanyar kungiyoyi masu haɗin kai tare da tsarin aiki guda ɗaya da kuma yawancin ƙa'idodin da suka dace, da nufin ragewa kaɗan kaɗan, don gudanar da dandamali na duniya don ganowa da faɗakar da aikace-aikace, kuma yana da mahimmanci don samun karbuwa mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta bayyana tsarin aikinta na gwamnati, mai suna Bluetooth, a sarari.
A ranar 10 ga watan Afrilu, 2020, Google da Apple, kamfanonin da ke kula da Android da iOS, sun sanar da cewa za su yi kokarin gano mutumin da suka yi hulɗa da su ta hanyar haɗuwa da fasaha mai ƙarancin wutar lantarki da kuma ɓoye sirrin sirri.
Sun kuma bayyana cikakkun bayanai game da manyan fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, za a saki tsarin a matakai uku:
An kirkiro kayan aiki don taimakawa gwamnatoci wajen samar da wani app na gano yiwuwar hulɗa don kare su daga cutar ta coronavirus, wanda ba a san shi ba.
Wannan aikin zai haɗa kai tsaye tare da iOS, Android, Google da Apple, da farko ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki da kuma magance jerin matsalolin sa ido, sannan kuma kawar da shi ta hanyar da ta dace idan barazanar ta wuce.
B' sake amfani da magani (wanda aka fi sani da sake amfani da miyagun ƙwayoyi, sake fasalin, sake aiki, ko sauya magani) shine sake amfani da magani wanda aka amince dashi don magance wata cuta ko yanayin asibiti daban da wanda aka fara samarwa.
Wannan shi ne wani ɓangare na bincike na kimiyya, wanda a halin yanzu ana amfani dashi don ci gaba da inganta ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da gano rigakafin COVID-19 da kuma canja wurin ruwan sama don kawar da cutar. SARS-CoV-2 yana da kimanin sunadarai 66 masu magani, kowannensu yana da filayen haɗin kai da yawa.
Binciken waɗannan rukunin haɗin gwiwa ya ba da ingantaccen shirin samar da alluran rigakafin cutar da ke da tasiri akan furotin COVID-19.
Abubuwan da suka fi muhimmanci a cikin masu amfani da SARS-CoV-2 sun hada da proteins kamar popane, RNA-based RNA-based RNA polymerases, helix, S protein, da ATP ribosphate.
Hussain AA, da sauransu sun yi nazarin wasu kwayoyin bincike da yawa, sannan suka yi nazarin su don inganta su da kuma daidaita su da magunguna masu izini tare da mafi girman amincewa. An gudanar da wannan ne don hanzarta ci gaban magungunan cutar anti-SARS-CoV-2 (SARS-CoV-2) a cikin binciken da ya yi kafin a ba da shawarar a cikin tsarin binciken asibiti.
Ana amfani da shi don yaki da cutar ta maleriya, wato, maganin maganin hallaka cutar.
A ranar 18 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta sanar da cewa, a cikin magunguna hudu da aka yi nazari a matsayin wani ɓangare na gwajin gwaji, akwai chlorogin da kuma related hydroxychloroquine.
Gwamnan jihar New York Andrew Cuomo ya sanar da cewa gwajin chloroguine da hydroxychloroquine zai fara a jihar New York a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da sulfate na hydroxychloroquine da phosphate na chloroguine a karkashin Hukumar Kula da Amfani da Gaggawa (EUA).
Wannan magani ba shi da izini ta hanyar FDA ta hanyar gwajin likita, kuma an ba shi izini a ƙarƙashin EUA don yin amfani da shi azaman magani na gaggawa kawai don gaggawa ga marasa lafiya da aka kwantar da su asibiti amma ba za su iya samun magani a cikin gwajin likita ba.
"CTC ta ce ba a kafa amfani da HydroxyCloroquine ba, ko kuma tsawon lokaci, don rigakafi ko maganin SARS-CoV-2".
"Lokacin da likitoci suka ce, 'Babu wata hanyar,' sai suka ce, 'Ina amfani da wannan magani.'
Wata ƙungiyar bincike ta Turkiyya a Istanbul ta gudanar da karamin bincike kan amfani da chloroquine tare da bitamin A, C da D.
Akwai manyan bincike a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar Likita ta NYU Langkawi ta gudanar da gwaji kan aminci da ingancin amfani da maganin hana amfani da Hydroxy Chloroguine.
"Binciken asibiti na kasar Sin da aka gudanar a Wuhan da Shenzhen ya nuna cewa maganin Favipravir yana da ""amfani mai kyau""".
A Shenzhen, an tabbatar da cewa marasa lafiya 35 sun kasance marasa lafiya a matsakaici na kwanaki 4, yayin da a cikin marasa lafiya 45 an tabbatar da cewa suna da kwanaki 11.
A wani binciken da aka gudanar a Wuhan, an ba da rabin Favipravir ga mutane 240 da ke fama da cutar pneumonia kuma an ba da rabin su a kan Yumifenovir.
Kamfanin na Italiya na Pharmaceutical ya tunatar da mutane cewa akwai karancin shaidu na yanzu da ke tallafawa miyagun ƙwayoyi.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don ta kasance a wurin, kuma za ta yi amfani da sojoji don samar da magunguna ga asibitocin jami'a, inda za a yi amfani da magungunan don magance marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya sanar da gwamnatin Trump cewa zai iya samun karamin tasiri saboda an samu kamuwa da cutar a baya.
Ba zai zama lafiya ba ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki.
"A cikin wani bincike na lobinovir/ridonavir (Kalethra), an kammala cewa haɗuwa da maganin rigakafi kamar lobinovir da ridonavir ba su da ""amfani""".
An tsara wadannan magunguna don hana cutar HIV ta hanyar ɗaurewa da furotin.
Wata ƙungiyar masu bincike a Jami'ar Colorado na kokarin canza magunguna don gano wani fili wanda ke ɗaure da furotin SARS-CoV-2. Akwai ƙin yarda a cikin kimiyyar kimiyya game da tura shaidu don sake amfani da magunguna da aka kirkira musamman don cutar HIV/AIDS.
WHO ta haɗa da Lopinavir / Ritonir a cikin gwajin haɗin gwiwar duniya.
Gillied Sciences ta kirkiro kuma ta inganta Remdesvir don magance cututtukan Ebola da Marburg. Gillied Sciences ta gano cewa Remdesvir yana da aikin rigakafi na rigakafi a kan yawancin ƙwayoyin cuta na philo, nico, paramix, da corona.
Yin amfani da maganin rigakafi ta hanyar rikice-rikice a cikin maganin rigakafi zai haifar da mummunan cutar da yaduwa.
Wasu karatun farko na asibiti sun nuna cewa Remdesvir na iya samun babban hanawar kwayoyin halitta don hana maganin. Akwai gwaji da yawa na asibiti, ciki har da gwaji biyu da asibitocin Jami'ar Cleveland suka gudanar; ɗaya ga waɗanda ke da rashin lafiya mai tsanani, ɗayan kuma ga waɗanda ke da rashin lafiya mai tsanani.
Ana gudanar da gwaje-gwaje uku na asibiti na Vitamin C, wanda aka yi wa masu fama da COVID-19 a asibiti kuma ana ba su ta hanyar jijiya; biyu sun kasance masu ƙuntatawa (China, Kanada) da kuma ɗaya ba su da ƙuntatawa (Italiya).
Jihar New York ta fara gwajin kwayoyin cuta na asithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) ta shirya gwajin asibiti na Allvesco (cicleonide) na maganin rigakafi na cartigoesteride dizin don asma wanda zai dace da maganin marasa lafiya masu alamun cutar novel coronavirus.
Ana gudanar da gwajin na biyu na enzymes 2 na angiodentase-transforming, wanda aka zaɓa daga cikin marasa lafiya 200 da aka kwantar da su daga asibiti tare da mummunan rauni a Denmark, Jamus da Austria don tantance tasirin magani.
Masu bincike daga Cibiyar Montreal Heart a Kanada a halin yanzu suna nazarin rawar Colgisin wajen rage kumburi da matsalolin huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
A cikin binciken da aka yi da sunan Colcorona, an gano cewa akwai manya 6,000 da suka kai shekaru 40 da haihuwa da suka kamu da COVID-19 kuma suna da alamun rashin lafiya ba tare da shiga asibiti ba.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba su da ingantaccen maganin hana haihuwa ba sun zama marasa cancanta.
Ana gwada wasu maganin hana jini a Italiya.
Ana amfani da ƙananan nauyin kwayar cutar Heparin a cikin marasa lafiya, wanda shine dalilin da ya sa Hukumar Magunguna ta Italiya ta wallafa jagororin amfani da ita.
An sanar da binciken a Italiya a ranar 14 ga Afrilu a kan 300 marasa lafiya da aka yi nazari akan amfani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar.
Saboda SARS-CoV-2 cutar ce, akwai ci gaba da mayar da hankali ga kimiyya kan sake samar da magungunan rigakafin cutar da aka amince da su don cutar da ba a zata ba kamar cutar MERS, SARS da West Nile.
Revavirin: An bayar da shawarar Revavirin a matsayin magani ga COVID-19 bisa ga binciken na 7 na kasar Sin
Umfenovir: An bayar da shawarar umfenovirin a matsayin magani don COVID-19 bisa ga binciken na 7 na kasar Sin
Wasu daga cikin kwayoyin da aka gano suna da amfani a maganin COVID-19:
Dosilizum (mai karɓar IL-6 antibody): An amince da shi ta kasar Sin.
Duba kuma Dosilesumap #COVID-19
Hanyar rigakafin COVID-19 ta Beta A ita ce allurar rigakafin da aka yi zato don cutar sankara ta Corona 2019.
Ko da yake babu wani magani da ya kammala gwajin asibiti, ana ci gaba da yin ƙoƙari don samar da irin wannan maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba a sa ran samun allurar rigakafin cutar SARS-CoV-2 a cikin watanni 18 ba.
A cikin gwajin tsaro na farko a watan Afrilu, akwai alluran rigakafi guda biyar da za a yi gwaji da su.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020 an samu mummunan yaduwar cutar a duk duniya, wanda ya haifar da babban saka hannun jari da ayyukan bincike don samar da rigakafi.
Yawancin kamfanoni suna amfani da kwayoyin halitta da aka riga aka buga don samar da yiwuwar allurar rigakafi ga SARS-CoV-2.
A watan Afrilu, CEPI ta ce a cikin ayyukan gano allurar, saurin, inganci, ingantaccen aiwatarwa da samun damar duniya suna da mahimmanci.
A watan Afrilu, masana kimiyya na CEPI sun bayyana cewa akwai ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci.
Babban mahimman manufofi na ci gaba a cikin binciken tsaro na farko sune:
DNA da RNA (Fase na farko na samarwa da nazarin allurar rigakafi: Moderna, Manzon Allah (MRNA-1273)
Mai amfani da kwayoyin cuta (mai samar da mataki na farko da mai yin allurar rigakafi: Consino Biology, mai amfani da adenocarcinoma type 5)
A watan Afrilu, masana kimiyya na CEPI sun sanar da cewa, akwai allurai 115 na alluran rigakafi a farkon matakin samarwa, an tabbatar da shirye-shirye 78 masu aiki (a cewar Milken 79) da kuma wasu 37 da aka sanar, amma akwai karancin bayanai na jama'a (wanda ake zaton ana tsarawa ko tsarawa).
Mataki na I-II na gwaji yana gudanar da gwajin farko na aminci da rigakafi a kan kwayoyi da yawa, wanda ba a saba gani ba, wanda ba a tsara shi ba, wanda ke ƙayyade mafi daidaito, ingantattun sigogi.
Gwaje-gwaje na uku yawanci sun ƙunshi ƙarin mahalarta, gami da ƙungiyar kulawa, da kuma gwajin gwajin rigakafin rigakafin cutar, yayin da ake lura da tasirin tasirin tasirin da za a samu daga maganin da aka ba da shi a mafi kyawun sashi.
"A cikin candidates 79 na allurar rigakafi a cikin ci gaba mai aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 har yanzu ba a shiga cikin binciken kimantawar mutum ba (har yanzu suna cikin binciken ""preclinical"")."
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin ikon allurar Clamp ta Kwayoyin halitta, wanda zai iya canza kwayoyin cutar don haifar da amsa rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar Hoto ta Duniya (Vido-Intervac) a Jami'ar Saskatchewan a Kanada ta sanar da cewa za ta fara aiki a kan allurar rigakafi, tare da nufin fara gwajin a kan mutum a 2021.
An sanar da shirye-shiryen gano allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, kamfanonin samar da magunguna na Jensen, karkashin jagorancin Hannake Shutmaker, sun sanar da cewa sun fara aikin samar da rigakafin.
Jensen na samar da maganin baki tare da abokin aikinsa na fasaha na rayuwa, Vaxart.
A ranar 18 ga Maris, 2020, Emergent Bio Solutions ta sanar da haɗin gwiwa tare da Vaxart don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, cibiyar bincike ta Angogen a Romania ta fitar da wani bincike kan yadda za a kirkiro wani rigakafi mai fasahar kama da rigakafin neon antigens da ake amfani da shi wajen magance cutar kansa.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa ya tabbatar da hada-hadar rigakafin kuma zai fara gwaji.
A ranar 27 ga watan Fabrairun 2020, kamfanin NewGenrex Immuno-Oncology, wanda ke da alaƙa da Generex, ya sanar da cewa zai fara shirin yin allurar rigakafin Li-Kee peptide don cutar COVID-19.
Sun so su samar da rigakafin da za a iya gwadawa a cikin mutane a cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Hukumar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da da da Kula da Kula da Kula da da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da da Kula da
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa za ta yi aiki tare da Novavax Inc.
A cikin ci gaba da samar da allurar rigakafi.
Abokan hulɗa sun kuma sanar da shirye-shiryen gudanar da gwajin farko na gwaji da gwaji na magani kafin Yuli 2020.
A ranar 12 ga watan Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa, ana gudanar da ayyuka 11 na musamman don samar da alluran rigakafi, kuma ko da an yi aiki da sauri, zai ɗauki shekaru 1.5 zuwa 2 don samar da allurar.
A ranar 12 ga Maris, 2020, kamfanin MedicaGo, wani kamfanin kere kere mai ci a Quebec, Quebec, ya sanar da cewa zai samar da wani bangare na kudade daga cibiyoyin bincike na kiwon lafiya na Kanada don bunkasa kwayoyin cutar Corona.
Labarin ya ce ana gudanar da gwajin a kan mutum a watan Yuli ko Agusta 2020.
"A farkon wannan makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba Kurweg ""babban adadin kudi don samun damar yin amfani da allurar COVID-19"," wanda gwamnatin Jamus ta yi adawa da shi. "
A ranar 17 ga Maris, 2020, kamfanin Pharmaceutical na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioTech na Jamus don samar da allurar rigakafi ta hanyar amfani da sinadarin mRNA.
A halin yanzu, rigakafin RNA-based, BNT162, yana cikin preclinical trial, wanda ana sa ran zai fara gwaji a watan Afrilu 2020.
A ranar 17 ga Maris, 2020, kamfanin Daxis Biotech a Italiya ya sanar da cewa za su ba da sakamakon gwajin su na asibiti a watan Afrilu na 2020, kuma za su iya fara gwaji a kan mutane tare da allurar.
A Faransa, a ranar 19 ga Maris, 2020, kungiyar ta Coalition for Pandemic Product Innovation (CEPI) ta sanar da cewa COVID-19 Vaccin Research Federation ta hada da Jami'ar Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh, ta amince da zuba jari na dala miliyan 4.9 na Amurka.
Cibiyar ta CEPI ta kasance da sauran masu saka hannun jari a cikin samar da allurar COVID-19, kamar su Moderna, CureWake, Innowayo, NovaVex, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin kwayoyin halitta na alluran rigakafi guda shida.
Masu binciken daga Kwalejin Imperial College London sun sanar da cewa suna samar da rigakafin RNA mai kaifin kai don COVID-19 a ranar 20 ga Maris, 2020.
An samar da alluran a cikin kwanaki 14 bayan samun tuntuɓar daga China.
A karshen watan Maris, Gwamnatin Kanada ta sanar da bayar da tallafin dala miliyan 275 ga ayyukan bincike 96 kan maganin rigakafin COVID-19, wanda ya hada da kokarin neman maganin rigakafi a cibiyoyin da ke cikin Kanada da jami'o'i, ciki har da Jami'o'in Medicago da Saskatchewan.
"A kusan lokaci guda, gwamnatin Kanada ta ba da sanarwar dala Kanada miliyan 192 don samar da allurar COVID-19, wanda ke shirin kafa wani "Bankin Allurar rigakafi" na kasa wanda zai ƙunshi sabbin alluran rigakafi da za a iya amfani da su idan wani cutar ta kamuwa da cutar ta Korona ta taso".
"A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ce sun gwada yiwuwar rigakafin COVID-19 da ake kira Bitcoach a cikin beraye, kuma sun ce, ""Sars-Corona Virus-2 (SARS-CoV-2) S1 da aka bayar ta hanyar MNA, yana nuna tasirin anti-antibody a cikin [berayen] wanda zai iya tsayayya da ƙirar takamaiman immunity.
A ranar 16 ga Afrilu, 2020, Jami'ar Waterloo Pharmacy a Kanada ta sanar da cewa tana tsara allurar ta DNA a matsayin maganin hanci.
An tsara wannan DNA ne don yin amfani da kwayoyin cuta don samar da ƙwayoyin cuta masu kama da cutar a cikin kwayoyin mutum, wanda zai iya haifar da rigakafin jiki don samar da wasu kwayoyin cuta a kan SARS-CoV-2.
A watan Maris na 2020, Hewlett Packard ta haɗu da Cloud Computing tare da kamfanin Enterprise, Amazon, Microsoft da Google, don samar da albarkatun samun damar shiga manyan kwamfutoci daga IBM.
Wasu alluran rigakafi suna da sakamako daban-daban, wanda ake kira sakamako na musamman.
Wannan yana nufin cewa za su iya samun fa'idodi fiye da cutar da suke hana su.
Wani sabon gwaji a Australia yana neman shiga ma'aikatan kiwon lafiya 4,170.
Ana iya ganin cewa alluran da ake ci gaba da samarwa ba su da lafiya ko tasiri.
Binciken farko na kimanta ingancin rigakafin ta amfani da samfurin COVID-19 na musamman na dabbobi na coronavirus kamar su ACE2-mutane mai canzawa, sauran dabbobi na dakin gwaje-gwaje da kuma wadanda ba mutane ba, ya nuna buƙatar matakan kariya na 3 na rayuwa don magance ƙwayoyin cuta kai tsaye da haɗin gwiwar duniya don tabbatar da ingantattun hanyoyin kariya.
An gwada alluran rigakafin SARS da MERS a kan samfurori na dabbobi marasa mutum.
A shekarar 2020, babu wani magani ko rigakafin kariya da aka tabbatar da cewa SARS yana da lafiya da tasiri a cikin mutane.
A cewar wani binciken da aka wallafa a shekara ta 2005 da 2006, ganowa da kuma inganta sabbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
A lokacin da MERS ke da yawa, ana tsammanin cewa binciken SARS na yanzu zai iya samar da ingantaccen samfurin don samar da alluran rigakafi da hanyoyin magance cutar MERS-CoV.
A watan Maris na shekarar 2020, an kammala gwajin farko na rigakafin cutar MERS a cikin mutane, kuma an ci gaba da gwajin guda uku, dukansu rigakafin cutar-mutuwar cutar, rigakafin cutar-mutuwar cutar biyu (ChAdOx1-MERS, PVRS-GamVac), da kuma rigakafin cutar MVA-MERS-S.
Sakonnin kafofin sada zumunta na yada ka'idojin da ke nuna cewa an gano cutar da ke bayan COVID-19 kuma riga an riga an sami rigakafin cutar.
Patents da aka ambata ta hanyar shafukan sada zumunta daban-daban sun nuna cewa akwai wasu magungunan rigakafin cutar coronavirus kamar su patents don tsara kwayoyin halitta da kuma SARS.
Cutar Corona ta 2019 (COVID-19) cuta ce mai yaduwa da ke tattare da cutar coronavirus 2 (SARS-CoV-2), cuta mai tsanani ta numfashi.
Alamomin da aka fi sani da su sun hada da zazzabi, tari, da kuma numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, ciwon ciki, ciwon wuya, rashin wari, ciwon ciki.
Yawancin lokaci, kwanaki biyar ne na fara bayyanar bayyanar cututtuka amma zai iya zama daga kwana biyu zuwa kwana goma sha huɗu.
Yawancin cututtuka suna da alamun rashin ƙarfi, amma akwai ci gaba ga cutar pneumonia da kuma rashin aiki na kwayoyin halitta.
A ranar 17 ga Afrilu, 2020, an samu kamuwa da cutar sama da miliyan 2.24 a kasashe da yankuna 210 da suka yi sanadiyar mutuwar mutane sama da 153,000.
Fiye da mutane 5,68,000 ne suka warke. Wannan cuta tana yaduwa ne ta hanyar yin magana da mutane, kuma tana yaduwa ne ta hanyar saurin zubar da ciki, ta hanyar yin tari ko kuma ta hanyar magana.
Wadannan faduwar suna faruwa ne lokacin da numfashi ya fita, kuma suna fadawa ƙasa ko saman ƙasa fiye da yadda suke faruwa a nesa.
Idan mutum ya taɓa wani abu da ya kamu da cutar, zai iya kamuwa da cutar ta hanyar taɓa idanu, hanci ko baki.
A saman, wannan kwayar cutar tana iya rayuwa har zuwa awanni 72.
Yana da matukar yaduwa a cikin kwanaki uku na farko da bayyanar cututtuka, kodayake yana yiwuwa a yada shi kafin bayyanar cututtuka da kuma a cikin matakan cutar. Hanyar daidaitacciyar hanyar ganewa ita ce ainihin lokacin baya daga kwayar cutar nasopharneal ta hanyar hanyar kwayar cutar ta hanyar hanyar hanyar yin amfani da siginar siginar siginar sigina (RRT-PCR).
Ana ba da shawarar yin amfani da masks ga waɗanda ake zaton suna da cutar da masu kula da su.
Shawarwarin yin amfani da abin rufe fuska ta jama'a sun bambanta, wasu hukumomi suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar yin amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman maganin rigakafin COVID-19.
A cikin yankuna shida na WHO, an sami yawancin ƙasashe da ke da cutar a cikin gida.
Waɗanda suke fama da wannan cuta za su iya zama marasa bayyanar cututtuka ko kuma suna da alamun zazzabi kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsa lamba, rikicewa, wahalar tashi, da kuma fuska ko lebe mai launin shuɗi; idan waɗannan alamun sun faru, ana ba da shawarar magani na gaggawa.
A wasu lokatai, ana iya samun alamun numfashi na sama, kamar su kumburi, ƙwanƙwasawa a hanci ko kuma ƙwanƙwasawa.
A cikin kashi daban-daban, an lura da bayyanar cututtuka na hanji kamar su kumburi, vomiting da kuma ciwon ciki.
Wasu cututtuka a kasar Sin sun fara ne kawai tare da rigakafi da kuma harbi.
A wasu marasa lafiya, cutar tana iya ci gaba zuwa cutar huhu, rashin aiki da yawa, da mutuwa.
Wannan shi ne lokacin da ake kira lokaci na bayyanar cututtuka.
Lokacin bayyanar cututtuka na COVID-19 (lokacin bayyanar cututtuka) yawanci kwanaki biyar zuwa shida ne amma zai iya zama daga kwana biyu zuwa 14.
Rahotanni sun nuna cewa kashi 97.5 cikin 100 na mutanen da suka kamu da cutar sun kamu da cutar a cikin kwanaki 11.5 bayan kamuwa da cutar.
Har yanzu ba a san cikakken matsayin waɗannan masu ɗaukar cutar ba a cikin yaduwar cutar; kuma bayanan farko sun nuna cewa suna iya taimakawa wajen yaduwar cutar.
A halin yanzu ba a san yawan mutanen da suka kamu da cutar ba kuma a cikin binciken, Cibiyar Kula da Cututtuka da Rigakafin Koriya (KCDC) ta ce kashi 20% na marasa lafiya da suka kamu da cutar sun kasance ba su nuna alamun cutar ba yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada wadanda suka kamu da cutar a ranar 1 ga watan Afrilu, wadanda ba su da wata alama a cikin wadanda suka kamu da cutar a yau; daga cikin kamuwa da cutar 166 da aka kamu da su a wannan rana, 130 (78%) sun kasance marasa alamar cutar a lokacin gwajin.
Koda kuwa ruwan tsami da kuma ruwan zuma suna dauke da kwayoyin cuta masu yawa.
Yin magana da ƙarfi yana haifar da ƙarin ɓarna fiye da yadda ake magana da shi a yau.
Bincike ya nuna cewa, idan ba a rufe bakinsu ba, za su iya tafiya daga nesa da mita 4.5 (ƙafa 15).
Ko da yake cutar ba ta yaduwa ta hanyar da aka koya a cikin al'ada ba, Academy of Sciences ta National Science ta ba da shawarar cewa yaduwar bioaerozal na iya yiwuwa kuma masu tattara iska da aka sanya a cikin zauren waje da ɗakunan jama'a sun ba da samfurin da ke da kyau ga RNA na cutar.
Ana iya yin amfani da wasu hanyoyin magani kamar su allura da kuma numfashi na zuciya (CPR) don yayyafa magungunan numfashi, wanda zai iya haifar da yaduwar kwayoyin cutar a cikin iska.
Ko da yake akwai damuwa cewa cutar za ta iya yaduwa ta hanyar cutar, ana ganin cewa wannan haɗarin ba shi da yawa. Kwayar cutar tana da matukar haɗari yayin da mutane ke da alamun cutar; amma haɗarin ya rage sosai kafin bayyanar cututtuka.
Cibiyar Tsaro da Kula da Cututtuka ta Turai (ECTC) ta ce, ko da yake ba a san yadda cutar take yaduwa ba, yawanci mutum biyu zuwa uku ne ke kamuwa da cutar, kuma cutar tana rayuwa a farfajiya na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cewa kwayar cutar tana rayuwa har zuwa kwana ɗaya a kan katako, har zuwa kwana uku a kan man shafawa (polypropylene) da bakin karfe (AISI 304), da kuma har zuwa awa hudu a 99% na tagulla.
Duk da haka, zai bambanta dangane da zafi da zafin jiki.
Sabulu da kuma wanka suna da amfani idan aka yi amfani da su yadda ya kamata; sabulu suna lalata kuma suna lalata ƙwayar mai da ke kare ƙwayoyin cuta, kuma suna cire su daga fata da sauran farfajiyar.
Wasu masu narkewa, kamar su benzodiazepine chloride da chlorhexidine gluconate (masu kashe kwayoyin cutar) sun yi aiki sosai. A wani bincike na Hong Kong, an yi amfani da samfurori na ruwan wankewa bayan kwana biyu bayan an yi musu asibiti.
Ga mutum biyar cikin shida, samfurin farko ya nuna karin ƙwayoyin cuta, kuma mutum na shida ya nuna karin ƙwayoyin cuta a rana ta biyu ta gwaji.
Cutar huhu mai tsanani mai tsanani mai suna SARS-CoV-2 (SARS-CoV-2) ita ce sabuwar cuta mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai tsanani mai suna Wuhan mai suna Wuhan.
Dukkanin abubuwan da ke faruwa na kwayar cutar coronavirus a cikin yanayi zasu faru a cikin kwayar cutar SARS-CoV-2.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke haifar da fashewar kumburin kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Guda da ya fi fama da COVID-19 shi ne huhu, saboda cutar tana kaiwa ga ƙwayoyin mahaifar ta hanyar enzyme na angiodentase-transforming enzyme 2 (ACE2), wanda yake da yawa a cikin ƙwayoyin alveolar na huhu na nau'i na II.
Wannan ƙwayoyin cuta suna amfani da wani nau'in halitta mai suna acupressin (peplomer) don yin hulɗa da ACE2 kuma su shiga wani kwayar halitta.
A Wuhan, China, kashi 12% na wadanda aka kwantar da su asibiti sun kamu da mummunan bugun zuciya, kuma ana samun wannan a cikin cututtuka masu tsanani.
A yayin ci gaba da cutar, ana samun karuwar yawan cututtukan zuciya saboda rashin aikin anti-inflammatory da cututtukan tsarin garkuwar jiki, amma mummunan bugun zuciya na iya kasancewa yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
ACE2 masu karɓa suna da yawa a zuciya kuma suna da hannu a cikin aikin zuciya.
A cikin marasa lafiya da ke da cutar COVID-19, an gano cewa cutar ta haifar da ƙarin jini a cikin jini (thrombosis 31%) da kuma jini a cikin hanci (Venus thrombombolism 25%) kuma yana iya kasancewa da alaƙa da mummunan hangen nesa. Binciken gawawwakin waɗanda suka mutu saboda COVID-19 ya nuna lalacewar ƙwayoyin cuta na huhu (difus alviolare damage-DAD-DAD), da kuma ƙwayoyin cuta na ƙwayoyin cuta na jini.
Ko da yake SARS-CoV-2 yana da alaƙa da ƙwayoyin epithelial na ACE2 na huhu, marasa lafiya masu tsanani na COVID-19 suna da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cut
Musamman, an nuna cewa GM-CSF na T-cell-extracting disease yana da alaƙa da IL-6 mai ƙonewa da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
A lokacin binciken, an gano cewa an samu wasu kwayoyin halitta a cikin jikin mutum.
Hukumar lafiya ta duniya (WHO) ta fitar da wasu ka'idojin gwaji don cutar.
Tsarin gwajin na yau da kullum shine ainihin lokacin bayanan bayanan bayanan polymerase chain reaction (RRT-PCR).
Ana yin gwaji ne a kan samfurori na numfashi da aka samo daga nasopharyngeal duck; duk da haka, ana iya amfani da samfurin nasopharyngeal duck ko chicken.
A yawancin lokaci, sakamakon zai kasance cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma yana bukatar a ɗauki jini biyu a cikin mako biyu, kuma sakamakon yana da ƙarancin ƙimar nan take.
Masana kimiyya na kasar Sin sun samu damar ware wani kwayar cutar coronavirus da kuma samar da kwayoyin halitta, don haka dakunan gwaje-gwaje a duk duniya za su iya samar da gwaje-gwaje na polymerase chain reaction (PCR) don gano cutar da cutar ke haifarwa.
Kamar yadda aka yi a ranar 4 ga Afrilu, 2020, gwajin rigakafi (wanda zai iya gano cututtukan da ke akwai kuma ya gano ko mutum ya kamu da cutar a baya) yana ci gaba, amma har yanzu ba a amfani da shi sosai ba.
Gwajin gwaji na kasar Sin ya nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin 100.
FDA a Amurka ta amince da gwajin farko na Point-of-Care a ranar 21 ga Maris, 2020, don amfani a ƙarshen wannan watan. Jagororin bincike da asibitin Zhangnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano cututtuka bisa ga yanayin asibiti da haɗarin kamuwa da cuta.
Hanyar da ke da bangare-bangare da ke da waje, mara kyau, da kuma rarraba baya na binary surface-glass optics na kowa ne a farkon kamuwa da cuta.
Za a iya samun rinjaye a cikin rami, numfashi mai zurfi (mai zurfi na interventory tare da masu cika narrowing), da kuma karfafawa yayin da cutar ta ƙaru.
Akwai wasu bayanai game da cututtukan ƙwayar cuta da kuma bayyanar cututtukan COVID-19.
Babban binciken da aka samu daga binciken gawawwakin:
Binciken jiki: ciwon huhu, ciwon zuciya, ƙuntataccen huhu, da kumburi na huhu
Akwai nau'i hudu na cutar pneumonia:
Rashin ƙwayar cuta mai sauƙi: kumburi na huhu, jini mai girma na jini, jini mai girma, kumburi na tsakiya tare da shiga cikin lymphocytic, da kuma samar da kwayoyin halitta masu yawa.
Rashin ƙwayar cuta mai tsanani:Rashin ƙwayar cuta mai tsanani (TAD) tare da ƙwayar cuta mai yaduwa.
Rashin karfin jini da kuma rashin karfin jini na da sanadin cutar ta ARDS.
Maganin cutar huhu: Tsarin kwari a cikin rami na alveolar da kuma fibrosis na huhu
Jini: DIC (dandatsawar jini mai yawa); karuwar jini
Matakan rigakafin da za a iya ɗauka don rage yiwuwar kamuwa da cutar su ne kasancewa a gida, guje wa wuraren da jama'a suke, wanke hannuwanku da sabulu da ruwa da yawa da kuma wanke hannuwanku na aƙalla sakan 20, kiyaye tsabtace numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko bakinku da hannayen da ba a wanke ba.
CDC ta bada shawarar rufe baki da hanci da tasa a lokacin da kake yin tawaye ko kuma yin tawaye kuma idan babu wani tasa, ka yi amfani da ciki na gwiwoyi.
Ana ƙarfafa kiyaye tsabtace hannu bayan tari ko kumburi.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a don hana yaduwar marasa lafiya. Dabarun nesa da jama'a suna nufin rage hulɗar da waɗanda suka kamu da cutar da manyan kungiyoyi ta hanyar rufe makarantu da wuraren aiki, hana tafiye-tafiye, da soke manyan tarurruka.
Ka'idodin nisantarwa sun haɗa da kiyaye mutane aƙalla 6 feet (1.8m) nesa.
Babu wani magani da zai iya taimakawa wajen hana COVID-19 saboda ba za a iya tsammanin samun rigakafi ba har zuwa 2021 da wuri-wuri, babban abin da ke cikin gudanar da COVID-19 shine rage cutar ta ƙarshe, wanda ake kira flattening.
CDC ta kuma ba da shawarar cewa mutane su wanke hannuwansu da sabulu da ruwa na akalla dakika 20, musamman bayan sun je bayan gida ko kuma hannuwansu sun ƙazantu, kafin cin abinci da kuma bayan sun shafa hanci, sun yi haushi ko sun yi tawaye.
Har ila yau, ya ba da shawarar yin amfani da kayan tsabtace hannu na tushen giya wanda ya ƙunshi aƙalla 60% barasa, amma kawai idan sabulu da ruwa ba su samuwa nan da nan. Ga yankunan da ba a samun kayan tsabtace hannu na kasuwanci nan da nan ba, WHO tana ba da da dabaru biyu don samar da gida.
A cikin waɗannan dabaru, aikin antibacterial ya samo asali ne daga ethanol ko isoprophanol.
"Ana amfani da hydrogen peroxide don cire kwayoyin cuta a cikin giya; ba shi da ""abu mai aiki ga maganin hana kamuwa da cuta"."
Ana ƙara shi a matsayin mai sanyaya iska ta hanyar glacier.
Ana kula da mutane da kulawa mai taimako, wanda zai iya haɗa da maganin ruwa, ba da rai, da kuma tallafawa wasu manyan sassan da suka kamu.
CDC ta ba da shawarar cewa duk wanda ya yi zargin cewa yana dauke da cutar ya sa abin rufe fuska mai sauki.
An yi amfani da shi don magance matsalar rashin numfashi, amma amfanin sa har yanzu yana cikin la'akari.
Ana ba da shawarar kula da lafiyar mutum da kuma ingantaccen salon rayuwa da kuma abinci don inganta rigakafi.
Ƙarin magani zai taimaka wa waɗanda ke da alamun bayyanar cututtuka a farkon lokacin kamuwa da cutar. Hukumar lafiya ta duniya da Hukumar Lafiya ta kasar Sin sun ba da shawarwari don kula da waɗanda aka kwantar da su asibiti tare da COVID-19.
Masana ilimin likitancin Amurka da likitocin huhu sun tattara shawarwarin magani daga wasu cibiyoyi a cikin wani kayan aiki mai suna IBCC.
A watan Afrilu na shekarar 2020, babu takamaiman magani ga COVID-19.
Don bayyanar cututtuka, wasu likitoci suna ba da shawarar acetaminophen (paracetamol) maimakon ibuprofen don amfani na farko.
Dole ne a dauki matakan tsaro don rage yaduwar cutar, musamman a lokacin da tsarin kiwon lafiya zai iya fitar da saukad da kamar shigar da bututu ko amfani da na'urar numfashi ta hannu.
CDC ta ba da shawarar cewa a cikin kulawar da ke kula da COVID-19 a cikin gidajen lafiya, a cikin ƙarin amfani da matakan tsaro, matakan tuntuɓar da kuma matakan yaduwar cutar ta iska, a sanya mutum a cikin dakin keɓewar cutar ta iska (AIIR).
Abubuwan da aka ba da shawarar: PPE, mai ɗaukar numfashi ko abin rufe fuska, kayan kariya ga idanu, da safofin hannu na likita.
An amince da kayan numfashi na N95 don ƙungiyoyin masana'antu, amma FDA ta amince da masks don amfani a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
An tsara su don kare su daga ƙwayoyin iska kamar ƙura, amma ba a ba da tabbacin ingancin su a kan takamaiman wakili na halitta don amfani da shi ba.
CDC ta ba da shawarar yin amfani da abin rufe fuska a lokacin da babu abin rufe fuska, ko kuma a ƙarshe, ana iya amfani da abin rufe fuska na gida.
Yawancin masu cutar COVID-19 ba su da mummunan yanayin da zai iya buƙatar numfashi ko maye gurbin, amma akwai wasu kashi.
Ana nazarin nau'in tallafin numfashi ga mutanen da ke da matsalar numfashi ta COVID-19 tare da wasu shaidu cewa ana iya guje wa shiga cikin asibiti tare da babban jijiyoyin jijiyoyin jini ko matsin lamba mai kyau na iska mai matsin lamba.
Ba a san ko waɗannan abubuwa biyu suna da amfani iri ɗaya ga waɗanda suke da ciwo mai tsanani ba.
Wasu likitoci suna son injin numfashi mai guba (invasive mechanical ventilation) lokacin da ake samun sa, saboda wannan fasaha tana hana yaduwar kwayoyin cuta idan aka kwatanta da bututun hanci mai zurfi (hyflow nasal cannula).
Yawancin ƙasashe masu tasowa ba su da isasshen asibiti na asibiti na mutum, wanda ke iyakance ikon cibiyoyin kiwon lafiya na kula da marasa lafiya na COVID-19 waɗanda ke buƙatar izinin asibiti mai saurin tashi.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na mutanen da aka shigar da su a cikin asibitocin gaggawa, kashi 2.3 cikin 100 na mutanen da ke bukatar taimakon injin iska, da kuma kashi 1.4 cikin 100 na mutanen da suka mutu.
Kashi 30 cikin 100 na mutanen da suka kamu da COVID-19 a kasar Sin da ke asibitoci a ƙarshe suna shiga cikin ICU.
COVID-19 ya haifar da ciwon cutar ta hanyar numfashi mai tsanani (ARTS) wanda ke haifar da wahalar oxygenation wanda ke haifar da rikitarwa ga iska.
Ana buƙatar matsin lamba da kuma kayan numfashi na AI masu ƙwarewa na PEEP don rage haɗarin cutar huhu da ke tattare da iska da kuma cutar huhu ta pneumothorax da kuma ƙara yawan iskar oxygen.
Tsoffin masu iska na iya rasa babban PH.E.P.
An fara binciken yiwuwar magani a watan Janairun 2020 kuma ana gwada magungunan rigakafin cutar a asibiti.
Redesvir yana da kyakkyawan fata.
Ko da yake zai iya ɗaukar har zuwa 2021 don samar da sababbin magunguna, yawancin magungunan da ake gwadawa an riga an amince da su don wasu aikace-aikace ko kuma suna cikin gwajin ci gaba.
Ana iya gwada maganin rigakafi a cikin marasa lafiya masu tsanani.
Hukumar ta FDA ta ba da izinin wucin gadi ga mai cutar da aka yi wa ruwa a matsayin magani na gwaji a lokuta da rayuwar mutum ke da tsanani ko kuma nan take.
Ba a gudanar da bincike na asibiti ba don tabbatar da cewa yana da lafiya da kuma amfani ga cutar.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani app na wayar hannu domin magance yaduwar cutar
Ana buƙatar masu amfani su shigar da sunayensu da lambar ID.
Wannan app na iya gano idan akwai kusanci da bayanan sa ido kuma yana gano yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya duba matsayin sauran masu amfani uku.
Aikace-aikacen ba kawai yana ba da shawarar yin zaman lafiya ba amma yana faɗakar da hukumomin kiwon lafiya na gida idan an gano haɗari. Bayanan wayar hannu, fasahar gano fuska, gano wurin wayar hannu da kuma ilimin kere-kere suna ba da damar gano mutanen da ke da cutar, da kuma sanin wanda suka tuntube a Koriya ta Kudu, Taiwan, da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta taimaka wa hukumomin tsaro wajen saka idanu kan bayanan wayar salula na mutanen da ake zargin suna dauke da cutar coronavirus.
An dauki wannan matakin ne don aiwatar da keɓewa da kuma kare wadanda zasu iya tuntuɓar 'yan ƙasa da suka kamu.
A watan Maris na shekarar 2020, Deutsche Telecom ta raba bayanan da aka hada da kamfanin Robert Koch na gwamnatin tarayya ta Jamus don gudanar da bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar fuska don gano masu keta dokar ware.
"Kwamishinan lafiya na yankin Italiya, Giulio Galeira, ya ce an sanar da shi ta hanyar masu samar da sabis na wayar hannu cewa ""40 cikin dari na mutane suna ci gaba da tafiya""".
Gwamnatin Jamus ta gudanar da taron karshen mako na tsawon sa'o'i 48 tare da masu halarta sama da 42.000.
Shugaban Estonia, Kersti Kalijulaiyu, ya yi kira ga dukkan duniya da su yi aiki don hana yaduwar cutar.
Mutane na iya fuskantar azaba daga keɓewa, ƙuntatawa a kan tafiya, sakamako masu illa na magani, ko tsoron kamuwa da cuta.
BBC: Rory O'Connor, ya nuna cewa karuwar warewar zamantakewa, kadaici, damuwa game da lafiya, damuwa da tattalin arziki da kuma koma baya sune guguwar da ta dace da za ta iya cutar da lafiyar mutum da kuma lafiyar jiki.
Wannan cuta na iya faruwa a cikin yanayi mai kyau tare da wasu alamomi ko ba tare da bayyanar cututtuka ba, wanda zai iya zama kamar sauran cututtukan numfashi na sama kamar sanyi na yau da kullum.
Matsakaicin sakamako na iya warkewa cikin makonni biyu, yayin da waɗanda ke da cututtuka masu tsanani ko kuma masu rikitarwa na iya ɗaukar makonni uku zuwa shida don warkewa.
Bayanai daga wasu ƙwayoyin cuta kamar SARS da MERS sun nuna cewa mata masu juna biyu na iya samun haɗarin kamuwa da COVID-19 mai tsanani, amma bayanai na COVID-19 ba su da iyaka. A wasu mutane, COVID-19 na iya shafar huhu kuma ya haifar da cutar pneumonia.
A cikin mutanen da ke da mummunan rauni, COVID-19 na iya hanzarta ci gaba zuwa cututtukan numfashi mai tsanani (ARDS), wanda zai iya haifar da rashin numfashi, tashin hankali, ko kuma rashin aiki.
Matsalolin da ke tattare da COVID-19 sun hada da cutar jini, rashin ƙarfi da kuma cututtukan zuciya, koda da hanta.
An bayyana rashin lafiyar jiki, musamman karuwar lokacin prothrombin, a cikin kashi 6% na masu asibiti da COVID-19, yayin da kashi 4% na waɗannan marasa lafiya ke da rashin aikin koda.
Kimanin kashi 20-30% na mutanen da ke kamuwa da COVID-19 suna da karuwar ƙwayar hanta (transmins).
A cewar wannan rahoton, matsakaicin lokacin da ake nuna alamun cutar da mutuwa shine kwanaki 10, daga cikinsu kwanaki biyar ana kwantar da su a asibiti.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin kwanaki bakwai tsakanin shigar da su asibiti da mutuwa.
A cikin binciken farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, kuma daga kwanaki shida zuwa kwanaki 41 a gaba ɗaya.
A wani bincike da hukumar lafiya ta kasar Sin ta gudanar, an samu mace-mace da kashi 2.8 cikin dari a maza, mata kuma da kashi 1.7 cikin dari.
Binciken da aka yi na istopathologic na samfurori na huhu a cikin gawawwakin ya nuna lalacewar haƙori wanda zai iya yaduwa ta hanyar zubar da jini ta hanyar zubar da jini a cikin huhu biyu.
An gano cewa an samu wasu canje -canje a cikin ƙwayoyin cuta na ƙwayoyin cuta.
Hoton huhu ya yi kama da na cututtukan huhu masu tsanani (ARDS).
Hukumar lafiya ta kasar Sin ta ce, an samu karuwar yawan mutuwar da suka kai kashi 11.8 cikin dari, ciki har da cututtukan zuciya da kuma ciwon zuciya.
A cewar bayanan watan Maris na Amurka, kashi 89% na wadanda aka kwantar da su asibiti suna da rashin lafiya na baya. Samun albarkatun kiwon lafiya da tattalin arzikin yanki na iya shafar mutuwar.
Saboda bambancin yankuna, amma saboda matsalolin tsari, ƙididdigar mutuwa ta bambanta daga wannan yanayin.
Idan ba a yi la'akari da yawan marasa lafiya ba, hakan zai sa yawan mutuwar ya yi yawa.
Amma, mutuwar da aka samu daga cututtukan da suka gabata na iya nuna cewa an rage yawan mutuwar da ake samu a yanzu.
Masu shan sigari suna da damar da ta fi girma na samun alamun COVID-19 sau 1.4 kuma suna da kusan damar da ta fi girma na buƙatar magani mai tsanani ko mutuwa sau 2.4 idan aka kwatanta da waɗanda ba sa shan sigari.
Hukumar asibitocin Hong Kong ta gano cewa a wasu mutanen da suka warke daga cutar, ƙarfin huhu ya ragu da kashi 20 zuwa 30 cikin dari, kuma hotunan hotunan huhu sun ba da shawarar cewa cutar ta lalace.
Wannan zai haifar da bayyanar cututtuka bayan an warke.
A watan Maris na 2020, ba a san ko yana ba da tasiri da rigakafi na dogon lokaci ga mutanen da ke warkewa daga cutar da ta gabata ba.
Ana ganin cewa rigakafin zai iya kasancewa dangane da halayyar sauran coronavirus, amma an sanar da cewa waɗanda suka warke daga COVID-19 sun sami gwajin da ya dace da coronavirus a baya.
Ana ganin cewa marasa lafiya sun fi samun cutar ta yau da kullum fiye da sake kamuwa da ita.
Ana ganin cewa cutar ta samo asali ne daga dabba ta hanyar kamuwa da cutar ta kai tsaye.
Ba a san ainihin asalinsa ba, amma har zuwa Disamba 2019, cutar ta kasance tana yaduwa daga mutum zuwa mutum.
A cikin binciken da aka buga a cikin The Lancet a watan Janairun 2020, na farko da aka tabbatar da cewa an kamu da COVID-19, an bayyana ranar farko da alamun suka bayyana a matsayin 1 ga Disamba, 2019.
Hukumar lafiya ta duniya (WHO) ta fitar da sanarwar cewa a ranar 8 ga watan Disamba na 2019 ne aka fara gano alamun cutar.
Ana amfani da hanyoyi da yawa don ƙididdige mutuwar.
Wadannan lambobi sun bambanta dangane da yankuna da lokaci, kuma suna shafar halaye na yawan jama'a kamar su yawan gwajin, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da aka fara kamuwa da cutar da kuma shekaru, jinsi, da kuma lafiyar gaba ɗaya.
A ƙarshen 2019, Hukumar Lafiya ta Duniya ta sanya alamun cutar ICT-10 na gaggawa a matsayin U07.1 ga mutuwar SARS-CoV-2 da aka tabbatar da lab da cutar da cutar da aka gano ta hanyar likita ko cutar ta hanyar COVID-19 ba tare da cutar SARS-CoV-2 da aka tabbatar da lab ba.
A cewar bayanan daga Jami'ar Johns Hopkins, adadin kamuwa da cutar da ya shafi duniya-da-mutuwa ya kai kashi 6.9% (1,53,822/2,24,0191) a ranar 17 ga Afrilu, 2020.
Yawan ya bambanta ta hanyar yanki. Sauran matakan sun haɗa da kamuwa da cutar (CFR) wanda ke nuna yawan mutanen da suka kamu da cutar da ke mutuwa daga cutar (wanda aka gano da wanda ba a gano ba) da kuma kamuwa da cutar (IFR) wanda ke nuna yawan mutanen da suka kamu da cutar da ke mutuwa daga cutar.
Wadannan kididdigar ba su da iyaka kuma hanyar da za a iya yin maganin ita ce bin wani rukuni na mutane da suka kamu da cutar.
Ko da yake ba a samar da maganin rigakafi ga kowa ba, kasancewa da maganin zai iya ba da bayani game da yawan mutanen da suka kamu.
A tsakiyar annobar da ta barke a Italiya, mutane 4,60,080 (1.7%) sun riga sun mutu a karamar kauyen Castiglione di Ada.
A Kankel, cutar ta bazu ne ta hanyar bukukuwan Carnival, kuma ta bazu ga matasa, ta haifar da ƙananan mutuwar, kuma ba a tsara dukkan mutuwar COVID-19 ba.
Ƙari ga haka, tsarin kiwon lafiya na Jamus ba shi da yawa.
A cikin Netherlands, an kiyasta cewa kashi 3 cikin 100 na mutane suna da rigakafi.
An tabbatar da mutuwar 69 (kashi 0.004%) daga COVID-19.
Sakamakon cutar da kuma mutuwar ta bambanta ga maza da mata.
A cikin binciken da aka yi a China da Italiya, maza ne suka fi mutuwa.
A cikin maza, akwai haɗari a cikin shekaru 50, kuma a tsakanin maza da mata, akwai kawai kusan shekaru 90.
A kasar Sin, yawan mutuwar mata da maza ya kai kashi 2.8 cikin 100 kuma mata ya kai kashi 1.7 cikin 100.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma akwai yiwuwar cewa akwai wasu abubuwa masu yawa da suka shafi hali da kuma hali.
Rashin rashin lafiyar da ke tattare da jima'i, rashin shan sigari a cikin mata, da kuma bayyanar cututtuka na jini a cikin maza a cikin matasan da suka fi mata, na iya haifar da ƙarin mutuwa a cikin maza.
A Turai, maza sun kai kashi 57% na wadanda suka kamu da cutar da kashi 72% na wadanda suka mutu da COVID-19.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta kula da bayanan jima'i na kamuwa da cutar COVID-19 ba.
Bincike ya nuna cewa cututtukan cututtuka kamar Ebola, HIV, kamuwa da cuta mai tsanani da kuma SARS suna shafar maza da mata dabam-dabam.
Ma'aikatan kiwon lafiya, musamman ma ma ma'aikatan jinya, mata ne, kuma suna da mafi yawan damar kamuwa da cutar.
Hukumar lafiya ta duniya (WHO) ta sanar da cewa, a ranar 11 ga watan Fabrairun 2020 ne cutar ta zama "COVID-19".
Shugaban WHO, Tetros Adhanom Gabreyes, ya bayyana cewa CO na nufin Coronavirus, VI na nufin Virus, T na nufin cuta, kuma 19 na nufin 31 ga Disamba 2019 lokacin da aka fara gano yaduwar cutar.
An sanya sunan ne bisa ga shawarar kasa da kasa na hana sanya sunaye da nufin haifar da tabo don kauce wa nuna wani yanki na musamman (misali China), dabba ko rukuni na mutane.
"WHO ta yi amfani da ""COVID-19 virus"" da kuma ""COVID-19 virus"" a cikin sadarwa ta jama'a".
Ana kiran cutar da cutar da cutar ta coronavirus.
A lokacin farkon annobar a Wuhan, China, an san wannan cuta da cutar da ake kira Coronavirus da Wuhan Coronavirus.
A watan Janairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar sunayen tsakiya na 2019-Angov da 2019-Angov na cutar ta numfashi mai tsanani don cutar da cutar a matsayin sunayen tsakiya don wannan cutar da cutar a cikin 2015 ta jagora kan amfani da sunayen wurare don cututtuka da cututtuka.
An fitar da sunayen hukuma, COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayayyakin kiwon lafiya kamar na'urar wankewa da na'urorin numfashi.
Alal misali, a lokacin da asibiti na Italiya ke bukatar bawul na iska a gaggawa, kuma mai ba da sabis bai iya ba da lokacin da ya dace ba, wani kamfanin farawa na gida ya yi aikin injiniya kuma ya buga bawul 100 da ake bukata a cikin dare.
Bayan farkon barkewar COVID-19, ka'idojin da ba daidai ba da kuma bayanan da aka yi game da asalin cutar, girman cutar, rigakafi, magani da sauran fannoni sun fito fili kuma sun bazu cikin sauri a cikin shafukan yanar gizo.
Da alama mutane suna da ikon watsa cutar zuwa wasu dabbobi.
Wannan binciken ya kasa gano wata hujja game da karbar cutar a cikin alade, kaza da kaza.
Babu wani magani ko allurar rigakafi da aka amince da ita don magance cutar.
Binciken duniya kan alluran rigakafi da magunguna na COVID-19 yana gudana ne ta hanyar hukumomi, kungiyoyin ilimi da masu bincike na masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya (WHO) ta kaddamar da wani 'gwajin jituwa' don tantance tasirin maganin kwayoyin cuta guda hudu da ke aiki sosai dangane da ingancin da ake da shi a yanzu".
Babu alluran rigakafi a halin yanzu, amma kamfanoni daban-daban suna aiki sosai wajen samar da rigakafi.
Ana amfani da ayyukan da suka gabata na SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da ACE2 masu karɓa don shiga cikin ƙwayoyin mutum.
Ana yin bincike kan dabarun rigakafin guda uku.
Da farko, masu bincike sun yi niyyar samar da cikakken rigakafin cutar.
Yin amfani da irin wannan cutar, ko dai ta zama mara aiki ko ta mutu, yana nufin nuna rigakafin jikin mutum game da sabon kamuwa da COVID-19.
Hanyar ta biyu, na tallace-tallace na tallace-tallace, na nufin samar da rigakafin da zai sa rigakafin jikin mutum ya zama mai saurin kamuwa da cutar ga wasu ƙananan kwayoyin cutar.
Game da SARS-CoV-2, irin wannan bincike ya mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar kwayar ACE2.
Hanyar ta uku ita ce allurar nucleic acid (DNA) ko allurar RNA, wani fasaha na zamani don samar da allurar.
Ana buƙatar gwada gwajin rigakafin da aka samo daga waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar tare da masu sa kai hudu a Seattle.
Wannan rigakafin yana da lambar kwafin da ba ta da illa ta hanyar kwafin cutar da ke haifar da cutar. An ba da shawarar ci gaban rigakafin rigakafi a cikin samar da rigakafi don SARS-CoV-2 (SARS-CoV-2), amma yana da matukar damuwa.
A watan Afrilu na shekarar 2020, an gudanar da gwaji sama da 300.
Gwaje-gwaje bakwai sun kimanta maganin cutar malaria da aka riga aka amince da ita, ciki har da gwaje-gwaje hudu na hydroxychloroquine ko chloroguine.
A cikin binciken kasar Sin, ana samun maganin rigakafin da aka yi amfani da shi, kuma ana sa ran samun sakamakon gwaji na tara na uku akan Remdesvir a ƙarshen Afrilu.
Ana yin nazarin rigakafin cutar da ake samu don maganin COVID-19 da kuma masu ba da gudummawar magani har zuwa watan Afrilu 2020. Ana kimanta alluran rigakafin cutar da ake samu don magance COVID-19, wanda ya hada da Remdesivir, Chloroguine da Hydroxychloroquine, Lobinavir/Ridonavir da Ritonavir a hade da Lobinavir/Interferon Be.
Kamar yadda na Maris 2020, akwai shaidar wucin gadi na yin aiki da Remdesivir.
Akwai ci gaba a cikin asibiti ga marasa lafiya da ba a ba da izinin yin magani da Remdesivir ba.
Ana gudanar da gwaje-gwaje na asibiti na mataki na uku a Amurka, China da Italiya. Chloroguine, wanda aka yi amfani da shi don magance malaria, an yi nazari a kasar Sin a watan Fabrairun 2020 tare da sakamakon farko.
Duk da haka, akwai kira ga mai gudanar da bincike da ya yi aiki tare da su don sake yin nazari.
Hukumomin kiwon lafiya na kasar Korea da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwaya, ta ce, a daidai da a cikin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwaya, sun ba da Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwaya, sun nuna, sun ba da ake, kuma sun ba da ake da ake da ake da ake da'yan kwayar cutar, kuma sun nuna cewa, kuma sun nuna cewa, sau sau sau biyu sau biyu sau biyu sau sau biyu sau biyu sau biyu sau biyu sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine a kan shawarar likitoci masu kula da COVID-19. Interferon, ribavirin ko umfenovir suna cikin jagororin fitowar 7 na kasar Sin don amfani da su a kan COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban adadin ribavirin don hana cutar SARS-CoV-2.
An ba da shawarar ƙarin nitasoxaneid a cikin binciken Vivo bayan an tabbatar da ƙarancin hanawar SARS-CoV-2. Nazarin ya nuna cewa farkon furotin furotin na farko ta hanyar Transmembrane Protease Serine 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2.
Nazarin hydroxychloroquine ko chloroquine tare da ko ba tare da acetromycin ba yana da iyaka sosai kuma yana hana duniya ta likita karɓar su ba tare da ƙarin bincike ba. Oseldavir ba ya hana SARS-CoV-2 a zahiri kuma ba shi da wani sanannen matsayi a cikin maganin COVID-19.
Cytokine Storm na iya zama matsala a cikin matakan gaba na COVID-19 mai tsanani.
Akwai shaidu da ke nuna cewa hydroxychloroquine na iya samun halayen hawan iska na cytokine. Dosilizumab an haɗa shi a cikin jagororin kula da Hukumar Lafiya ta Kasa ta China bisa ga sakamakon karamin binciken.
A Italiya, an gudanar da gwajin gwaji na biyu a matakin kasa bayan an samu sakamako mai kyau a cikin marasa lafiya masu tsanani.
Yin amfani da gwajin jini na Ferritin don gano hadari na cytokine yana nufin fuskantar wasu irin wannan ci gaban da ake ganin ya haifar da mutuwar wasu daga cikin wadanda suka kamu.
A shekara ta 2017, FDA ta amince da maganin Interleukin-6 mai karɓa bisa ga nazarin da aka yi game da kamuwa da cutar ta gaba don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttan.
Har zuwa yau, babu wata hujja ta bazuwar da ta tabbata cewa dosilismap magani ne mai kyau ga CRS.
Ana neman canja wurin wasu abubuwa masu tsabta da kuma masu karuwa da ke samar da rigakafin rigakafin mutanen da suka warke daga COVID-19 ga waɗanda suke buƙatar su a matsayin hanyar da ba ta da allurar rigakafi don rigakafin rigakafi.
An yi amfani da wannan dabarar ne don gwada Sarkin tare da sakamakon da ba a tabbatar ba.
Yin amfani da kwayar cutar shine tsarin da ake tsammani na aiki wanda zai ba da damar yin amfani da maganin antiprotein mai aiki don kare kariya daga SARS-CoV-2.
Duk da haka, wasu hanyoyin da suka dace kamar antiprotein-based cellular cytotoxicity da / ko bacocytosis suna yiwuwa.
Sauran nau'ikan maganin anti-active, misali, amfani da anti-active analogues, suna ci gaba.
Ana iya ƙara samar da ruwan sama mai ƙonewa daga jini daga marasa lafiya da aka dawo da su da kuma samar da ruwan sama mai ƙonewa wanda ke dauke da takamaiman rigakafi ga wannan cutar don saurin amfani.
A cikin wannan labarin, an rubuta wasu cututtuka na cutar coronavirus da ke da alaƙa da su.
Likita Li Wenliang, likitan asibitin Wuhan, ya kamu da COVID-19 bayan ya sanar da yaduwar cutar.
